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Globally, cancers, diabetes mellitus and obesity have emerged as the major health and 
development challenges which are responsible for millions of deaths annually. 
Population-based prevention strategies have been advocated and adopted as a public 
health approach. However, unfortunately, no country has achieved their expected results 
in the past 30 years.  
An important way to control cancers, diabetes mellitus and obesity is to focus on reducing 
the risk factors associated with these non-communicable diseases. However, previous 
case or cohort studies into the risk factors associated with the three epidemics have 
controversial findings which may be the results of circumstantial study designs. It may 
be necessary to use broadly based ecological study to obtain new insights into the 
associations between risk factors and epidemic at population level. 
The international health organizations, such as the WHO and the International Diabetes 
Federation (IDF) monitor and publish country specific health data in relation to the cancer, 
diabetes and obesity. These data have been helping governments, policy-makers, 
funders and researchers track and investigate the priorities of health research and 
development based on public health needs and ensure that funds and resources are 
used to meet the priorities.   
In terms of tracking and investigating the risk factors of the epidemics, ecological studies 
have several advantages in study designs over case or cohort researches: 1) More risk 
factors can be included in the data analysis. 2) Cumulative/ prolonged effects of risk 
factors on epidemics can be considered in the studies through backdating the risk data. 
3) The data on risk variables used in ecological studies are objective because they are 
collected independent from epidemiological data. In patient-based surveys or 
anonymised clinical records people with any disease tend to exaggerate negative life 
events in comparison to people with average or good health. For instance, obese people 
may misinform how much sugar they have consumed trying to appear more cautious in 
their dietary choices than they really are.  
With the advantages of ecological studies, this thesis seeks to show that reduced natural 
selection, nutrition/diet and birth behaviour may be independent predictors of the modern 
noncommunicable epidemics. To achieve this, we collected and analysed data from 191 




Natural selection is considered a force of evolution that adapts populations to their 
environments. However, humans manipulated their environments and supplemented 
natural properties of their bodies by medical procedures and technologies, so that natural 
selection no longer is a force of adaptation. Its operation as a force differentiating 
reproductive success of individuals has been seriously relaxed. This allows practically 
any person to pass their genes to the next generation, thus leading to accumulation of 
deleterious mutations whose effects are controlled by artificial means. 
In Investigations 1-3, it is proposed that modern humans may not be naturally well 
adapted to the current environment because their survival capacity and “fitness” have 
been maintained by application of high levels of medical services, nutrition and public 
health advocacy. The studies were conducted through analysing correlations between 
relaxed natural selection indexed by the Biological State Index (Is) with incidence rates 
of cancers and Type 1 diabetes mellitus, and prevalence rates of sex-specific obesity.  
Meat has been advocated as one of the major contributors to obesity prevalence 
because it contains high energy component of fat. It is a fact that selective 
breeding, butchery and cooking which aim for leanness (more protein) have minimized 
the fat intake in our daily diet. However, meat is still reported as a contributor to body 
weight increase significantly because of its protein content.  
Investigation 4 hypothesized that meat protein in modern diet may have been providing 
energy surplus to our daily life which contributes to obesity. The hypothesis was 
examined through analysing the correlations between obesity prevalence and total meat 
and meat protein consumption respectively.  
Both meat and sugar (sucrose) in our daily diet contain the slower digested component 
and cause insulin resistance. However, it is widely accepted that sugar has been a major 
contributor to obesity. The role of meat in this regard has not been widely recognised. 
Investigation 5 compared the use of sugar and meat to predict obesity prevalence 
worldwide showing that meat availability predicts increase of obesity to the same extent 
as sugar availability. 
Red meat and processed meat have been proposed as the major predictors of prostate 
cancer, but those studies are circumstantial, and the findings are controversial. Total 
meat (flesh) has not been associated with prostate cancer.  
Investigation 6 postulated that total meat (flesh) may be an independent predictor of 
prostate cancer. This postulation was examined using country specific data, from a 




incidence rate of prostate cancer, with empirical, macro-level data collected from the 
major international organizations.        
Gluten has been considered as the trigger of a number of diseases. Worldwide, 
incidence of gluten-related diseases is increasing. Wheat, the storage proteins, is the 
main source of gluten, but the adverse effects of wheat on obesity have not been tested.  
Investigation 7 analysed and compared the associations between obesity prevalence 
and wheat, rice and maize, and identified that wheat is the hidden risk factor of obesity. 
Contrarily, consumption of maize and rice showed the protective role in obesity 
prevalence. Therefore, the adverse effects of wheat on increasing body weight may have 
been covered by maize and rice when cereals consumption is advocated as the healthy 
diet component.    
Previous studies into the relationship between low parity and risk of cancers revealed 
that the decreasing number of children born into a family was associated with the risk of 
cancers of the mother and a few other cancers of family members. However, these 
studies did not identify that parity may be the most influential predictor of breast cancer 
and ovarian cancer. Neither did these studies show that greater parity has the protecting 
effects on developing site cancers of family members.   
Investigation 8 hypothesized that greater family size may protect the whole family from 
developing cancers. The hypothesis was examined through analysing relationships 
between total fertility rate, indexing family size and incidence rates of male and female 
cancers.  
Investigations 9 and 10 analysed and compared the contributing effects of multiple risk 
factors of female breast cancer and ovarian cancer and identified that low parity (indexed 
by birth rate) may be the most influential risk factor of female breast cancer and ovarian 
cancers respectively.  
The information gathered from the ten studies reveals that 1) Reduced natural selection 
may be the significant predictor of cancer, Type 1 diabetes and obesity; 2) Meat 
consumption may be the risk predictor of obesity and prostate cancer; 3) Wheat may be 
a hidden contributor to obesity prevalence worldwide. 4) The number of children born 
into a family may be the strong predictor of female breast cancer and ovarian cancer and 
it may be associated with the cancer risk of all family members.   
In general terms, the investigations presented in this thesis show that “ecological 
analyses” of worldwide data confirm known relationships between some risk factors and 
incidence/prevalence of non-communicable diseases and can reveal new, hitherto 
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Chapter 1: Relaxed natural selection & global public health 
challenges 
 
Article 1/10: Cancer incidence increasing globally: The role of relaxed natural 
selection (Published at Evolutionary Applications 2017) 
 
Wenpeng You1, Maciej Henneberg1,2 
 
1 Biological Anthropology and Comparative Anatomy Unit, Adelaide Medical School, the 
University of Adelaide, Adelaide, SA, Australia,   
2 Institute of Evolutionary Medicine, University of Zürich, Zürich, Switzerland 
 
Published: Wenpeng You, Maciej Henneberg. Cancer incidence increasing globally: 
The role of relaxed natural selection. Evolutionary Applications, DOI: 10.1111/eva.12523 
 Correspondence: Wenpeng You  wenpeng.you@adelaide.edu.au   
 
Contextual Statement  
Natural selection is the key mechanism of evolution, which changes heritable traits 
characteristics of a population over generations.   
In the past 100-150 years, medical care advancement has reduced natural selection 
more than previously thought. It has been like a double-edged sword acting on human 
noncommunicable diseases. It saves the lives of those people with the non-
communicable diseases which have strong heredity. Meanwhile, it offers the 
opportunities for those people to pass on their deleterious genes/mutations to their next 
generation. With 4-5 successive generations subject to the reduced natural selection, 
the phenotype of the accumulated deleterious genes/mutations may be noticeable.  
We hypothesized and tested that reduced natural selection (indexed by opportunity for 
reproduction at population level) may be an independent predictor of incidence of 









Cancer incidence increase has multiple aetiologies. Mutant alleles accumulation in 
populations may be one of them due to strong heritability of many cancers. The 
opportunity for the operation of natural selection has decreased in the past ~150 years 
because of reduction of mortality and fertility. Mutation-selection balance may have been 
disturbed in this process and genes providing background for some cancers may have 
been accumulating in human gene pools. Worldwide, based on the WHO statistics for 
173 countries the index of the opportunity for selection is strongly inversely correlated 
with cancer incidence in peoples aged 0-49 and in people of all ages. This relationship 
remains significant when GDP, life expectancy of older people (e50), obesity, physical 
inactivity, smoking and urbanization are kept statistically constant for fifteen (15) out of 
twenty-seven (27) individual cancers incidence rates. Twelve (12) cancers which are not 
correlated to relaxed natural selection after considering the six potential confounders are 
largely attributable to external causes like viruses and toxins. Ratios of the average 
cancer incidence rates of the 10 countries with highest opportunities for selection to the 
average cancer incidence rates of the 10 countries with lowest opportunities for selection 
are 2.3 (all cancers at all ages), 2.4 (all cancers in 0-49 years age group), 5.7 (average 
ratios of strongly genetically based cancers) and 2.1 (average ratios of cancers with less 
genetic background). 
Keywords: Biological State Index, Mutations, Life expectancy, Cancer heritability 
Introduction 
Worldwide, cancer incidence rate has increased to make it the second leading cause of 
death after cardiovascular disease. Environmental factors, such as tobacco smoking, 
urbanization and its associated pollution and changing diet patterns together with 
increased wealth associated with better medical services and extended post-
reproductive life span have been considered responsible for this phenomenon. 
Prevention and treatment measures focusing on environmental factors have been 
implemented, but little progress in reducing incidence of cancers has been made [1].  
Malignant neoplasms are results of somatic mutations of certain genes [2, 3]. Studies 
investigating transmission of cancer susceptibility in family lines suggested genetic 
background for incidence of many types of malignancies [4]. It is possible, then that this 




Mutations are more common than previously thought [5-7]. For instance, it has been 
estimated that an average neonate has some 74 de novo point mutations [5, 8]. Multiple 
mutations may accumulate in genomes over time spanning just a few generations [9]. 
When selection against a certain mutation does not operate, the frequency of mutated 
alleles doubles every generation [10]. The mutation load is directly proportional to the 
mutation rate and inversely proportional to the rate of selection [10, 11]. Thus, when 
selection rates approach zero mutation load approaches infinity. These rates are 
expressed per generation. Human generations do overlap due to the length of the 
reproductive life span which in females is approximately 30 years. Assuming, for 
simplicity’s sake, zero selection, it can be shown that mutation load at a given locus can 
triple or quadruple during one century (2-3 generations).  In the recent past, selection 
operating in human populations has been significantly relaxed [8, 11, 12] by medical and 
fpublic health actions. This results in accumulation of mutations, especially mildly 
deleterious mutations. Interactions between alleles of various loci may magnify mutation 
rates including rates of somatic mutations that result in neoplastic cell growth because 
of the way DNA replicates and is repaired which is similar in germline and in somatic 
cells [8]. Combination of effects of mutations with relaxed selection produces a real 
possibility of deterioration of biological integrity of human organisms, observable in the 
time of a few generations in most advanced societies.  
Human morphological characteristics that have a heritable, polygenic background have 
been evolving during the Holocene very fast: e.g. rate of cranial capacity change was -
10.8 darwins while the cranial index (the ratio of braincase width to its length) changed 
at a rate of +65.2 darwins [13] and stature at +606.2 darwins [14]. These are polygenic 
characters with incomplete heritability, we cite them here as an illustration of how 
development of technological and social adaptations lowering natural selection rates in 
the last few millennia can influence the course of change in human biological 
characteristics.  
Natural selection is a process that differentiates reproduction of individual genomes into 
new generations depending on how genetic endowment of parents influences the 
number of offspring that will replace them in the future [15]. Following Fisher’s (1958) 
definition of the reproductive value, “Biological State Index (Ibs)” has been proposed to 




next generation. Ibs calculation combines data on mortality and fertility [9, 16-19]. The 









dx = the frequency of deaths at age x  
sx =the probability of not possessing the complete number of births at age x 
          𝜔: the age at death of the oldest member of the group 
Ibs expresses a probability for an average individual born into a population to pass on 
genes to the next generation. Index value of 1.0 means that there is no opportunity for 
natural selection through differential mortality because all individuals survive until the 
end of their reproductive period. 
This index is a more precise calculation than what Crow (1958) called the Pd [11]– 
proportion of individuals dying before reaching age of reproduction that is used to 
calculate the index of total selection due to mortality. For this index a “…source of error 
is that no allowance was made for women who died during the childbearing period after 
having one or more children.” [11]. In the Ibs such allowance is made by using sx and dx 
values for ages 15-49 years. By analogy to the Crow’s mortality index of Pd/Ps (where Ps 
is a proportion of individuals surviving to the reproductive age) an index of total 
opportunity for selection through differential mortality (including its portion during 
reproductive years) is constructed Is = (1-Ibs)/Ibs. Theoretically, following Fisher’s 
formulation, the opportunity for selection must include the variance of fertility, more 
precisely, this portion of the variance of fertility that is heritable Vf/x2 (where x is the 
average number of children per female surviving to the menopause and Vf variance of 
this number). In humans, however, heritable variance in actual fertility is very low even 
in couples who do not control family size. According to our study [20] of 7503 births from 
1525 Polish and American historical couples in 12 groups free of conscious birth control, 
the genetic variance of fertility is less than 0.01 of its squared mean. Furthermore, 




over 100 years and became widespread in at least the last two generations, further 
diminishing any heritable fertility differentials, the contribution of genetic variance in 
fertility to the opportunity for natural selection in humans is practically non-existent. 
Therefore, the use of Is measuring opportunity for selection through differential mortality 
provides sufficient approximation of the maximum selective pressures in modern human 
populations. 
The primary role of natural selection is that of the “janitor of the gene pool” purging 
deleterious mutations. In the past ~100 years, there has been a great reduction in 
mortality and in fertility that has been limiting the overall opportunity for natural selection 
[9, 17, 21]. It follows that genes potentially providing background for some cancers have 
been accumulating in various populations. Cancer incidence may be greater in those 
populations who have experienced less opportunity for natural selection.  
We hypothesise that in a global perspective, extent of relaxation of natural selection in 
various national populations may be positively correlated to greater cancer incidence.  
Materials and Methods  
The country specific variables were collected for this ecological study. 
1. Dependent variables: The GLOBOCAN 2012 estimates of incidence rates (C50) [22]  
We extracted the cumulative incidence rates of all cancers excl. non-melanoma skin 
cancer (C00-97, but C44) among people of all ages and people aged 0-49 years 
respectively for 184 countries. We also captured separate estimates of incidence rates 
of 27 site cancers from the same source of data for people of all ages. The site cancers 
are: Lip and oral cavity (C00-08), Nasopharynx (C11), Other pharynx (C09-10,C12-14), 
Oesophagus (C15), Stomach (C16), Colorectum (C18-21), Liver (C22), Gallbladder 
(C23-24), Pancreas (C25), Larynx (C32), Lung (C33-34), Melanoma of skin (C43), 
Kaposi sarcoma (C46), Breast (C50), Cervix uteri (C53), Corpus uteri (C54), Ovary (C56), 
Prostate (C61), Testis (C62), Kidney (C64-66), Bladder (C67), Brain (C70-72), Thyroid 
(C73), Hodgkin lymphoma (C81), Non-Hodgkin lymphoma (C82-85,C96), Multiple 
myeloma (C88+C90) and Leukaemia (C91-95). The cancer incidence rate indicates the 
number per 100,000 persons who were diagnosed with cancer in 2012. The rate was 
age-standardized using the world standard population to increase the comparability.  
Women age 50+ years enter menopause, which brings their fertility to zero. Female 
reproductive behaviour has been associated with various female cancers [23-25]. The 
Ibs reflects mortality up to the age 50 years, considered the end of the reproductive life 




means that natural selection we measure cannot “reach” beyond age 50 years. For these 
reasons, we included specifically the incidence rate of all cancers in the age range 0-49 
years (pre-reproductive and reproductive life span) since these cancers can directly 
produce mortality and fertility differentials influencing reproductive success of individuals.   
2. Independent variable: The index (Is = (1-Ibs)/Ibs) of natural selection opportunity at 
population level  
The Ibs was calculated [16, 17] with the data of the world fertility published by United 
Nations in 2008 [26] and the data of life tables published by World Health Organization 
(WHO) in 2009 [27].  
James Crow [11], based on the Fisher’s (1958) concept of the reproductive value [28], 
proposed to measure the total opportunity for natural selection (I) as the ratio of variance 
in offspring size of a couple (V) to the squared average offspring size of a couple (x2 ) 
that will replace parents in the next generation. In the application to human populations 
this approach encounters two problems. The first is the birth control, which is very 
substantial in many modern societies. The second one is the overlapping of generations 
due to long reproductive period of females and males. The first problem can be tackled 
by separating contributions of fertility and mortality to the opportunity for selection and 
using only the portion of selection resulting from mortality. According to Crow [11], the 
index of opportunity for natural selection through differential mortality (Im) is the ratio of 
individuals dying before reaching reproductive age (Pd) to the individuals surviving (Ps): 
Im= Pd/Ps. Since not all individuals surviving to reproductive maturity will survive through 
the entire reproductive life span, a correction for deaths during the reproductive period 
is needed. This is introduced in the form of the Biological State Index (Ibs) that combines 
age specific mortality (dx) with age specific opportunity for producing offspring in the 
future life (sx) (Figure 1) [16, 17]. The Biological State Index accumulates mortality data 
in the way similar to “survival” biometric function of the life table and depends on the 
distribution of age specific relative fertility expressed as the fraction of the Total Fertility 
Rate remaining to be produced by a person of age x. Multiplication of the Ibs value for a 
given population by the Total Fertility Rate of this population (number of children born by 
females surviving to the menopause) produces the Net Reproductive Rate, a 
generational measure of population growth. Details regarding Ibs are explained in several 
previously published studies [13, 16-19]. Henneberg (1980) [20] proposed that 
considering low heritable variance of fertility and the widespread birth control that allow 
us to neglect opportunity for natural selection through differential fertility, the index of the 




of this index, the less opportunity for natural selection exists. None of the three indices 
discussed here (Im, Ibs or Is) has any unit because they are ratios of offspring numbers or 
proportions and probabilities. Indices of the opportunity for selection measure the upper 
limit of the total selection pressure. Actual selection pressures can be lower because not 
all mortality differentials are heritable, but the magnitude of selection cannot exceed 
index values. Therefore, decreasing values of opportunity for selection indices certainly 
show reduction in possibility of selection to occur, while they do not measure the actual 
magnitude of selection that can be lower.  
Gross Domestic Product per capita (GDP), life expectancy of older people (e50), obesity 
(BMI ≥ 30 kg/m2) prevalence rate [29], physical inactivity prevalence rate [30-32], 
smoking and urbanization [30, 33-35] have been associated with cancer initiation. They 
were considered as the confounders when we conducted the data analysis in this study.  
3. The World Bank published data [36] on GDP   
GDP is used as the index of socio-economic level and it is expressed in per capita 
purchasing power parity (PPP in current international USD) in 2010. Socio-economic 
levels measured with GDP have been related to cancer incidence rate [22, 33, 37, 38].  
4. The United Nations Statistics Division estimates of the life expectancy [39]   
Increasing life expectancy of older people, indexing ageing in this study, has been 
considered as a factor possibly promoting increasing cancer incidence [40, 41]. 
Therefore, the life expectancy (e50, 1990-95) was extracted from abridged life tables 
(1950-2100) [39] published online by the United Nations.   
5. The WHO Global Health Observatory (GHO) data on estimated obesity prevalence 
rate, physical inactivity, smoking rate and urbanization [29]    
The obesity prevalence is expressed as the percent of population (2010) aged 18+ with 
Body Mass Index (BMI) ≥ 30 kg/m2.  
Physical inactivity is defined as the percent of a particular population attaining less than 
150 minutes of moderate-intensity physical activity per week, or less than 75 minutes of 
vigorous-intensity physical activity per week, or equivalent in 2010. 
Smoking is expressed as the percent of adults aged 15 years and over (age-
standardized rate) who smoked any tobacco product daily in 2010.  
Urbanization is expressed with the percent of total population living in urban areas in 




including diet with more energy dense components, such as high fat and high alcohol 
consumption in daily diet, and less physical exercise.   
Data Selection  
We used country specific cancer incidence rates, life tables and fertility rates (for Is 
calculation), GDP, life expectancy at 50 years of age (e50), obesity prevalence rate, 
physical inactivity prevalence rate, smoking and urbanization for all countries where data 
were available. We aligned cancer incidence rates with Is by country and we obtained a 
set of data consisting of 173 countries. Quality of the country-specific cancer estimation 
depends upon the quality and the amount of the information available for each country 
[42]. For data robustness check, we clustered the countries with “high quality” data as 
defined by the International Agency for Research on Cancer (IARC) [42], obtaining a 
subset of data comprising 64 countries. This smaller data set was analysed separately 
from the other set of data consisting of all 173 countries. Country specific GDP, life 
expectancy (e50), obesity prevalence rate, physical inactivity prevalence rate, smoking 
and urbanization were matched with the listing of 173 countries which have both cancer 
incidence rate and Is. Numbers of countries included in the analysis of relationships with 
other variables may have differed somewhat because all information was not uniformly 
available for all countries.     
All data included in this study were published by UN agencies. No ethical approval or 
written informed consent for participation was required.  
Data analysis 
Various statistical analysis methods were applied in this study to explore the correlation 
between Is and cancer incidence rates. Each country was treated as an individual subject 
in the analysis. To examine the correlation between Is and cancer incidence rates, the 
analysis proceeded in five steps: 
1. Pearson’s r and nonparametric correlations (Spearman’s “rho”) were used to evaluate 
the strength and direction of the correlation between all the variables. Pearson’s 
correlations and partial correlations were calculated using log-transformed (ln) variables 
to minimise non-homoscedascity of their distributions. Fisher’s z-transformation of 
correlation coefficients was used to assess significance of individual correlation 
coefficients values and of differences between correlation coefficients values. 
2. The independent relationships between Is and each cancer incidence rate for all ages 




controlled for the six variables, which are GDP [38], life expectancy (e50) [43-45], obesity 
prevalence rate [46] [45], physical inactivity prevalence rate [46], smoking [45, 46] and 
urbanization [46]. Life expectancy (e50) was not controlled for when the independent 
relationship between cancer incidence rate among the people aged 0-49 years and Is 
was studied because this potential confounder is not relevant to this group of people.    
We controlled for GDP not only because it stands for cancer treatment service, but also 
because it is associated with cancer diagnoses level. Therefore, we considered GDP as 
a potential confounder and controlled for in our data analysis, which may reduce the 
influence of GDP associated cancer diagnose rate.  
Urbanization, representing a major demographic shift, entails lifestyle changes, including 
diet with more energy dense components, such as high fat, high alcohol consumption, 
less vegetables and fruits in daily diet, and less physical exercise [30-32].  
Those individual (site) cancers whose incidence rates were significantly and negatively 
correlated to Is in partial correlation are classified as “cancers with strong genetic 
background”. Those individual cancers whose incidence rates were not significantly or 
negatively correlated to Is are called “Less genetic cancers”.    
Cohen’s f2 was used to calculate and to report the “effect size” in this study. 
3. Standard multiple linear regression (enter) was performed to describe the relationships 
between the outcome variables (all cancers among all ages and 0-49 years age group) 
and the explanatory variables (GDP, life expectancy (e50), obesity prevalence rate, 
physical inactivity prevalence rate, smoking [46] and urbanization [46]). Standard 
multiple linear regression (stepwise) was performed to identify the most significant 
predictors of all cancer incidence rates among all ages and 0-49 years respectively.  
Life expectancy of older people (e50) was not included as an independent predictor in the 
standard multiple linear regression analysis when we explored the relationships between 
all cancer incidence rate among the population aged 0-49 years and Is because this 
potential confounder is not relevant to this group of people.    
4. In order to demonstrate the universal association between all cancer incidence rate 
(all ages) and Is, we categorized the countries for correlation analyses based on: 1) the 
WHO regional classifications, Africa (AFR), Americas (AMR), Eastern Mediterranean 
(EMR), Europe (EU), South-East Asia (SEAR) and Western Pacific (WPR)  [47]; 2) the 
World Bank income classifications: high income, upper middle income, low-middle 
income and low income; 3) countries with the strong contrast in terms of geographic 




correlation in the six country groupings: the Arab World [48], countries with English as 
the official language (government websites), the Organisation for Economic Co-
operation and Development (OECD) [49], the Asia-Pacific Economic Cooperation (APEC) 
[50], Asia Cooperation Dialogue (ACD) [51] and the Southern African Development 
Community (SADC) [52]. In our analysis, we only included those countries for which we 
could access their data for the specific groupings. To a large extent, grouping countries 
for analysis may also allow us to align our findings against previous local or regional 
studies regarding heterogeneous cancer epidemiology due to various geographic 
locations and ethnicity.  
Socioeconomic level in different regions has been considered as the major contributor 
to regional variations of cancer incidence rates [22, 37, 38]. Therefore, the correlation 
coefficients between groupings in different socioeconomic levels were compared with 
Fisher’s r-to-z transformation.  
5. IARC-WHO has reported that GDP is associated with cancer incidence rate [22, 37, 
38, 53]. Naturally, this drove us to consider the incidence rate of all cancers (all ages) 
without the contributing effect of GDP. This allows us to explore the association between 
Is and incidence rate of all cancers (all ages) which excludes the contributing effect of 
GDP.  
Scatter plots (simple regression analysis) were used to explore and visualize the 
correlations between all cancer incidence rate (all ages) and Is. The strength and form of 
the relationship between incidence rate of all cancers (all ages) and Is was analysed 
using actual values of the two variables. The equation (y = -41.97ln(x) + 36.831) of the 
best fitting trendline (logarithmic) displayed in the scatter plots analysis of relationship 
between GDP and all cancer (all ages) incidence rate was used to calculate and remove 
the contributing effect of GDP on all cancer (all ages) incidence rate. This allowed us to 
obtain a new dependent variable “Residual of all cancer (all ages) incidence 
standardised on GDP”. The relationship between Is and “Residual of all cancers (all ages) 
incidence standardised on GDP” was explored with scatter plots (Figure 2).  
In order to assess the magnitude of possible changes in the incidence of cancers due to 
relaxation of natural selection we have calculated a “rate of incidence increase” by 
dividing the average incidence rates in the 10 countries with the lowest Is values by the 
average incidence rates in the 10 countries with the highest Is values. These rates allow 
us to estimate to what extent alteration of the mutation-selection balance over short 
periods could be responsible for the change in incidence. This is an approximate 




Pearson, non-parametric and partial correlations, and the multiple linear regression 
analysis were conducted using SPSS v. 22 (SPSS Inc., Chicago Il USA). Scatter plots 
and calculation of “Residual of all cancer (all ages) incidence standardised on GDP” were 
performed in Excel® (Microsoft 2016). The raw data are used for scatter plots and 
calculation of “Residual of all cancer (all ages) incidence standardised on GDP”. The 
significance value is recorded for each correlation, and significance level is kept at the 
0.05, but 0.01 and 0.001 levels can be found from the reported actual significance values. 
Standard multiple linear regression analysis criteria were set at probability of F to enter 
≤ 0.05 and probability of F to remove ≥ 0.10. 
Results  
The relationship between Is and all cancer incidence was negative and strong 
(R2=0.5435, Figure 1).  
Figure 1. The relationship between Is and all cancer incidence rate (all ages) 
 
When the contributing effect of GDP on all cancer incidence rates was removed, Is was 
still in negative and significant correlation to all cancer incidence (R2=0.1187, Figure 2).    
































Figure 2. The relationship between Is and residual of all cancer incidence rate (+50, all ages) 
standardised on GDP   
 
Globally, Is was significantly and negatively correlated to the incidence rates of all 
cancers at all ages (r=-0.738, p<0.001) and at 0-49 years (r=-0.719, p<0.001) in 
Spearman rho analysis (Table 1). This relationship trend remained (r=-0.319, p<0.001 
and r=-0.380, p<0.001 respectively) when we controlled for potential confounding effects 
of GDP, life expectancy, obesity, physical inactivity, smoking and urbanization in partial 
correlation analysis (Table 1). When exploring partial correlations of Is to individual 
cancers significant negative correlation was found for 15 out 27 site cancers (Table 1). 
Similar results were observed in the correlation analysis with the data comprising 64 
countries with “high quality” data (Table 1).  Rates of incidence increase for all cancers 
at all ages (2.3) and in 0-49 years age group (2.4) are practically the same, while for 
individual cancers these rates of incidence increase vary from fractional (=decrease) for 
cancers not significantly or not negatively correlated with Is to over 10 for some cancers 
significantly negatively correlated with Is. Overall, for cancers with the strong genetic 
background which were significantly negatively correlated with Is the average rate of 





















































incidence increase is 5.7 while for the less genetic cancers the average rate of incidence 
increase is 2.1.  
Relationships between Is and some site cancer correlations were illustrated in Figure 3. 
As can be seen, cancers that had predominantly external causes such as cervical cancer 
or oesophageal cancer showed no correlation to Is, while those with possible genetic 
background do correlate with Is. Partial correlation between Is and 15 cancers remained 
significant after removal of the confounding effects (Table 1) of the six potential 
confounders.  
The multiple linear regression model (Table 2) showed that, globally, Is had the greatest 
beta coefficient than the potential confounders in the “Enter” analysis, whereas the 
stepwise regression model identified Is as the most significant predictor of all cancers 
incidence rates among all ages and 0-49. Similar results were revealed after the multiple 
linear regression model was calculated within the dataset which only included those 64 




Table 1 Spearman rho and partial correlations between Is and all cancers incidence rates of all ages and 0-49, and 27 site cancers respectively 
  
Independent Variables (Cancer) 
All countries   Countries with “High quality” data 
Nonparametric  Partial   Nonparametric  Partial  




rho p n  r p df 
Effect 
Size 
All cancers (C00-97, but C44), all ages    -0.738 <0.001 173  -0.319 <0.001 98 0.113  -0.650 <0.001 64  -0.348 0.024 40 0.132 
All cancers (C00-97, but C44), 0-49 ǂ -0.719 <0.001 173  -0.380 <0.001 99 0.168  -0.607 <0.001 64  -0.446 0.003 41 0.248 
Bladder (C67)  -0.709 <0.001 173  -0.217 0.030 98 0.049  -0.571 <0.001 64  -0.248 0.114 40 0.065 
Brain (C70-72) -0.738 <0.001 170  -0.247 0.013 98 0.065  -0.389 <0.001 64  -0.405 0.008 40 0.196 
Breast (C50) -0.737 <0.001 173  -0.290 0.003 98 0.092  -0.723 <0.001 64  -0.300 0.054 40 0.099 
Cervix uteri (C53) 0.608 <0.001 173  0.071 0.485 98 0.005  0.407 <0.001 64  -0.040 0.803 40 0.002 
Colorectum (C18-21) -0.845 <0.001 173  -0.455 <0.001 98 0.261  -0.723 <0.001 64  -0.433 0.004 40 0.231 
Corpus uteri (C54) -0.674 <0.001 172  -0.337 <0.001 98 0.128  -0.528 <0.001 64  -0.405 0.008 40 0.196 
Gallbladder (C23-24) -0.509 <0.001 158  -0.226 0.024 98 0.054  -0.096 0.452 63  0.106 0.502 40 0.011 
Hodgkin lymphoma (C81) -0.666 <0.001 166  -0.270 0.007 98 0.078  -0.491 <0.001 64  -0.347 0.024 40 0.137 
Kaposi sarcoma (C46) 0.564 <0.001 120  0.325 0.004 76 0.118  0.286 0.052 47  0.275 0.128 30 0.082 
Kidney (C64-66) -0.850 <0.001 167  -0.485 <0.001 98 0.308  -0.562 <0.001 64  -0.425 0.005 40 0.221 
Larynx (C32) -0.448 <0.001 168  -0.144 0.154 98 0.021  0.005 0.966 64  -0.182 0.248 40 0.034 
Leukemia (C91-95) -0.800 <0.001 171  -0.392 <0.001 98 0.182  -0.585 <0.001 64  -0.352 0.022 40 0.141 
Lip and oral cavity (C00-08) -0.257 <0.001 173  -0.037 0.712 98 0.001  -0.359 0.004 64  -0.335 0.030 40 0.126 
Liver (C22) 0.300 <0.001 173  -0.033 0.745 98 0.001  0.041 0.750 64  0.136 0.392 40 0.019 
Lung (C33-34) -0.782 <0.001 173  -0.295 0.003 98 0.095  -0.483 <0.001 64  -0.244 0.119 40 0.064 
Melanoma of skin (C43) -0.482 <0.001 168  -0.155 0.124 98 0.025  -0.613 <0.001 63  -0.283 0.069 40 0.087 
Multiple myeloma (C88, C90) -0.663 <0.001 157  -0.236 0.018 98 0.059  -0.547 <0.001 64  -0.077 0.626 40 0.006 
Nasopharynx (C11)  0.221 <0.001 154  0.114 0.257 98 0.013  0.334 0.008 63  0.144 0.364 40 0.021 





Independent Variables (Cancer) 
All countries   Countries with “High quality” data 
Nonparametric  Partial   Nonparametric  Partial  




rho p n  r p df 
Effect 
Size 
Esophagus (C15)  0.009 0.907 172  0.132 0.189 98 0.018  0.008 0.951 64  -0.004 0.978 40 0.000 
Other pharynx (C09-10, C12-14) -0.347 <0.001 168  -0.091 0.367 98 0.008  -0.371 0.003 63  -0.263 0.093 40 0.074 
Ovary (C56) -0.608 <0.001 173  -0.309 0.002 98 0.106  -0.449 <0.001 64  -0.469 0.002 40 0.282 
Pancreas (C25) -0.802 <0.001 170  -0.453 <0.001 98 0.258  -0.602 <0.001 64  -0.396 0.009 40 0.186 
Prostate (C61) -0.498 <0.001 173  -0.114 0.260 98 0.013  -0.577 <0.001 64  -0.301 0.053 40 0.100 
Stomach (C16) -0.412 <0.001 173  -0.243 0.015 98 0.063  0.049 0.700 64  -0.281 0.072 40 0.086 
Testis (C62) -0.777 <0.001 153  -0.315 <0.001 98 0.110  -0.681 <0.001 64  -0.459 0.002 40 0.267 
Thyroid (C73) -0.684 <0.001 170  -0.322 <0.001 98 0.115  -0.346 0.005 64  -0.113 0.477 40 0.013 
GDP PPP 2010 -0.853 <0.001 168  - - - - - -0.760 <0.001 63  - - - - 
Life expect (e50), 1990-95 -0.822 <0.001 173  - - - - - -0.666 <0.001 64  - - - - 
Obesity -0.572 <0.001 173  - - - - - -0.003 0.984 64  - - - - 
Physical inactivity  -0.315 <0.001 132  - - - - - -0.103 0.453 55  - - - - 
Smoking, Daily any tobacco product -0.551 <0.001 123  - - - - - -0.234 0.086 55  - - - - 
Urbanization 2010 -0.712 <0.001 169  - - - - - -0.455 <0.001 64  - - - - 
ǂ Life expectancy (e50) was not controlled as it is not relevant in population aged 0-49 years old.  
Age Standardised Incidence Rate (ASR, All ages, World) per 100,000, GDP PPP is in per capita USD per year 








Is was correlated to incidence rate of all cancers (all ages) universally in all country 
groupings (Table 3). However, there was a tendency for the correlations to be stronger 
in the more developed country groupings than those in the less developed groupings. 
This trend was revealed in country groupings divided in consideration of geographic 
locations (5 WHO regions), income classifications (4 groups of the World Bank) and other 
factors, such as cultural backgrounds (Arab World, countries with English as official 
language) and international organizations (OECD, APEC, ACD, SADC).  
The more developed regions, Americas and Europe, had stronger correlations than 
those in other regions. Fisher r-to-z transformation revealed that the correlation between 
Is and incidence rate of all cancers (all ages) in Europe was significantly stronger than 
those in the three developing regions, Africa (z=4.41, p<0.001) and Eastern 
Mediterranean (z=3.8, p<0.001) and South-East Asia (z=2.78, p=0.0027). It was also 
revealed that in the World Bank income classifications, the correlation between Is and 
incidence rate of all cancer (all ages) in the upper middle-income grouping was 
significantly stronger than that in low income classification (z=2.48, p=0.0066).      
The correlation between Is and incidence rate of all cancers (all ages) in high income 
classification was not as strong as that in the upper middle classification. It was almost 





collected by the major international agencies (WHO, IARC and the World Bank) are fairly 
crude, and may contain some random errors arising from methods of reporting incidence 
of specific diseases, reliability of diagnoses and possible administrative errors. Thirdly, 
not all the contributing factors, such as alcohol consumption, can be included as the 
potential confounders in data analysis due to data availability or quality. Furthermore, 
the opportunity for natural selection is only measured with respect to postnatal mortality, 
while gametic selection and intrauterine mortality are not included [54]. Despite these 
limitations the findings in this study from different data analysis methods constantly and 
consistently showed significant correlation between reduced natural selection and all 
cancer incidence (all ages and 0-49 respectively) and incidence of most of site specific 
cancer groups, especially those for which genetic background may be expected. 
Obviously, the changes in the genetic code of the human populations may not fully 
explain the increasing cancer incidence rate. These changes may be cumulative, each 
one of minor effect, and may contribute to increasing cancer incidence together with 
other carcinogenic factors.   
Various genes contribute to cancer, e.g. proto-oncogenes can increase proliferation of 
mutated cells and tumour suppressor genes could inhibit self-regulation of abnormal cells, 
but their balance may still increase cancer incidence in various ways because these 
genes have pleiotropic effects. In this study, some of cancer groups have incidences that 
do not correlate with Is value, or even show reversed correlations (Table 1, Fig. 4). These 
include cancers of well-known viral causes – cervical cancer – immune problems related 
cancers like non-Hodgkin lymphoma, and cancers caused by toxins, like lip and oral 
cavity cancers. These cancers also have incidence “increases” below zero indicating 
their greater incidence in countries with larger opportunity for natural selection. This is 
most likely a result of countries with greater mortality having also poorer hygienic 
conditions and less medical services.    
While specific genes determining risks of specific cancers may be still unknown, the 
general tendency is clear – relaxation of natural selection allows accumulation of 
detrimental genetic material, especially if single detrimental alleles have mild effects [7]. 
Studies have shown that a partially heritable disease, phenylketonuria was only 
noticeable after being accumulated for several generations [9] with about 2% increase 
each [55]. Two recent studies also reported that relaxed natural selection has been 
contributing to the increasing prevalence of two non-communicable diseases, obesity 




human population. However crudely calculated our rates of “incidence increase” (Table 
1) indicate rates of increase compatible with alteration of mutation-selection balance. We 
only have at our disposal recent data, but it can be hypothesised that observed 
differences among countries in the opportunity for natural selection have existed for a 
few generations. With a simple accumulation of mutations under zero selection, the 
incidence rates should double every generation, when selection is not entirely relaxed, 
but still strongly limited, the increase will be somewhat less than double. Considering 
that declines in mortality in ‘developed’ countries started in the second half of the 19th 
century, we can estimate that changes in mutation-selection rates occurred over lifetime 
of some four, maybe five, generations. Incidence increases of all cancers (2.3-2.4) 
indicate approximately doubling over that time, while for cancers correlated significantly 
with Is the average increase is 5.7. Of course, not the entire incidence increase can be 
attributed to alteration in mutation-selection balance, because quality of data collection 
and reporting and presence of carcinogenic external factors may differ between the 10 
countries of the lowest opportunity for selection and 10 countries of the highest selection 
opportunity. Our choice of 10 countries of each kind, instead of only 5 or 20, also 
influences precision of the numerical indices calculated. What is important here is that 
the order of magnitude of incidence increases, and their positive relationship to the 
relaxation of selection, especially in cancers with supposed genetic background, are 
compatible with expectations of population genetics. In short – such increases in the 
incidence of cancers are possible upon significant relaxation of natural selection through 
differential mortality. 
Overall, cancer is an inheritable non-communicable disease due to its strong genetic 
background. Cancer genes may be cumulative at the reduced natural selection. Natural 
selection had an ample opportunity to eliminate defective genes introduced by mutations 
[9, 13, 17, 21, 56-59]. However, natural selection has been significantly reduced in the 
past 100-150 years, and the direct consequence of this process is that nearly every 
individual born into a population can pass genes to the next generation, while some 150 
years ago, only 50% or less of individuals had this chance [13, 59]. Therefore, population 
allowing more people with cancer genes survive reproduction cycle may boost cancer 
gene accumulation. For instance, genetic predisposition to childhood leukaemia exists 
[60]. Patients who survive it will have a chance to pass this predisposition to the next 
generation. Similar argument may be made with respect to other cancers occurring 
during pre-reproductive or reproductive period of life. Currently used cancer treatments 
are not targeting genetic causes of the disease but dealing with its phenotypic 




proliferation is curtailed by chemotherapy and radiation therapy. Although successful in 
a portion of cases, these treatments have side effects and do not deal directly with the 
cause of the disease, therefore, though undoubtedly helpful to a number of patients, they 
are not optimally effective.  
Table 3 showed that country groupings with higher socioeconomic level had stronger 
associations between Is and cancer incidence. This finding is consistent with the studies 
conducted by the WHO cancer research agent, IARC [22, 37, 38, 61]. Similarly, reduced 
natural selection and type 1 diabetes prevalence also showed stronger association in 
developed regions [18]. One of the explanations may be that people in developed regions, 
such as Europe and Americas have been able to access better health services, which 
has made them to escape natural selection more often and pass their detrimental genes 
onto their next generation. The long effect from escaping natural selection may allow 
those genes, including cancer related genes, to accumulate in those populations faster 
[9, 18, 55].  
The association between Is and cancer incidence was strong and significant in both 
Upper Middle and High income economic classifications (the World Bank). However, it 
was stronger in Upper Middle income economic classification. This may be attributable 
to: 1) Almost all people in the countries in High income grouping may be able to escape 
natural selection due to high level of health services. This is shown by the extremely low 
Is values of these countries, which are close to 0 (Supplemental Document 1). 2) Fast 
developing GDP in Upper Middle country grouping has driven their medicine level to 
develop quickly, which may have made more and more people escape natural selection.      
Conclusion   
Assuming that the increasing genetic load underlies cancer incidence as one of the 
contributing factors, the only way to reduce it remains genetic engineering – repair of 
defective portions of the DNA or their blockage by methylation and similar approaches. 
These techniques, though theoretically possible, are not yet practically available. They 
will, however, need to be developed since they provide the only human-made alternative 
to the disappearing action of natural selection since any eugenics-like approaches are 
ethically and morally reprehensible.   
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Contextual Statement  
Natural selection is the key mechanism of evolution, which changes heritable traits 
characteristic of a population over generations.   
In the past 100-150 years, the advanced medical care has reduced natural selection 
more than previously thought. It has been like a double-edged sword. It saves the lives 
of those people with type 1 diabetes which is featured with strong heredity. Meanwhile, 
it offers the opportunities for those people to pass on their genes of type 1 diabetes to 
their next generation. With 4-5 successive generations subject to the reduced natural 
selection, the phenotype of the accumulated type 1 diabetes genes/mutations may be 
noticeable. 
We hypothesized and tested that reduced natural selection (indexed by opportunity for 







Objective: Prevalence of type 1 diabetes disease (T1D) is increasing worldwide. We 
aim to test correlation of T1D prevalence to the reduced natural selection measured by 
Biological State Index (Ibs).  
Research Design and Methods: Country-specific estimates of type 1 diabetes 
prevalence, life expectancy, obesity prevalence rate, urbanization rates, per capita 
sugars consumption and per capita GDP were obtained. Ibs and country-specific 
longevity (e50) increase for each country were self-calculated. These data were then 
matched to T1D prevalence by country for our ecological study among 118 countries. 
Countries were also grouped to study the associations in different regions. SPSS v. 22 
was used for correlation analysis.     
Results: Worldwide, both Ibs and life expectancy at birth (Ibs proxy) were significantly 
correlated to T1D prevalence in Pearson r (r=0.713, p<0.001 and r=0.722, p<0.001 
respectively) and Spearman’s rho (r=0.724, p<0.001 and r=0.689, p<0.001 respectively). 
T1D prevalence was not correlated to longevity increase measured as life expectancy at 
50 years old. T1D prevalence was significantly associated with Ibs (r=0.307, p<0.001) and 
newborn life expectancy (r=0.349, p<0.001) independent of per capita total sugar 
consumption, per capita GDP, urbanization and obesity prevalence in partial correlation. 
Globally, both life expectancy at birth and Ibs exponentially correlated to T1D prevalence. 
Pearson correlations generally existed in different country categorizations by geographic 
region, culture background and economic status.  
Conclusions: Reduced natural selection may have contributed to the increasing T1D 
prevalence worldwide. T1D epidemiology study in total population may be the practical 
solution to identify the causes of increasing T1D prevalence. 
Key Words: Type I diabetes, Biological State Index, Epidemiology, Life expectancy, 
Insulin  
Background  
Type 1 diabetes (T1D) is an autoimmune disease with a strong genetic component [1, 
2]. It can occur at any age, but tends to develop in childhood [3], so it has long been 
called “juvenile diabetes”. T1D is characterized by destruction of pancreatic beta cells, 
culminating in absolute insulin deficiency [4]. As of 2014, an estimated 387 million people 
have diabetes worldwide [5], of which T1D accounts for between 5% and 10% [6]. 




with T1D [7]. Great efforts have been made to assess the incidence and prevalence of 
T1D. Unfortunately, the exact etiology and pathogenesis of T1D is still unknown. 
Generally, longitudinal or cross-sectional studies are often locally or regionally performed. 
Consequently, it is difficult to access generalizable results because the epidemiology of 
T1D is known to be heterogeneous regarding geography and ethnicity. Genetic 
predisposition to T1D is only alleged to explain some of the geographic variability in T1D 
occurrence, but it cannot account for its rapidly increasing frequency [8]. A number of 
studies have associated gross domestic product (GDP) level with T1D prevalence or 
incidence [8-11], but GDP does not fully explain variations and trends in T1D prevalence 
rates observed in many countries, for example Japan. It has been postulated that 
environmental factors may be able to trigger an autoimmune destruction of the beta cells 
leading to absolute dependence on insulin treatment [8, 9, 12-17], however, these 
environmental factors are circumstantial [13].  
Natural selection, as one of the basic mechanisms of evolution, is the differential survival 
and fertility of individuals due to differences in phenotype that reflect genetic differences. 
In our modern society, natural selection still acts on all members of a population, 
selecting those individuals that have an increased reproductive success (survival and/or 
fertility) [18]. The “Biological State Index (Ibs)” has been proposed to measure the 
populational reproductive success by taking into account potential loss of reproductive 
success by dying at age x, summed over all age categories [19, 20]. The Ibs is calculated 
by combining age-specific death frequency (dx variable of a life table) with an age-
specific reproductive loss (sx): 




Where: dx is the frequency of death at age x or represents the mortality rate. sx is the 
reproductive loss from dying at age x is measured sx, i.e. the estimated probability of not 
possessing the complete number of births at age x. sx is based on the cumulative number 
of births at specific ages [20, 21]. The construction and interpretation of the Ibs was 
predicated upon the assumption that heritability of human fertility variance is negligible 
[22].  
An Ibs value of one indicates total adaptation of the population to their environment (ability 
to overcome selection pressures that are present). An Ibs value of zero signifies a total 
lack of adaptation (inability to overcome selection pressures that are present), and an 
impossibility to give life to the next generation. An Ibs value close to zero indicates large 




surviving to produce offspring. In such a scenario there is a possibility for fast evolution, 
since many genes may not be passed to the next generation. An Ibs value close to one 
indicates that natural selection is not having much effect on the population since many 
individuals are able to maximally contribute to producing the next generation. Thus, the 
Ibs permits the estimation of the magnitude of the successful reproduction of a population.   
The genetic trait of T1D may allow individuals from a population to pass their T1D genes 
on to their next generation. What fraction of a population had a chance to fully participate 
in reproducing under a given set of mortality conditions may be associated with the 
proportion of population carrying T1D genes in the next generation. Previously, Stephan 
and Henneberg [23] raised a concern that the developed populations may have 
accumulated more unfavourable genes, such as T1D genes because natural selection 
(measured by the Ibs) has been greatly reduced. Recently, a systematic review concluded 
that the T1D prevalence rate was associated with age increase in population [3]. 
Therefore, the objective of the current paper was to use country specific data to test, 
from a global perspective, that population with greater Ibs value, fuelled by life expectancy 
at birth, may have higher T1D prevalence, using empirical, macro-level data collected 
from the major international organizations.   
Material and Method 
The dependent variable in the analysis was the country-specific estimate of T1D 
prevalence (sum of rates in 0-14 and 15+ years old groups) which were published by the 
International Diabetes Federation (IDF) in 2000 [24]. We used Ibs and life expectancy at 
birth of each country as the independent variables. The Ibs was calculated as proposed 
by Henneberg [20] and Henneberg and Piontek [19] with the fertility data of each country 
published by United Nations in 2008 [25] and the mortality data of life tables (2009) 
published by World Health Organization (WHO) in 2012 [26]. Life expectancy at birth is 
a proxy for Ibs since it expresses an opportunity of a newborn to survive to a specific age, 
which is usually an age falling into reproductive life span or above it. We extracted the 
country specific life expectancy (years) at birth by country published by WHO in 2013 
[27].  
GDP [8-11], urbanization [8] and body weight status [17] have been associated with T1D 
prevalence. It has been suggested that a population with greater sugar consumption may 
have greater diabetes (total) prevalence [28] and that sugar consumption may affect 
health of T1D patients [29]. Therefore, we controlled for market availability of sugars and 




Nations Food and Agricultural Organization (FAO) Food Balance Sheet, per capita gross 
domestic product (GDP expressed in purchasing power parity in 2010 US dollars for 
comparability among countries) and urbanization (percentage of population living in 
urban areas in each country in 2010) from the World Bank World Development Indicators 
Database, and obesity prevalence rate (percentage of the population aged 18+ years old 
with body mass index greater than or equal to 30 kg/m2 in each country 2010) from the 
WHO.    
No ethical approval or written informed consent for participation was required in this 
study as all the aforementioned data were freely downloaded from the United Nations 
agents’ websites.  
We aligned all independent variables and confounding factors with the country-specific 
T1D prevalence and obtained a set of data for 118 countries. All country specific data 
were put in a uniform format. Each country was treated individually, and all of their 
available information was analysed. Data of calculated Ibs and summary statistics are 
further described in the Supporting Information (Tables S1 & S2).  
In order to demonstrate the universal association between T1D prevalence and Ibs and 
life expectancy at birth respectively in different country groupings, we categorized the 
countries for correlation analyses based on 1) the WHO regional classifications [30]; 2) 
the strong contrast in terms of geographic distributions, per capita GDP levels and/or 
cultural backgrounds. We analysed the correlation in the six country groupings: Latin 
America and the Caribbean (LAC) [31], the Arab World [32], the Organisation for 
Economic Co-operation and Development (OECD) [33], European Economic Area (EEA) 
[34], Asia Cooperation Dialogue (ACD) [35] and the Asia-Pacific Economic Cooperation 
(APEC) [36]. In our analysis, we only included those countries for which we could access 
their data for the specific groupings.  
To a large extent, grouping countries for analysis may also allow us to align our findings 
against previous local or regional studies regarding heterogeneous T1D epidemiology 
due to various geographic location and ethnicity.   
It might be considered that T1D prevalence is a result of the increase in longevity rather 
than relaxed natural selection of the genetic background of T1D since general health and 
advances in medical care improve survival of T1D patients. This consideration is clarified 
by much stronger correlation between T1D prevalence and Ibs than that between T1D 
and life expectancy (e50) increase (across two periods of 1950-55 and 2005-10). The 




expectancy based on this segment of the population may not be biased with child (0-15 
years) mortality, in particular due to deaths caused by T1D disease, and 2) that deaths 
of adults, especially females, during the reproductive life span (15-50 years) that may 
differentiate numbers of T1D genes passed on to new generations. Thus, we obtained 
country specific life expectancies (e50) for the periods of 1950-55 and 2005-10 
respectively from the WHO life tables [37]. And then we calculated the life expectancy 
increase from the period of 1950-55 to the period of 2005-10 for each country producing 
a new variable, which is “life expectancy increase (e50, 1950-2010)” for each country 
across the 55 years. We repeated the above correlation analysis after we replaced the 
variable of “life expectancy at birth” with life expectancy increase (e50, 1995-2010).    
Pearson’s correlation coefficient, Spearman’s rho and partial correlation analyses were 
conducted using SPSS v. 22 (SPSS Inc., Chicago Il USA). In this study, the data were 
log transformed for correlation analysis in SPSS.   
Results  
Worldwide T1D prevalence was in significant associations with Ibs using Pearson r 
(r=0.713, p<0.001) and Spearman’s rho (r=0.724, p<0.001) respectively. The similar 
associations were also observed between T1D and life expectancy in Pearson model 
(r=0.722, p<0.001) and Spearman’s model (r=0.689, p<0.001) respectively (Table 1). 
Further investigation with partial correlation analysis showed that worldwide the 
association between T1D prevalence was still strongly associated with Ibs (r=0.307, 
p<0.001) and life expectancy (r=0.349, p<0.001) when we controlled for per capita total 
sugars availability, per capita GDP, urbanization and obesity prevalence (Table 1). All 
confounders were in significant associations with T1D prevalence rate in both Pearson r 
and Spearman’s rho.  
 Table 1: Global associations between T1D prevalence rate and Ibs and life expectancy (years) at 
birth respectively 
 Pearson's r    Spearman’s rho  Partial Correlation  
 R n  r n  r df 
Log Ibs 0.713 118  0.724 118  0.307 103 
Log Life Expectancy at birth 0.722 118  0.689 118  0.349 103 
Log Sugars per capita 0.666 109  0.534 109  - - 
Log GDP per capita 0.720 116  0.749 116  - - 
Log BMI ≥ 30 prevalence 0.636 109  0.538 118  - - 
Log Urbanization 0.507 118  0.567 118  - - 
* All correlations are significant at the 0.001 level (2-tailed).  





Table 2 presented that Europe had the significant associations with Ibs (r=0.502, p=0.001) 
and life expectancy (r=0.610, p<0.001) respectively. The sub-Europe (EEA) also had the 
very strong associations of T1D prevalence to both Ibs (r=0.479, p=0.009) and life 
expectancy (r=0.574, p=0.001) (Table 3). We observed the slightly negative correlations 
of T1D prevalence rate to the Ibs and life expectancy respectively in two Asian country 
groupings, SEARO (South-East Asia) and the ACD (Table 3). Both Ibs and life expectancy 
were insignificantly associated with T1D prevalence rate in other four WHO regions, 
AFRO, AMRO, EMRO and WPRO (Table 2).  
Table 2 Associations between T1D prevalence and Ibs and life expectancy (years) at birth 
respectively in the WHO regions 
WHO Region 
Ibs  Newborn Life Expectancy 
Pearson's r Significance  Pearson's r Significance 
AFRO (n=21) 0.343 0.128  0.214 0.351 
AMRO (n=28) 0.145 0.461  0.173 0.380 
EMRO (n=15) 0.783 0.001  0.541 0.037 
EURO (n=38) 0.502 0.001  0.610 <0.001 
SEARO (n=5)   -0.479 0.415  -0.436 0.463 
WPRO (n=11) 0.345 0.298  0.330 0.322 
 
Table 3 showed that the T1D prevalence rate was associated with both the Ibs and 
newborn life expectancy in the groupings consisting of countries with similar cultures 
(Arab World and EEA) and different cultures (APEC and OECD), with similar economy 
status (OECD) and those with economy status in disparity (APEC), and with the 




Table 3 Associations between T1D prevalence rate and both the Ibs and life expectancy 
(years) at birth in different country groupings categorized considering their soci-
economic, geographic location and cultural backgrounds   
Country Grouping 
Ibs  Life Expectancy at birth 
Pearson's r Significance  Pearson's r Significance 
APEC (n=16) 0.340 0.197  0.369 0.160 
Arab World (n=13) 0.748 0.003  0.469 0.106 
EEA (n=29) 0.479 0.009  0.574 0.001 
ACD (n=20) -0.268 0.253  -0.392 0.087 
OECD (n=34) 0.365 0.034  0.155 0.382 
LAC (n=26) 0.524 0.006  0.044 0.831 
 
Table 4 showed that in general T1D prevalence is not correlated to longevity increase, 
but strongly correlated to Ibs at country level. Life expectancy increase (e50, 1950-2010) 
does not correlate significantly with T1D prevalence in Pearson correlation (r=0.165, 
p=0.079) or Spearman’s rho (r=0.166, p=0.077). These contrasted with the correlation 
between Ibs and T1D prevalence in Pearson correlation (r=0.713, p<0.001) and in 
Spearman rho (r= 0.724, p<0.001) respectively. In partial correlation analysis, when we 
controlled for GDP, BMI≥30, urbanization and sugars intake, T1D was negatively and 
insignificantly correlated to life expectancy increase (e50, 1950-2010) (r=-0.070, 
p=0.487), but it was in strong and significant correlation to Ibs (r=0.276, p=0.005).   
 
Table 4: Comparing correlations between type 1 Diabetes prevalence and Ibs and life 
expectancy increase (e50)  
 Pearson's r    Spearman’s rho  Partial Correlation*  
 r p n  r p n  r p df 
Log Ibs 
0.713 <0.001 118 
 
0.724 <0.001 118 
 
0.276 0.005 98 
Log Life expectancy (e50) 
increase 
0.165 0.079 114 
 





Log Sugars per capita 0.666 <0.001 109  0.534 <0.001 109  - - - 
Log GDP per capita 0.720 0.720 116  0.749 <0.001 116  - - - 
Log BMI ≥ 30 prevalence 0.636 <0.001 109  0.538 <0.001 118  - - - 






The worldwide trend of increased T1D prevalence likelihood has multiple etiologies, 
which may act through multiple mechanisms. By assessing the T1D prevalence rate data 
for 118 countries we have shown that globally and regionally population which had 
greater value of Ibs (less opportunity for natural selection) may have greater T1D 
prevalence and secondly, that newborn life expectancy was significantly associated with 
T1D prevalence rate at population level.  
Overall, the operation of natural selection on contemporary populations is declining due 
to modern medicine [23], but the magnitude of the decline may differ between countries 
due to their specific level of sanitation, medical interventions and public health measures. 
Natural selection is still one of the major evolutionary forces that informs changes in gene 
frequencies in a population through the action of differential fertility and mortality over 
generations [38]. For example, studies have shown that the increasing prevalence rates 
of a partially heritable disease, nasal septa and lacrimal bone defects may be attributed 
to the decreasing effect of natural selection [39]. More than 40 genetic loci located in 
different chromosomes have been associated with T1D in multiple studies [1, 2]. 
Although T1D can be fatal, the majority of genetically predisposed people do not develop 
T1D [40]. This allows for accumulation of genetic predisposition in human populations. 
This accumulation will increase when fewer persons who developed a disease would die. 
Differential fertility and mortality are the basic events of natural selection, which operate 
singly or jointly to determine the fitness (reproductive success) of a particular population 
in a given environment [38]. The country specific fertility and mortality based Ibs at 
different levels may indicate their different successful reproduction opportunities of 
individuals in the succeeding countries [23]. The reproduction success opportunity of 
each population may determine their magnitude of T1D genes accumulation, thus 
influenced prevalence rate of T1D patients in their next generations. In the present study, 
the correlation of Ibs to the T1D prevalence rate has been observed, which was 
compatible with suggestion that lower opportunity for selection allows accumulation of 
unfavourable genes [23, 41]. Our analysis of correlations between T1D prevalence and 
Ibs by region or by WHO grouped countries seem to indicate that in regions where insulin 
was available earlier and that had better availability of health care the relationship is 
stronger. This provides the analogue of a snapshot what could happen at different times 
in the same region as time from insulin introduction and improvement of health care 
increased. Thus, the distribution across different populations could be interpreted as a 
surrogate measure of the evolution in time of T1D prevalence after the introduction of 




may have played a key role in reducing natural selection as insulin enables countless 
people with onset T1D to survive [3] and maintain normal reproductive capacity [42]. This 
may have been boosting T1D genes accumulation and prevalence of T1D. T1D can 
affect people of any age, but usually occurs in children or sexually mature young adults 
[3] who have greater potential to reproduce than older adults. T1D has been historically, 
and continues to be, the most common type of diabetes in children and adolescents [43]. 
Insulin is the priority for T1D treatment. Otherwise, T1D patient may only live up to one 
year, some only a week. Several human generations have benefited from insulin since it 
was discovered and became available in early 1920s [44]. Reduced natural selection 
boosted by insulin treatment of several generations may have enabled cumulative effect 
of T1D genes frequency in human population to occur quickly and to be noticeable for a 
couple of decades [9]. Studies have shown that a partially heritable disease, 
phenylketonuria was only noticeable after being accumulated for several generations [23] 
with about 2% increase each [45].  
T1D prevalence/incidence is increasing worldwide [46] with special regard to the 
developed countries [9, 10][47]. This may be partially attributable to earlier and greater 
affordability of insulin, in addition to relative more reduced natural selection (greater Ibs 
values) in those developed countries. Although exogenous insulin can be obtained from 
animals (bovine and porcine) [44], production, transportation, storage and administration 
of such insulin was extremely expensive [48], which may be beyond the affordability of 
many T1D patients, especially those from developing countries. Biosynthetic insulin 
based on DNA technology has been commercially available since 1982 [44] and it has 
been thought that it can continue to accommodate global demand [44] because of low 
cost from the production to administration. However, unfortunately life-saving insulin is 
still less accessible, affordable, or both to people diagnosed with diabetes in a developing 
country than their counterparts in the developed world [49]. This lower survivorship of 
T1D patients may contribute to lower prevalence figures directly, besides the fact that 
less predisposing genes have accumulated in the gene pools of those countries.  
Our study showed that the relationship between life expectancy and T1D prevalence rate 
was exponential (Figure 2, R2=0.5266). The Australian Institute of Health and Welfare 
(AIHW) also indicated the exponential relationship between T1D prevalence rate 
between age increase of Australian population through the Australian National Diabetes 
Register [50]. Additionally, Neville et al. reported that the increased longevity of diabetic 
patients contributed to the increasing prevalence of diabetes in Japanese population [51]. 




significantly [52] due to developments in sanitation, medical interventions and public 
health measures. Therefore, the underlying reason for the exponential relationship in our 
study may be because the number of individual T1D patients have increased in the 
human population [3]. The American Diabetes Association has also stated that the 
majority of individuals with T1D are adults even though T1D has been more frequent and 
a relatively straightforward diagnosis in children [53].      
The correlations of T1D prevalence rates to both Ibs and life expectancy were not only 
observed worldwide, but also in different country groupings sharing specific 
characteristics like geographic locations (Table 2), culture backgrounds (Table 3) and 
affiliations to international functional organizations (Table 3). Results’ highlights indicated 
that the correlations of Ibs and life expectancy to T1D were significant or very strong in 
European country groupings (WHO-Europe in Table 2 and in EEA in Table 3 
respectively), but very weak in Asian country grouping (WHO-SEA in Table 1 and ACD 
in Table 3 respectively). This may be attributable to high genetic predispositions [13-15, 
46] in Europe, but low genetic predisposition in Asia [46, 53].  
Although we found that the correlations of both Ibs and life expectancy to T1D prevalence 
rate existed globally and in different country groupings categorized with a variety of 
criteria, there are several limitations, including the intrinsic limitations (conceptualized as 
ecological fallacy) to this study.  
Firstly, the data analysed were calculated for per capita in each country, so we could 
only demonstrate the relationships between T1D prevalence rate and Ibs and life 
expectancy at country/population level, which does not necessarily correspond to the 
same relationships holding true at the individual level. We also need to point out that it 
would be difficult to test the relationships at the individual level due to very rare T1D 
occurrence rate.  
Secondly, the slow changes in the genetic code of the human populations may not fully 
explain the increasing T1D prevalence. Nongenetic (environmental) factors partially 
determine whether, and how risk-associated genotypes may lead to overt T1D disease. 
Unfortunately, our Ibs does not indicate if fitness change at population level is due to 
evolution of individuals or change/s. It may also be that altered lower natural immunity to 
infections following decades of using antibiotics may influence increased rates of 
autoimmune diseases including T1D.   
Thirdly, the data compiled and/or collected by the major international agencies (IDF, 




Finally, current evidence of the increasing frequency of many heritable genetic disorders, 
including T1D does not appear to be available. To the best of our knowledge, the T1D 
prevalence rate for all age groups at country level published by IDF may be the only 
version to single out T1D prevalence worldwide after consulting the major diabetes 
research or data collecting institutions. This may be because clinically, adult T1D is 
difficult to discriminate from certain forms of type 2 diabetes and from Latent Autoimmune 
Diabetes in Adults (LADA) [53]. Therefore, we don’t know how much this set of data was 
confounded by other forms of diabetes.          
The current prevailing paradigm on the increasing prevalence of T1D is that 
environmental pressures are now able to trigger genotypes [8, 9, 12-17]. Currently, 
medical gene intervention in modern medicine at this stage cannot remove T1D genes, 
and eugenics (improvement in the genetic stock) can offer no direction due to ethics 
issue. Therefore, study of T1D epidemiology based on prevalence/incidence T1D data 
of all age groups has become imperative as it may offer optimal solution to address or at 
least slow down T1D genetic load increases in different populations.  
Conclusions  
Our study suggested that reduced natural selection (Ibs) may be the major contributor to 
the increasing prevalence of T1D worldwide with special regard to European countries. 
It seems that T1D epidemiology study based on all age groups may be the practical 
solution to identify the causes of increasing T1D prevalence and to address, or at least 
slow down, T1D genetic load increases in different populations as modern medicine 
cannot operate effectively at the gene level yet.  
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Supporting document  
Table S1. Ibs values of 118 countries 
Country Ibs Country Ibs Country Ibs 
Iceland 0.994 Turkey 0.975 Nigeria 0.782 
Cyprus 0.994 Bahamas 0.974 Mali 0.774 
Singapore 0.994 Venezuela  0.974 Zambia 0.761 
Japan 0.993 Colombia 0.974 Cameroon 0.760 
Switzerland 0.993 Tunisia 0.972 Mozambique 0.752 
Sweden 0.992 Thailand 0.971 Congo, DR 0.729 
Luxembourg 0.992 Egypt 0.971 New Zealand 0.988 
Germany 0.992 Belize 0.969 TFYR Macedonia 0.986 
Italy 0.992 El Salvador 0.969 Chile 0.986 
Czech Republic 0.992 China 0.969 USA 0.985 
Spain 0.992 Sri Lanka 0.969 Qatar 0.985 
France 0.992 Peru 0.967 Malaysia 0.985 
Denmark 0.991 Fiji 0.967 Costa Rica 0.984 
Norway 0.991 Panama 0.967 Bulgaria 0.984 
Netherlands 0.991 Paraguay 0.967 Romania 0.983 
Israel 0.991 Libya 0.966 Barbados 0.981 
Greece 0.991 Saudi Arabia 0.966 Bahrain 0.981 
Austria 0.991 Iran 0.963 Kuwait 0.980 
Finland 0.991 Georgia 0.963 Uruguay 0.980 
Portugal 0.991 Ecuador 0.962 Lebanon 0.980 
Belgium 0.990 Jordan 0.961 Philippines 0.953 
Malta 0.990 Suriname 0.956 Tonga 0.953 
Ireland 0.990 Dominican Republic 0.956 Kyrgyzstan 0.951 
Australia 0.990 Jamaica 0.956 Guyana 0.949 
United Kingdom 0.990 Trinidad and Tobago 0.956 Indonesia 0.945 
Slovenia 0.990 Honduras 0.955 Guatemala 0.939 
Estonia 0.989 Morocco 0.955 Iraq 0.936 
Canada 0.989 Kazakhstan 0.955 Bolivia 0.931 
Hungary 0.989 Pakistan 0.877 Bangladesh 0.921 
Slovakia 0.989 Kenya 0.872 Madagascar 0.912 
Croatia 0.989 Haiti 0.871 India 0.898 
Cuba 0.989 Senegal 0.870 Papua New Guinea 0.892 
Poland 0.989 Togo 0.854 Gabon 0.890 
Republic of Korea 0.988 Gambia 0.849   
Lithuania 0.988 Tanzania 0.830   
Ukraine 0.977 Sudan 0.821   
Mauritius 0.977 Uganda 0.817   
Argentina 0.976 Ethiopia 0.815   
Mexico 0.976 South Africa 0.811   
Syrian Arab Republic 0.976 Congo 0.810   
Albania 0.975 Zimbabwe 0.809   








N Range Minimum Maximum Mean 
Std. 
Deviation Skewness 
Statistic Statistic Statistic Statistic Statistic Statistic Statistic 
T1DM (Total) Prevalence (‰), IDF, 2000 118 8.58 0.03 8.60 1.17 1.20 2.77 
Ibs self-calculated 118 0.27 0.73 0.99 0.94 0.07 -1.70 
Life expectancy increase (e50, 1950-2010) 116 12.14 -0.57 11.57 5.87 2.46 -0.15 
Life expectancy (e50, 2005-10), UN 118 14.32 20.04 34.36 27.81 3.45 -0.19 
Life Expectany at birth (years), WHO, 2010 118 32.00 52.00 84.00 73.23 7.96 -0.89 
BMI≥ 30 prevalence 18+ (%), WHO, 2010 118 38.70 2.90 41.60 18.34 8.80 -0.11 
GDP PPP, the World Bank 2010  116 124775.41 619.47 125394.88 19773.82 19555.61 2.15 
Sugar availability (g/capita/day), FAO, 2010 118 167.62 0.00 167.62 86.99 46.40 -0.23 
Urban population (% of total) the World Bank, 2010 118 90.91 9.09 100.00 62.19 21.93 -0.37 
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Contextual Statement  
Natural selection is the key mechanism of evolution, which changes heritable traits 
characteristic of a population over generations.   
In the past 100-150 years, the advanced medical care has reduced natural selection 
more than previously thought. It has been like a double-edged sword. It saves the lives 
of those people with the non-communicable diseases which are featured with strong 
heredity. Meanwhile, it offers the opportunities for those people to pass on their 
deleterious genes/mutations to their next generation.  
Males and females may have inherited obesity related genes/mutations equally over the 
past 100-150 years. In general, female obesity is more prevalent than male obesity 
prevalence. However, this ratio of male to female obesity prevalence varies in different 
regions and different cultures. 
We hypothesized and tested that reduced natural selection (indexed by opportunity for 
reproduction at population level) offers the equal opportunities for males and females to 
accumulate the obesity related genes/mutations, but it may have more effects on males 







Objective: Relaxed natural selection, measured by Biological State Index (Ibs), results 
in unfavourable genes/mutations accumulation in population. We aim to examine and 
compare the effects of reduced natural selection on male and female obesity prevalence.    
Methods: Country specific data were captured for ecological study. Curvilinear 
regressions, bivariate and partial correlations, linear mixed models and multivariate 
linear regression analyses were used to examine the relationship between Ibs and sex-
specific obesity prevalence. Per capita GDP, urbanization and caloric intake were 
controlled for as the confounding factors. Fisher r-to-z transformation, R2 increment in 
multivariate regression and F-test were used to compare the correlations.  
Results: Curvilinear regressions, bivariate and partial correlations (controlled for GDP, 
urbanization and calories) revealed that Ibs was significantly correlated to obesity 
prevalence of both sexes, but significantly stronger to male than to female obesity 
prevalence. Curvilinear regression models also showed strong correlations, but not 
significantly different between two sexes. Mixed linear models, with effects of GDP, 
urbanisation and caloric intake controlled for, showed that male and female average 
obesity prevalences were significantly higher in countries with greater Ibs value than their 
equivalents in countries with lower Ibs. Between higher and lower Ibs countries, the gap 
of male obesity prevalence is 60% greater than the gap of female obesity prevalence. 
Stepwise multiple regression identified that Ibs was a significant predictor of obesity 
prevalence of both sexes. Multivariate regression showed that, adding Ibs as an obesity 
predictor, R2 increment in male model was significantly greater than in female model.  
Conclusions: Reduced natural selection may drive males and females to accumulate 
metabolic faulty genes equally. Probably due to greater environmental intervention in 
regulating female body mass, reduced natural selection may show more contributing 
effects to male obesity prevalence. Gene therapy may be the optimal solution to address 
the obesity pandemic.   
Introduction  
Being overweight was once considered a problem only of high-income countries, but 
now obesity prevalence is rising worldwide and affects both the developed and 
developing countries [1]. Indeed, obesity and its sequelae are now so common that they 
are replacing traditional problems such as undernutrition and infectious diseases as the 
most significant causes of ill-health [2]. Moreover, people considered overweight or 




The Body Mass Index (BMI) is a common tool to determine body weight status. In WHO 
statistics [4-6], there are four body weight status definitions regarding individual adult’s 
BMI, i.e. obesity (BMI ≥30 kg/m2), pre-obesity (BMI > 25 kg/m2, but < 30 kg/m2), 
overweight (BMI ≥ 25 kg/m2) and health (BMI > 18 kg/m2, but < 25 kg/m2).  
BMI is a highly heritable human trait [7]. Despite this, in the past three decades, extensive 
studies explored how non-genetic factors, such as excessive intake of energy, changes 
of food components, sedentary lifestyle and gut flora imbalance, contributed to body 
weight increase [8-19]. Traditionally, obesity has been attributable to overeating, but how 
exactly obese people gain energy surplus is still vigorously debated [11-13, 17]. Recently, 
a couple of novel studies based on experiments reported that micro flora balance in 
human guts plays an important role in human energy metabolism [20-23]. Although 
conclusions of these studies are controversial and/or circumstantial, some researchers 
questioned the importance of genetics in the aetiology of obesity [7].  
Natural selection is a key mechanism of evolution. It has relaxed its effects in shaping 
humans as a species because modern living conditions, public health and medicine 
made it reduced sharply [24, 25]. Natural selection, together with mutations controls the 
frequency of genes, which determine human heritable traits. Population escaping from 
natural selection over successive generations may make the prevalence of their heritable 
traits subject to change due to changes in mutation/selection balance [7, 26]. A direct 
consequence of this process is that de novo mutations, including those affecting energy 
balance and metabolism, recently have accumulated at an unexpectedly significant pace 
[27-30]. Multiple mutations may be accumulated in genomes quickly, which influences 
the phenotype [31-33] after only a few generations.  
The Biological State Index (Ibs) measures the populational reproductive success [33-36]. 
Therefore, it can be used to measure the magnitude of reduced natural selection at 
population level. The Ibs calculation formula [34, 35] is: 





dx = the frequency of deaths at age x  
sx =the probability of not having completed fertility at age x 
          𝜔: the age at death of the oldest member of the group 
The Ibs expresses an opportunity for an average individual born into a population to pass 
on genes to the next generation. The greater Ibs value is, the less opportunity for natural 




population survive their reproductive period (15-50 years old). Further explanation and 
calculations of the Ibs are described in the Additional File 1 (Additional File: Text -AF 1) 
and for the Ibs value of each country see Additional File 2 (Additional File: Table AF 1). 
It was postulated that unfavourable genes may have been accumulating in human 
populations due to greatly reduced natural selection in the past 100-150 years [33, 36-
39]. This hypothesis has been tested in several studies [33, 36, 37, 40] and a very recent 
study argued that relaxation of natural selection may have been contributing to worldwide 
obesity prevalence due to accumulation of genes affecting metabolism in human 
populations [41]. The rationale of the study into the relationship between reduced natural 
selection and obesity prevalence increase is described as follows:  
The probable effect of de novo mutations is detrimental. Each population has a segment 
who carry metabolism and energy balance fault genes. When members of this segment 
of population participate in the reproduction, they may pass their metabolic fault genes 
into the next generation [30]. The frequency of metabolic fault genes will increase when 
a larger fraction of total population have opportunity to participate in reproduction under 
a given set of mortality conditions [34, 35]. However, only the contribution of relaxed 
natural selection to obesity prevalence in total population (both sexes) has been studied. 
No effects of reduced natural selection on obesity prevalence separately in males and 
females were considered.  
The topic of sex disparities in obesity remains largely underresearched, let alone 
addressed. From the perspective of total population at the country level, males and 
females in the next generation may share equal opportunities to inherit metabolic fault 
genes. However, worldwide, obesity is more prevalent in females (23.28%) than in males 
(15.89%) [42]. Studies of sex disparity in obesity considered differences in fat distribution 
[43, 44], body fat storage level [45-47], the role of parental investment [48] and the role 
of estrogen effect on obesity [49]. The interaction between genetic factors and sex in 
identical twins’ BMI has been reported [50, 51]. However, the effects of relaxed natural 
selection on obesity in different sexes at the population level have not been explored 
[52]. Due to obvious differences in body composition, fat distribution and hormonal 
regulation of metabolism, especially during pregnancy, lactation and post-partum periods, 
expression of different genes in males and females may be influencing energy balance 
of individuals.    
Therefore, the objective of the present study was to evaluate and compare the role of 
the Ibs contribution to male and female obesity prevalence from a global perspective 




Materials and Methods 
Data Collection and Selection  
The WHO Global Health Observatory (GHO) data (2014) on estimated sex-specific 
obesity prevalence rates by country were obtained and used as the dependent variables 
[42].  The estimates of sex-specific prevalence rates of obesity are expressed as the 
percentage of population aged 18+ with BMI equal to or over 30 kg/m2.  
We also extracted data on Ibs and on obesity prevalence rates of Australian females and 
males for the years 1976, 1981, 1986, 1991, 1996 and 2009 [53].   
Country specific Ibs values were used as the independent variable. The Ibs calculation [34, 
35] was based on the fertility data of each country published by United Nations in 2008 
[54] and the mortality data of life tables (2009) published by World Health Organization 
(WHO) in 2012 [55]. These calculations were the same as in the previous study 
published by Budnik and Henneberg [30]. Calculations and interpretations of Ibs are 
further described in the Supporting Information (Additional File: Text AF 1). Australian 
longitudinal Ibs was calculated using data published by the Commonwealth Bureau of 
Census and Statistics. In terms of data availability and quality, for Australia we were only 
able to calculate the Ibs for the years of 1976, 1981, 1986, 1991, 1996 and 2009.     
Urbanization (expressed as a percentage of the population living in urban areas in 2010) 
[56], mean caloric intake in 2011-2013 (expressed in grand total calories per capita per 
day) [57] and gross domestic product per capita (GDP, expressed in purchasing power 
parity in 2010 US dollars) [58] were considered and controlled for as the confounding 
factors. The selection criteria for potential confounding factors include: 1) Due to more 
affordability of the increases in caloric intake [59], obesity has traditionally been 
considered as an affluence-related medical condition [60]. 2) Living in urban setting leads 
to sedentary lifestyle (less physical activity) and poorer diets (more animal products and 
sugar), which have been considered an important factor to increase the risk of obesity 
[1, 7, 61-63]. Urban living setting also mirrors the Western lifestyle. 
We aligned the Ibs with prevalence rates of obesity in females and males and then 
matched them with GDP, caloric intake and urbanization. Country specific data for 191 
countries were put in a uniform format. Each country was treated as an individual subject 
and all of their available information was analysed. For some countries an estimate of 
one or the other variable was missing, thus specific analyses have sample sizes varying 




We also aligned Australian Ibs with obesity prevalence of Australian females and males 
for those years in which we were able to use the data for Ibs calculation in order to explore 
longitudinal trend.  
Although the WHO Global Health Observatory (GHO) data repository (2014) [42] defined 
four levels of BMIs for males and females (obesity, overweight, normal and underweight), 
we only chose obesity prevalence rates in females and males for modelling, analysing 
and reporting the correlation and regression results because the results for obesity can 
be compared with the findings of the previous study conducted by Budnik and Henneberg 
[30].  
Data Robusticity Check  
The diagnostic test was run to check if there was multicollinearity problem between the 
data we collected. All the tolerances were less than 0.20 and all the Variance Inflation 
Factors (VIF) were above 5, which indicates there was not multicollinearity issue [64] 
(Additional File: Table AF 2).  
The Kolmogorof-Smirnov and Shapiro-Wilk tests were performed with SPSS to test the 
normality of distributions of variables used (Details see Additional File: Table AF 4). All 
variables analysed here were not normally distributed, thus various data transformations 
as described below were performed for each method applied.  
Scatter plots  
Worldwide, the relationships between the Ibs and each of the male and female obesity 
prevalence rates were explored and visualized in Microsoft Excel® producing scatter 
plots. Scatter plots were also used to explore the longitudinal correlation between the 
Australia-specific Ibs and Australian sex-specific obesity prevalence rates. The best fit 
trendlines were reported respectively.  
Curvilinear Correlation Analysis  
Due to abnormal data distribution detected in the Kolmogorof-Smirnov and Shapiro-Wilk 
tests, partial correlation analysis was conducted using correlations of residuals, not the 
standard SPSS procedure. Logarithmic, exponential, power and polynomial regression 
models were fitted to the data and for each specific regression analysis, the model 
producing the greatest fit by the least squares criterion (greatest coefficient of 
determination - R2) was applied.  First, best curvilinear regression between GDP and 
sex-specific obesity prevalence has been obtained, then residuals of individual country 




regression of GDP-residuals on urbanisation were calculated (second-order residuals). 
These second-order residuals were regressed on the caloric intake and then residuals 
around this regression line calculated (third-order residuals). First order residuals (sex-
specific obesity prevalence standardised on GDP), second order (sex-specific obesity 
prevalence standardised on GDP and urbanization) residuals and third order residuals 
(sex-specific obesity prevalence standardised on GDP, urbanization and caloric intake) 
were regressed on Ibs thus obtaining correlations of Ibs to sex-specific obesity prevalence 
corrected for effects of GDP only, GDP and urbanisation, and GDP, urbanisation and 
caloric intake respectively.   
Data Analysis Based on Linear correlation models  
When data were logarithmed, similar levels of Pearson r correlation and Spearman rho 
between all variables were obtained. This allows us to consider that the logged data 
distributions, though not normal, provide homoscedastic distributions as required for 
linear correlations. Therefore, the data analysis was performed in four steps:  
1) Pearson and non-parametric correlation analysis were conducted to examine the 
strength and direction of the correlations between all variables.  
2) Partial correlation analysis was performed to explore the independent linear 
correlations of Ibs to male and female obesity prevalence rates respectively while we 
controlled for GDP, urbanization and caloric intake. 
Fisher’s r-to-z transformation was conducted to assess significance level of differences 
between the Pearson’s r and partial correlation coefficientsefficient of Ibs to male and 
female obesity prevalence rates. 
Cohen’s ƒ2 was used to calculate and report the “effect size” in the partial correlation 
analysis.  
3) Standard multivariate linear regression (Enter) was conducted on log-transformed 
data to obtain and compare the Beta coefficients between sex-specific obesity 
prevalence and all independent variables, which included Ibs, calories, GDP and 
urbanization.  
Standard multivariate linear regression (Stepwise) was performed to assess which non-
Ibs predictor(s) made substantial contributions to variation in obesity, and then Ibs was 
added to the list of predictors to show improvement in model fits for males and females. 
The magnitudes of improvements in the two model fits were firstly compared with the 




due to adding Ibs” and “the R2 improvement in female prevalence due to adding Ibs” 
respectively. F-test was used to compare and determine if there is significant difference 
between the magnitudes of the two improvements. We calculated the ratio (F value) of 
“the R2 improvement in male prevalence due to adding Ibs” to “the R2 improvement in 
female prevalence due to adding Ibs”. The calculated F value was compared with the 
value of p=0.05 and p=0.01 at degrees of freedom used in regression analyses.  
4) The linear Mixed Model Analysis was conducted to summarise the results allowing us 
to intercept change at the country and regional levels after the data were nested within 
the WHO regions.  
For the application of mixed-effects models that were based on linear relations between 
variables, scales of GDP, urbanisation and caloric intake were transformed from interval 
to ordinal. Values of each variable were ordered from the smallest to the largest, ranked 
and ranks standardised on numbers of observations because numbers of countries for 
which values of GDP, Urbanisation and Caloric intake were available differed somewhat 
(from 168 to 191). This way the rank of the country with the maximum value became 100 
while the rank of the country with minimum value was 100*1/N that is a fractional number. 
This procedure produced rectangular distributions of all variables, thus these 
distributions became homoscedastic and as such acceptable for linear analyses. 
Averages of ordinally measured variables in the entire sample are 50.0 and thus their 
averages in variously grouped subsamples are easily interpretable. The mixed model 
with nested terms fixed and random effects using the Restricted Maximum Likelihood 
method of estimation was run. 
Pearson’s r, Spearman’s rho coefficient, partial correlation, the linear Mixed Model 
Analysis and multiple-linear regression analyses were conducted using SPSS v. 24. The 
statistical significance was set at the 0.05 level, but the significance levels at 0.01 and 
0.001 were also reported. 
Results  
Ibs was in strong and significant correlation (exponential) to both male obesity (r=0.70, 
p<0.001) and female obesity (r=0.47, p<0.001). Fisher r-to-z revealed that Ibs was in 
significantly stronger correlation to male obesity than to female obesity (z=3.46, p<0.001) 





Figure 1 Relationships between Ibs and obesity prevalence estimates in males and 
female 
 
Similar longitudinal trends were revealed between Australia-specific Ibs and Australian 
male and female obesity prevalence (Figure 2).  













The worldwide trend of increased obesity prevalence may be a multi-factorial 
phenomenon with major contributions from the environmental factors and the genetics. 
By assessing the data from 191 countries on the prevalence rates of the sex-specific 
obesity, we have shown that, globally, countries which had greater value of the Ibs (less 
opportunity for natural selection) have greater obesity prevalence rates in both males 
and females. These trends remained independent of the commonly considered drives 
(total caloric intake, urbanization and GDP) of obesity Our finding supports a recent study 
conducted by Budnik and Henneberg that countries with more relaxed natural selection 
may have greater obesity prevalence in total population [41].  
Natural selection is about survival of the fittest individuals through the action of 
differential fertility and mortality in a population. Medical care service, especially in the 
developed world has made the selection relaxed abruptly in the last few generations [24, 
25, 33]. However, it still acts on phenotype of observable characteristics of human 
populations [38, 39]. Country specific health care service level and public health policies 
may determine magnitude of natural selection. Over generations, the phenotype 
disparities of human populations caused by the different magnitudes of natural selection 
may be observable [38, 39, 65]. The effects of reduced natural selection on accumulation 
of genes of partially heritable diseases have explained the increasing prevalence of 
deformed nasal septa [66], Type 1 diabetes [36] and lacrimal bone defects [67]. Likewise, 
the mutations producing metabolic faulty genes, which contribute to obesity, may be 
accumulating due to relaxed natural selection.    
Obesity is a morphological trait, but obese people are likely to develop a clustering of 
complications, such as cancer, diabetes, cardiovascular diseases (CVDs) etc. [68-70]. 
Some of these complications used to be very dangerous or fatal diseases, but they are 
not in the modern society because the advanced medical/health care can “cure” them 
[33, 36, 37], which keeps obese people “fat but fit” [71]. Therefore, obese people not only 
can live as well as other people with healthy body weight [71], but also can participate in 
the reproduction even if their life expectancy may be reduced [69, 72, 73]. This process 
may allow “fat but fit” people to pass their faulty genes into the next generation. Over a 
few generations, the effects of natural selection on metabolic fault genes accumulation 
in a population may become an observable phenotype (obesity and excessive thinness).  
Differential fertility and differential mortality, acting singly or together, are the 
fundamental events of natural selection to determine the fitness (successful reproduction) 




is calculated with the country specific fertility and mortality rates may express different 
successful average reproduction opportunities of their inhabitants [33]. The reproductive 
success opportunity (indexed with Ibs value) of each population may determine their level 
of accumulation of unfavourable for metabolism genes, and thus may influence 
prevalence rate of people of abnormal body mass – too thin and too fat. This may partially 
explain that countries with high level of medical care for long time may have more obesity 
issues due to greater accumulation of metabolically faulty genes. This theory has been 
successfully tested in the relationship between reduced selection and obesity prevalence 
[30].      
The other important finding in this study was that the Ibs was in significantly stronger 
correlation to male obesity prevalence than to female obesity prevalence. Theoretically, 
metabolic faults may be cumulative in females and males at the same pace in the 
process of relaxation of natural selection. Accordingly, the Ibs should be correlated to the 
obesity prevalence equally in females and males. The significantly weaker relationship 
between Ibs and female obesity prevalence in some of our analyses may indicate that the 
effects of reduced natural selection on obesity are moderated by environmental factors 
more in females than in males. In other words, the same magnitude of metabolic faulty 
mutations accumulation due to the reduced natural selection in males and females does 
not lead to the same phenotypes at population level (different obesity prevalence rates 
in males and females). Multiple environmental factors that may influence the female 
obesity prevalence in different countries or regions may explain the disparity of obesity 
prevalence in males and females. Female obesity prevalence, in general, correlates less 
strongly with country-characteristic variables than male obesity (Table 2). It may be the 
result of individual females’ decisions concerning their body mass being driven by 
requirements of fashion to a larger extent than those of males. It may, however, also 
reflect results of industrialisation and economic situation because the ratio of male to 
female obesity per country shows linear and strong correlation (r=0.77, P<0.001) to GDP 
with male/female ratios being less than one in countries with GDP below about 25,000 
USD and above 1 in wealthier countries [49]. The authors interpreted this as a result of 
greater presence of xenoestrogens in environments of wealthier countries, but there may 
be other reasons.  
Fertility is a nutritionally expensive process for women due to gestation and lactation [48]. 
Therefore, women at reproductive age have been especially susceptible to excessive fat 
storage from the perspective of evolutionary biology [48]. Birth rates are low in developed 




in females of developed countries, which is supposed to be used for successful 
reproduction, is simply kept without use, which increases body weight of females in the 
developed world.  This is a result of conscious birth control, unrelated to genetic variation. 
Oestrogen is the primary female sex hormone. Higher levels of oestrogen have been 
associated with greater adiposity in females [49, 76]. It also has been shown that 
xenoestrogens increase obesity [77]. Low birth rates in developed world [75] may make 
females exposed to more oestrogen, which may increase fat storage.  
Toward the end of the 20th century, there has been a transition away from agricultural 
labor (both for production and subsistence) to wage labor in many developing countries. 
This transition has decreased the physical activity of women more than men [78, 79].  
Importantly, worldwide, different sociocultural beliefs and practices may also affect 
female disparities in excessive weight gain [80-84]. To a large extent, females may 
artificially change their fat accumulation resulting from the genetic endowment. In general, 
women are socialized to be more appearance-focused than men [80], which makes 
females more prone to adjust their body weight to meet the expected appearance of the 
specific sociocultural beliefs. For instance, females have been overprotected and, due 
to cultural or religious barriers, cannot publicly participate in physical activity in 
conservative societies, such as in the developing countries in the Middle East and North 
Africa region and the developed countries of Oman, Kuwait, and Saudi Arabia [85-87]. 
On the other hand, in the “Western” countries, the female body ideal has been that of a 
thin person for the last 50 years. 
In this study, the curvilinear correlation was applied as the Kolmogorof-Smirnov and 
Shapiro-Wilk detected that the data distributions are not normal. It is revealed that Ibs is 
correlated to sex-specific obesity prevalence residuals which were obtained by removing 
the contributing effects of non-genetic (environmental) factors from obesity prevalence, 
but there is no significant difference between the two correlations within the 1st, 2nd and 
3rd order residuals. This finding may complement our hypothesis because this may imply 
that reduced natural selection has increased the frequencies of obesity genes/mutations 
in males and females equally.  
From evolutionary perspective, hypotheses of thrifty gene [88], drifty gene [89] and poor 
adaptation arising from migration [90] have been proposed to explain modern obesity 
pandemic. All these three hypotheses would require thousands of years evolution to 
slowly accumulate the genetic background of obesity. This makes these hypotheses 





Population-based prevention strategies targeting ‘‘obesogenic’’ environments have been 
advocated and adopted as a public health approach [94, 95]. However, unfortunately, no 
country has achieved their expected results in the past 30 years [96]. The process of 
natural selection reduction which has driven the accumulation of the energy balance and 
metabolic faulty genes/mutations in human populations may partially explain this 
phenomenon [33]. Random mutations are as likely to affect metabolism to produce too 
much adipose tissue as not to and reduce body mass excessively. There is, however, a 
simple imbalance between the two directions of metabolic faults – body mass of a living 
human being cannot be reduced below a certain level determined by the weight of 
musculo-skeletal, circulatory, urinary, reproductive, nervous and integumentary systems, 
while it can be doubled, tripled, or even, perhaps, quadrupled by increasing the amount 
of adipose and muscle tissue. This imbalance produces, on average, increase in body 
mass and in prevalence of obesity over that of underweight. 
Several generations of people in Europe and North America have had the access to 
advanced medical care earlier and easier than those from the developing areas, such as 
Africa and Asia. This may be one of the reasons that obesity has become a noticeable 
pressing issue much earlier in the developed regions. For instance, Olshansky et al. 
reported that the life expectancy in the USA may be reduced if obesity prevalence keeps 
rising in the future [97].  
Several limitations in this study need to be acknowledged:  
First, the relationship between Ibs and obesity prevalence reported here only shows 
coincidence, not causality.  
Second, we could only demonstrate the relationship between the Ibs and the obesity 
prevalence rate at country/population level, rather than at the individual level because 
both data analysed [34, 35] and the evolutionary approach [26] are population based. 
Third, the changes in the genomes of human populations may be too slow to fully explain 
the increasing obesity prevalence. Obesity is the result of an unfavourable interaction 
between our genomes and our current environment which might play more important 
role in developing obesity in some circumstances.  
Fourth, this study analysed the data across 191 countries. However, the results cannot 
be complemented by the longitudinal data analysis in individual countries, with exception 
of Australia and Poland [30] due to the fact that obesity only has been an issue in the 
last few decades. We could not access the combined obesity and Ibs data which are older 




Finally, the female complexities, adaptation for fertility [48], oestrogen [76] and double x 
chromosomes in cells [98] may have confounded our analysis of correlation of the Ibs to 
female obesity prevalence, but we could not obtain data to reduce or avoid such 
confounding effects.  
The natural selection has been universally reduced and this trend continues as, 
worldwide, the medical services keep improving quickly. In the past, eugenics has been 
proposed to improve genetic stock in humans, but it is unethical [99] and may potentially 
decrease gene diversity [100]. Instead of “people selection (eugenics)”, recent advances 
in genome editing have made gene therapy possible [101]. For instance. Gendicine and 
Glybera have been used for treatment of head and neck squamous cell carcinoma [102] 
and lipoprotein lipase deficiency [103] respectively. The obesity related genes/mutations 
accumulation in human populations through the process of reduction of natural selection 
may become more and more imperative. Advances in our knowledge of the molecular 
basis of obesity and obesity-associated diseases, and development of gene therapy may 
offer an alternative long-term treatment modality in the near future.  
Conclusions  
Recently accumulated high frequency of genes related to metabolic faults in human 
populations may be one of the important contributors to the increasing prevalence of 
obesity worldwide. The relaxed natural selection may have accumulated faulty genes in 
both males and females over successive generations. Reduced natural selection 
affecting less female obesity prevalence than its male equivalent may be attributable to 
female-specific physiological mechanisms and various socio-cultural practices. Public 
health approaches to develop population-based strategies for the prevention of excess 
weight gain may not be able to achieve expected results. Gene therapy should be 
considered as a solution to address the global problem of obesity.   
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Additional File 2:  
Table AF 2: Multicollinearity tests amongst the variables 
Table AF 2-1: Multicollinearity tests of male and female obesity prevalence to other predictors  
Independent Variables Tolerance VIF  Independent Variables Tolerance VIF 
Urbanization  0.535 1.869 Urbanization 0.535 1.869 
Ibs 0.471 2.124 Ibs  0.471 2.124 
Calories 0.386 2.590 Calories  0.386 2.590 
GDP 0.299 3.344 GDP 0.299 3.344 
 
Table AF 2-2: Multicollinearity tests of calories to other predictors in male and female samples respectively  
Independent Variables Tolerance VIF  Independent Variables Tolerance VIF 
GDP 0.304 3.290 GDP 0.358 2.793 
Urbanization 0.542 1.846 BMI ≥ 30, Female 0.697 1.434 
BMI ≥ 30, Male 0.324 3.084 Urbanization 0.558 1.791 
Ibs 0.424 2.360 Ibs 0.474 2.108 
 
Table AF 2-3: Multicollinearity tests of GDP to other predictors in male and female samples respectively  
Independent Variables Tolerance VIF  Independent Variables Tolerance VIF 
Urbanization 0.553 1.809 BMI ≥ 30, Female 0.712 1.404 
BMI ≥ 30, Male 0.351 2.848 Urbanization  0.580 1.723 
Ibs 0.453 2.207 Ibs 0.548 1.826 
Calories  0.425 2.353 Calories 0.472 2.119 
 
Table AF 2-4: Multicollinearity tests of Ibs to other predictors in male and female samples respectively  
Independent Variables Tolerance VIF  Independent Variables Tolerance VIF 
Calories 0.376 2.659  Calories 0.395 2.529 
GDP 0.288 3.476 GDP 0.346 2.888 
Urbanization 0.521 1.918 BMI ≥ 30, Female 0.709 1.410 
BMI ≥ 30, Male 0.351 2.848 Urbanization 0.530 1.886 
 
Table AF 2-5: Multicollinearity tests of urbanization to other predictors in male and female samples respectively  
Independent Variables Tolerance VIF  Independent Variables Tolerance VIF 
Ibs 0.419 2.385  Ibs 0.461 2.170 
BMI ≥ 30, Male 0.321 3.116 Calories  0.405 2.472 
Calories 0.387 2.586 GDP 0.319 3.134 
GDP 0.282 3.542 BMI ≥ 30, Female 0.701 1.427 
Note for the above 5 tables: 




Sex specific obesity prevalence is the percentage of defined population segment with a body mass index (BMI) of 
no less than 30 kg/m2.    
Data sources: Total calories data from the FAO’s FAOSTAT; BMI ≥30 data from the WHO Global Health 
Observatory; GDP data from the World Bank; Urbanization data from WHO. Biological State Index (Ibs) was self-
calculated with country specific fertility data published by the United Nations and the mortality data published by 




Additional File 3:  






Additional File 4:  
Table AF4: Tests of normality of distributions of studied variables 
 Kolmogorov-Smirnov
a  Shapiro-Wilk 
Statistic df Sig.  Statistic df Sig. 
BMI ≥ 30, Male 0.138 168 <0.001  0.933 168 <0.001 
BMI ≥ 30, Female 0.054 168 0.200*  0.984 168 0.052 
Caloric intake  0.045 168 0.200*  0.981 168 0.023 
GDP 0.249 168 <0.001  0.683 168 <0.001 
Ibs 0.252 168 <0.001  0.767 168 <0.001 
Urbanization 0.067 168 0.066  0.972 168 0.002 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
Sex specific obesity prevalence is the percentage of a defined population segment with a body 
mass index (BMI) of no less than 30 kg/m2.    
Data sources: Total calories data from the FAO’s FAOSTAT; BMI ≥30 data from the WHO Global 
Health Observatory; GDP data from the World Bank; Urbanization data from WHO.   Biological 
State Index (Ibs) was self-calculated with country specific fertility data published by the United 






Additional File 5:  
Text AF1: Calculation and significance of Biological State Index (Ibs) 
Natural selection is a key mechanism of evolution, it may produce the change in heritable traits 
of a population over successive generations [1]. In our modern society, natural selection still 
acts on all members of a population, selecting those individuals that have an increased 
reproductive success (survival and/or fertility) [2]. The “Biological State Index (Ibs)” has been 
proposed to measure the populational reproductive success by taking into account potential 
loss of reproductive success by mortality [3, 4].  
The Ibs is calculated by combining age-specific death frequency (dx variable of a life table) with 
an age-specific reproductive loss (sx): 




Where: dx is the frequency of deaths at age x, sx is the reproductive loss from dying at age x, 
i.e. the estimated probability of not possessing the complete number of births at age x. sx is 
based on the cumulative number of births at specific ages [4, 5]. The construction and 
interpretation of the Ibs was predicated upon the assumption that heritability of human fertility 
variance is negligible [6]. An Ibs value of one indicates total adaptation of the population to their 
environment (ability to overcome mortality selection pressures that are present). An Ibs value 
of zero signifies a total lack of adaptation (inability to overcome selection pressures that are 
present), and an impossibility to give life to the next generation. An Ibs value close to zero 
indicates large effective natural selection pressures acting on a population, since few 
individuals are surviving to produce offspring. In such a scenario there is a possibility for fast 
evolution, since many genes may not be passed to the next generation and little possibility for 
propagation of deleterious mutations. An Ibs value close to one indicates that natural selection 
does not have much effect on the population since many individuals are able to maximally 
contribute to producing the next generation.  
1. Hall, B.K.H., Benedikt, Strickberger's Evolution (4th ed.). . 2008: Sudbury, MA: Jones and Bartlett 
Publishers. ISBN 978-0-7637-0066-9. LCCN 2007008981. OCLC 85814089. 
2. Byars, S.G., et al., Colloquium papers: Natural selection in a contemporary human population. 
Proceedings of the National Academy of Sciences of the United States of America, 2010. 107 Suppl 
1: p. 1787-92. 
3. Henneberg, M. and J. Piontek, Biological state index of human groups. Przeglad Anthropologiczny, 
1975. XLI: p. 191-201. 
4. Henneberg, M., Reproductive possibilities and estimations of the biological dynamics of earlier 
human populations. Journal of Human Evolution, 1976. 5: p. 41-8. 
5. Henneberg, M., Notes on the reproduction possibilities of human prehistorical populations. Przeglad 
Anthropologiczny, 1975. 41: p. 75-89. 
6. Henneberg, M., Quantitative evaluation of actual intensity of natural selection through differential 





2nd Response to Reviewers’ comments 
 
PLOS ONE (PONE-D-17-11108) Review 
PONE-D-17-11108R1 
Reduced natural selection may contribute to global obesity increase more in males than in 
females 
PLOS ONE 
Wenpeng You, Maciej Henneberg  
 
Abstract 
I felt your sentence on regression could use some rephrasing with regard to the doubling of 
Rˆ2. reads a little off. 
Authors: The sentence was amended.  
R2 increment in multivariate regression due to adding Ibs as a predictor of male obesity was 
twice more than the improvement in R2 due to adding Ibs as a predictor of female obesity. 
Introduction 
In your classifications of BMI, you mean ‘healthy’ not just health? 
Authors: Since BMI status is described in  nouns,  “health” should remain in the sentence.  
Paragraph on natural selection has many typos. 
Authors: We checked and corrected the typos. Thanks  
Whilst I do like the concise nature of your introduction, I feel the overall rationale regarding the 
importance of studying sex differences in the final paragraph lacking. Why is this important? 
Authors: We inserted the following explanation to highlight the importance in studying the sex 
difference in obesity. 
Due to obvious differences in body composition, fat distribution and hormonal regulation of 
metabolism, especially during pregnancy, lactation and post-partum periods, expression of 
different genes in males and females may be influencing energy balance of individuals.    
Methods 
You use the term ‘confounders’, this should be **confounding factors/variables* throughout 
Authors: We changed the term “confounders” to “confounding factors/variables” throughout 




Please rationalise the use of stepwise over standard enter method regression 
Authors: The rationale for the use stepwise is:   
Comparing to the Enter linear regression, stepwise model is advantageous in selecting and 
ordering independent variables, which have statistically significant influence on male and 
female obesity prevalence, from the one that has most influence on the dependent variable 
down to the one that has least influence. Meantime, stepwise model also removes those 
variables that have no statistically significant influence on male and female obesity prevalence. 
In this study, stepwise model was performed to select and rank variables which had the 
statistically significant contribution to male and female obesity prevalence when Ibs was 
excluded and included as the independent variable respectively. To make it clearer, we 
included those variables which were not the significant predictors in the table, but they were 
denoted as “Removed”.  
Information regarding how strongly non-normal distributions were before transformation may 
be useful in an appendix or supplementary information. I would guess this was checked using 
something like kolmogorov smirnov? 
Authors: Supplementary file showing strength of non-normal distributions of all variables 
checked using kolmogorov smirnov was included as one of the additional files. This was also 
mentioned in Section of Methods in the manuscript.  
Table AF 4 Tests of normality of variables 
 Kolmogorov-Smirnov
a  Shapiro-Wilk 
Statistic df Sig.  Statistic df Sig. 
BMI ≥ 30, Male 0.138 168 <0.001  0.933 168 <0.001 
BMI ≥ 30, Female 0.054 168 0.200*  0.984 168 0.052 
Calories  0.045 168 0.200*  0.981 168 0.023 
GDP 0.249 168 <0.001  0.683 168 <0.001 
Ibs 0.252 168 <0.001  0.767 168 <0.001 
Urbanization 0.067 168 0.066  0.972 168 0.002 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
Sex specific obesity prevalence is the percentage of defined population segment with a body mass index 
(BMI) of no less than 30 kg/m2.    
Data sources: Total calories data from the FAO’s FAOSTAT; BMI ≥30 data from the WHO Global Health 
Observatory; GDP data from the World Bank; Urbanization data from WHO.   Biological State Index (Ibs) 
was self-calculated with country specific fertility data published by the United Nations and the mortality 





Due to abnormal distribution detected, the curvilinear correlation between Ibs and male and 
female obesity prevalence standardised on the confounding factors was explored respectively. 
Details see the section of Data Analysis of the manuscript.  
Results 
It appears from your figures you may have some polynomial data. Was this explored? 
Authors: Yes, we have realized this, and it has been explored and found that exponential 
relationship fits better our data than polynomial curve.  See Figure 1.   Most of our data are 
polynomial in the sense of having curvilinear relationships with many other data. This has 
been explored and variously controlled for in partial correlation analyses, mixed linear models 
and multiple regressions. 
Table 1 suggests multicollinearity amongst the predictors. Diagnostic tests should be reported, 
and controls taken to ensure this does not influence the end model. 
Authors: We have run diagnostic tests as shown below, and we have included tolerance 
figures in the manuscript. A tolerance of less than 0.20 or a VIF of above 5 indicates a 
multicollinearity problem (O’Brien 2007).  
 
Table AF 2-1: Multicollinearity (diagnostic tests) of male and female obesity prevalence to other predictors  
Independent Variables Tolerance VIF  Independent Variables Tolerance VIF 
Urbanization  0.535 1.869 Urbanization 0.535 1.869 
Ibs 0.471 2.124 Ibs  0.471 2.124 
Calories 0.386 2.590 Calories  0.386 2.590 
GDP 0.299 3.344 GDP 0.299 3.344 
 
Table AF 2-2: Multicollinearity (diagnostic tests) of calories to other predictors in male and female samples 
respectively  
Independent Variables Tolerance VIF  Independent Variables Tolerance VIF 
GDP 0.304 3.290 GDP 0.358 2.793 
Urbanization 0.542 1.846 BMI ≥ 30, Female 0.697 1.434 
BMI ≥ 30, Male 0.324 3.084 Urbanization 0.558 1.791 
Ibs 0.424 2.360 Ibs 0.474 2.108 
 
Table AF 2-3: Multicollinearity (diagnostic tests) of GDP to other predictors in male and female samples 
respectively  
Independent Variables Tolerance VIF  Independent Variables Tolerance VIF 
Urbanization 0.553 1.809 BMI ≥ 30, Female 0.712 1.404 
BMI ≥ 30, Male 0.351 2.848 Urbanization  0.580 1.723 
Ibs 0.453 2.207 Ibs 0.548 1.826 





Table AF 2-4: Multicollinearity (diagnostic tests) of Ibs to other predictors in male and female samples respectively  
 
Independent Variables Tolerance VIF  Independent Variables Tolerance VIF 
Calories 0.376 2.659  Calories 0.395 2.529 
GDP 0.288 3.476 GDP 0.346 2.888 
Urbanization 0.521 1.918 BMI ≥ 30, Female 0.709 1.410 
BMI ≥ 30, Male 0.351 2.848 Urbanization 0.530 1.886 
 
Table AF 2-5: Multicollinearity (diagnostic tests) of urbanization to other predictors in male and female 
samples respectively  
Independent Variables Tolerance VIF  Independent Variables Tolerance VIF 
Ibs 0.419 2.385  Ibs 0.461 2.170 
BMI ≥ 30, Male 0.321 3.116 Calories  0.405 2.472 
Calories 0.387 2.586 GDP 0.319 3.134 
GDP 0.282 3.542 BMI ≥ 30, Female 0.701 1.427 
 
You use both enter and stepwise regressions. What justified the use of stepwise? 
Authors: Stepwise analysis automatically selects and ranks the independent variables which 
contribute most to the variance of dependent variable- most important factors, whereas Enter 
produces coefficients for all the independent variables and this has been interpreted in the 
manuscript.  
I still think these data may be nested within countries or regions and a linear mixed model of 
some sort might neatly summarise your data allowing for intercept change at the country level. 
Authors: The linear Mixed Model Analysis was conducted to summarise the data quality after 
the data were nested within the WHO regions. After controlling for Calories, GDP and 
Urbanization, the male and female obesity prevalence rates were significantly different 
between WHO regions (F=35.95, P<0.001 & F=12.18, P<0.001 respectively).   Further details 
see Additional File: Table AF 4.  
Discussion 
In your discussion of the possible causes of the male/female differences you use bullet points 
- Change these to normal paragraphs. I think overall this section should take precedence to 
the rest of the discussion as this formed the main rationale behind the study and I felt it was 
skimmed over too quickly. This disparity is an interesting one and certainly one I would really 




Authors: This is a good point. The important finding of this study that female body weight varies 
more has been highlighted after we moved forward the possible rationale of female obesity 
variation in different countries/regions.  
There was not so much discussion around the longitudinal data in Australia in Fig2 
Authors: The following paragraph has been included in the discussion as one of the study 
limitation. 
Fourth, this study analysed the data across 191 countries. However, the results cannot be 
complemented by the longitudinal data analysis in the individual country due to the fact that 
obesity only has been an issue in the last three decades. We could not access the combined 
obesity and Ibs prevalence data which are older than 30 years  
 
General Comments 
Overall I think this is a much improved manuscript on an interesting topic. I still think the main 
issues surround the analysis section of the paper and do suggest to the authors a multilevel 
model may be appropriate and help summarise the data in a neater fashion taking into account 
possible clustering of country/region. It might be worth trying to vary the intercept by these 
factors and seeing if this results in better model fit. The standard method of adding variables 
one by one and comparing model fit might provide the authors some nice statistics for 
comparing the influence of each predictor on model fit. Also, lot of the predictors are highly 
correlated with one another causing multicollinearity. Clarity on how this is tackled should be 
included. 
Authors:  In this paper, we only explored one predictor, which is Ibs and obesity of males and 
females. 
It is inappropriate for us in this paper to explore influence of other factors beyond controlling 
for them. The reviewer’s comment is valuable as an idea for a new and different paper to 
explore influence of a number of factors on obesity. In the process of studying the issue of 
obesity, we have accumulated data on a large of number of variables such like, nutrients, food 
products, macronutrients and etc. it would be better to include all variables into such a new 
study rather than just a few in this paper. We would be happy to invite the reviewer as the co-





I felt the other area of weakness was a lack of depth regarding the male/female sex differences. 
I see the authors make an attempt to summarise some possible factors, but a better discussion 
I feel is required as it does form the basis of the main rationale (and title of the study). 
Authors: We included the multiple environmental factors in the discussion of the male/female 
sex differences. However, it seems that the interaction between genetic trait of obesity and 
environmental factors should have been highlighted although it is obvious that reduced natural 
selection may increase genetic background of obesity. The following paragraph has been 
inserted.  
In other words, the same magnitude of metabolic faulty mutations accumulation due to the 
reduced natural selection in males and females does not lead to the same phenotypes at 
population level (different obesity prevalence rates in males and females). Multiple 
environmental factors that may influence the female obesity prevalence in different countries 
or regions may explain the disparity of obesity prevalence in males and females.  










Chapter 2: Nutrients/diets & global public health challenges     
 
Article 4/10: Meat consumption providing a surplus energy in modern diet 
contributes to obesity prevalence: an ecological analysis 
(Published at BMC Nutrition, 2016)    
 
Wen-Peng You1, Maciej Henneberg1,2, 
 
1 Biological Anthropology and Comparative Anatomy Unit, School of Medical Sciences, 
the University of Adelaide, Adelaide, SA, Australia 5000.  
2 Institute of Evolutionary Medicine, University of Zürich, Switzerland.     
Published: Wenpeng You, Maciej Henneberg. Meat consumption providing a surplus 
energy in modern diet contributes to obesity prevalence: an ecological analysis. BMC 
Nutrition, 20162:22. DOI: 10.1186/s40795-016-0063-9  
 Correspondence: Wenpeng You  Wenpeng.you@adelaide.edu.au 
 
Contextual Statement 
Meat has been constantly associated with obesity. The prevailing explanation is that 
meat contains saturated fat. Misled by this dogma, lean meat has been included as the 
healthy food component in healthy dieting guidelines published by the authorities. A few 
previous studies have suggested that that it actually may be the main macronutrient of 
the meat, protein that contributes to obesity.   
We postulated and tested that, in modern diet, meat protein, instead of meat fat, may be 
a direct obesity contributor as carbohydrates and fats may provide enough energy for 







Background: Excessive energy intake has been identified as a major contributor to the 
global obesity epidemic. However, it is not clear whether dietary patterns varying in their 
composition of food groups contribute. This study aims to determine whether differences 
in per capita availability of the major food groups could explain differences in global 
obesity prevalence.  
Methods: Country-specific Body Mass Index (BMI) estimates (mean, prevalence of 
obesity and overweight) were obtained. BMI estimates were then matched to mean of 
three year-and country-specific availability of total kilocalories per capita per day, major 
food groups (meat, starch, fibers, fats and fruits). The per capita Gross Domestic Product 
(GDP) and prevalence of physical inactivity for each country were also obtained.  SPSS 
was used for log-transformed data analysis.  
Results: Spearman analyses of the different major food groups shows that meat 
availability is most highly correlated with prevalence of obesity (r=0.666, p<0.001) and 
overweight (r=0.800, p<0.001) and mean BMI (r=0.656, p<0.001) and that these 
relationships remain when total caloric availability, prevalence of physical inactivity and 
GDP are controlled in partial correlation analysis. Stepwise multiple linear regression 
analysis indicates that meat availability is the most significant predictors of prevalence 
of obesity and overweight and mean BMI among the food groups. Scatter plot diagrams 
show meat and GDP adjusted meat are strongly correlated to obesity prevalence.   
Conclusion: High meat availability is correlated to increased prevalence of obesity. 
Effective strategies to reduce meat consumption may have differential effects in 
countries at different stages of the nutrition transition.  
Keywords: Obesity, Food group, Meat, Macronutrient, Meat protein, Carbohydrates, Adaptation    
Background 
The global prevalence of obesity and its associated metabolic syndrome has increased 
markedly in adults and children over the past 20 years [1-6]. Once considered a problem 
only in high income countries, obesity is now dramatically on the rise in low- and middle-
income countries, particularly in urban settings. Obesity has been considered as one of 
major risk factors for a number of chronic diseases, including diabetes, cardiovascular 
diseases and cancer [7]. The World Health Organization (WHO) describes obesity as 




Body weight status is determined with reference to the body mass index (BMI). Those 
with a BMI ranging between 18-24.99 kg/m2 are considered healthy. In WHO statistics, 
population segment consisting of individuals with a BMI equal to 25 kg/m2 or higher is 
classified as overweight whilst obesity is reserved for those reaching or exceeding a BMI 
of 30 kg/m2 [9]. WHO also publishes the country-level estimate of mean BMI in kg/m2 to 
reflect its general body weight status.   
It is well recognised that diet and lifestyle are the major contributing factors, yet previous 
population based dietary interventions that focus on one dietary factor such as reducing 
fat intake have been ineffective in combating the increasing rates of obesity [10-12]. 
Although energy intake is recognised as a major contributing factor to the growing 
obesity rates, there is increasing evidence that some dietary patterns have a greater 
influence on promoting body weight gain than others [13]. Food production 
modernization and rising income levels in last decades have made a range of foods 
easily available and affordable with less seasonal variation [14].To combat obesity a 
common approach has been to limit energy intake, although weight loss is often achieved 
in the short term, studies are unable to show that this weight loss is maintained in the 
long term [15]. Of the food groups, meat when consumed at high levels has been shown 
to increase weight gain due to its high energy density and/or fat content [16-20]. Whether 
and how nutrients provided by other food groups contribute to this effect is not known. In 
addition, there is little evidence that diet containing different composition of food groups 
or macronutrients may also be important in determining the development of obesity, yet 
this has yet to be evaluated at the population level.    
Our group recently suggested that the portion size of animal and plant products in the 
modern diet has contributed to obesity prevalence [21]. People from different countries 
have different availability of meat due to their affordability and dietary habits. We 
hypothesise that the persistent consumption of high quantities of meat contributes to 
increasing adiposity and thus obesity when carbohydrates and fats consumed are 
sufficient or overabundant to satisfy caloric needs. Here we test this hypothesis using 
three country specific variables defined by BMI values (prevalence of obesity and 
overweight and mean BMI) and per capita availability data of various major groups of 
foodstuffs (meat, starch crop, fruits, fats and fibers) and the three macronutrients (fats, 
proteins and carbohydrates).     
Methods 




The WHO Global Health Observatory (GHO) data 
The WHO Global Health Observatory (GHO) data on estimated prevalence rates of 
obesity and overweight (percent of population aged 18+ with BMI ≥ 30 and 25 kg/m2 
respectively) and on mean BMI of the population aged 18+ by country was obtained for 
the year 2010 [22].  We did not use the most recent version of three levels of BMI 
(BMI=30, BMI=25 and mean BMI) in 2014, but used the 2010 year data because of other 
key variables of interest (described below). We included overweight prevalence and 
mean BMI in our study in case meat availability was a late-stage predictor of obesity.  
We also captured the estimated prevalence rate of physical inactivity for each country 
for the population aged 18+ [22]. The estimated prevalence rate of physical inactivity is 
defined as percent of defined population attaining less than 150 minutes of moderate-
intensity physical activity per week, or less than 75 minutes of vigorous-intensity physical 
activity per week, or equivalent.  
The GHO is an initiative of the WHO to share data on global health, including statistics 
by country and information about specific diseases and health measures. The GHO 
specifically assembles prevalence data of the biological risk factors, including obesity, 
overweight and mean BMI for WHO Member States using standardized protocols 
(http://www.who.int/gho/ncd/methods/en/).  
The FAOSTAT Food Balance Sheet (FBS) data  
The FAOSTAT Food Balance Sheet (FBS) data on major food group availability per 
capita per day of: i) total meat; ii) starch crops (mixed cereals and starchy root); iii) fibers 
(vegetables and pulses); iv) fats (plant oils and animal fats) and v) fruits [23]. The food 
items in each food group are indicated in the Supporting Information (Table S1).  
We also extracted the availability of grand total calories and macro-nutrients of fats 
(animal and plant, in g/capita/day) and proteins (animal, plant and meat, in g/capita/day) 
from FBS for our study. As animal protein includes meat protein, we subtracted meat 
protein from the animal protein to obtain the variable, “Animal protein, excluding meat 
protein” for more precise data analysis. Following the Atwater system [24], we calculated 
the energy from carbohydrates using the formula: carbohydrates energy per day = total 
calories- fat (grand total, in gram/day) x 9 – protein (total, in gram/day) x 4. For 
carbohydrates availability in g/capita/day, we used the energy in kilocalories (kcal) 
divided by 4. Because obesity develops after cumulative exposure to dietary risks (i.e. 
high intake of risk food groups today does not lead to immediate obesity, but a prolonged 




per person per day over a 3-year period (2007-2009) in each of these food categories to 
represent typical long-term exposure to each of these dietary components. The rationale 
for this decision is that studies have shown that three years is a practical period to 
develop metabolic syndrome leading to obesity after exposure to dietary risks (i.e. high 
intake of meat today does not lead to immediate obesity) [25-27]. Using the mean of 
three years of nutrients and food groups may also reduce the random errors during the 
data collection and calculation by FAO.  
The FAOSTAT database disseminates statistical data collected and maintained by the 
FAO. FAOSTAT data are provided as a time-series from 1961 in most domains through 
the Food Balance Sheet (FBS, http://faostat3.fao.org/home/E). The FBS presents a 
comprehensive picture of the pattern of a country's food supply during a specified 
reference period. The FBS shows for each food item i.e. each primary commodity 
availability for human consumption which corresponds to the sources of supply and its 
utilisation. The total quantity of foodstuffs produced in a country added to the total 
quantity imported and adjusted to any change in stocks that may have occurred since 
the beginning of the reference period gives the supply available during that period. On 
the utilisation side a distinction is made between the quantities exported, fed to livestock 
+ used for seed, losses during storage and transportation, and food supplies available 
for human consumption. The per capita supply of each such food item available for 
human consumption is then obtained by dividing the respective quantity by the related 
data on the population actually partaking in it [28].  
Minimum Dietary Energy Requirements, expressed as kcal per person per day, is the 
weighted average of the minimum energy requirements of the different gender-age 
groups in the population with light activity. Grantham et al. reported that when a mixed 
meal of protein, carbohydrate and fat is consumed, carbohydrates and fats are digested 
faster and metabolised to satisfy body's energetic needs while slower digested protein is 
ultimately and stored as fat [29]. Therefore, we extracted the Minimum Dietary Energy 
Requirements from the FAO website (http://www.fao.org/) and compared it and with the 
energy from carbohydrates and fats by country to see if the energy from the proteins is 
the surplus.   
The World Bank data  
The World Bank dataset measures progress on aggregate outcomes for member 
countries for selected indicators.  GDP PPP is gross domestic product converted to 
international dollars using purchasing power parity rates 




average income in constant 2010 $US adjusted for purchasing power parity for cross-
country comparability.   
WHO, FAO and the World Bank are intergovernmental organizations using specialized 
information relevant to their respective fields. Their professional personnel should have 
evaluated these data in consideration of their possible use, e.g. for scientific research 
and decision making, before they were published. Therefore, the data reporting is as free 
of bias and error as it can be with government statistics. This means that errors are 
reduced but some inaccuracies related to reporting quality may still be present in the 
data. Similar data from the same sources were recently used to analyse the relationships 
between nutrients and obesity [31, 32] and diabetes [33-35] in a number of publications.   
We obtained data for 170 countries after we matched the prevalence estimates of obesity 
and overweight and mean BMI to the year-and country-specific food and other variables. 
Each country was treated individually as the subject and all their availability for other 
variables information was analysed. The detailed information of country-level estimates 
is in the Supporting Information (Table S2).     
For particular analyses, the number of countries included may have differed somewhat 
because all information on other variables was not uniformly available for all countries 
due to unavailability from relevant UN agencies. All the data were extracted and saved 
in Microsoft Excel® for analysis. Data sources and summary statistics are further 
described in the Supporting Information (Table S3).    
Statistical analysis 
The prevailing dogma of obesity is that obesity is an affluence related medical conditions 
[36], which is generally caused by eating too much (too much calories intake) [37] and 
moving too little (physically inactive) [38]. Therefore, in this study we used GDP PPP, 
total calories and prevalence of physical inactivity as the potential confounders and the 
other variables are divided into two sets, i.e. major food group and macronutrient for data 
analysis in 5 steps.   
Spearman rank correlation analyses was used to evaluate the strength and direction of 
the associations between food group and macronutrient availability for consumption and 
prevalence estimates of overweight and obesity and mean BMI.  
Partial correlation was used to find the unique variance between each food group and 
macronutrient and prevalence of obesity and overweight and mean BMI respectively 




order to show the independent correlation of meat and meat protein to the three variables 
defined by BMI (BMI≥30, BMI≥25 and mean BMI) respectively, we controlled for three 
potential confounders (total calories, GDP PPP and physical inactivity) plus all other food 
groups and all other macronutrient variables respectively for partial analysis.  
Stepwise multiple linear regression modelling was performed to identify and rank 
predictors (independent variables) of prevalence of obesity, overweight and mean BMI 
respectively from two sets of data of food groups and macronutrients respectively.  
Scatter plots were used to explore the relationship between meat and meat protein (both 
GDP adjusted) and three variables defined by BMI. Scatter plots were also used to 
explore the relationship between prevalence of obesity and each food group and 
macronutrient respectively.  
Human diet patterns varying in different food components may be affected by the types 
of food availability in a particular region, socio-economic status and cultural beliefs. In 
order to demonstrate that correlation universally exists between meat availability and 
obesity regardless of these factors, countries were grouped for correlation analyses. The 
criteria for grouping countries the World Bank income classifications [39], WHO regions 
[40], countries sharing specific characteristics like geography, culture, development role 
or socio-economic status, like Latin America and the Caribbean (LAC) [41], Organisation 
for Economic Co-operation and Development (OECD) [42], Asia-Pacific Economic 
Cooperation (APEC) [42], Southern African Development Community (SADC) [43], the 
Arab World [42], Latin America (LA), and Asia Cooperation Dialogue (ACD) [44]. All the 
country listings are sourced from their official websites for matching except LA which is 
self-classified based on region primarily speaking romance languages. Countries 
included in LA are listed in the Supporting Information (Table S4).  
SPSS v. 22 (SPSS Inc., Chicago Il USA) was used for data analysis and the statistical 
significance was set at the 0.01 level (two-tailed). Prior to analysis data were log-
transformed to bring their distributions close to normal.  
Results 
Spearman rank correlation analyses of the different major food groups shows that meat 
availability is most highly correlated with prevalence of obesity (r=0.666, p< 0.001) and 
overweight (r= 0.800, p< 0.001) and mean BMI (r= 0.656, p< 0.001) and that these 
relationships remain when total caloric availability, prevalence of physical inactivity and 
GDP PPP are kept statistically constant in partial correlation analysis (Table 1). Starch 




p< 0.01) and overweight (r=-0.228, p< 0.01) and mean BMI (r= -0.318, p< 0.001), but the 
relationship does not remain in our partial correlation analysis (Table 1). Interestingly, in 
Spearman rank correlation analyses fats group is second to meat in significant 
correlation with prevalence of obesity (r=0.517, p< 0.001) and overweight (r= 0.728, p< 
0.001) and mean BMI (r= 0.438, p< 0.001). However, these relationships nearly 
disappear in the succeeding partial correlation analysis with controlling for total caloric 
availability, prevalence of physical inactivity and GDP (Table 1).   
Table 1 also presents the strongest significant correlation between meat protein 
availability and prevalence of obesity (r=0.673, p< 0.001) and overweight (r= 0.793, p< 
0.001) and mean BMI (r=0.660, p<0.001). This correlation is sustained when total caloric 
availability, prevalence of physical inactivity and GDP PPP are kept statistically constant 
in partial correlation analysis (Table 1). Animal protein (excluding meat protein) shows 
quite high nonparametric correlation coefficients with prevalence of obesity (r=0.522, p< 
0.001) and overweight (r= 0.741, p< 0.001) and mean BMI (r=0.516, p<0.001), but this 
correlation is not sustained in succeeding partial analysis (Table 1). Plant protein group 
shows slightly negative correlation with all the three stages of body weight (BMI ≥ 30, 
BMI≥25 and mean BMI) in Spearman rank correlation analyse, but the relationships are 
relative strong (not at significance level of p<0.001 yet) in partial correlation analysis with 
controlling for total caloric availability, prevalence of physical inactivity and GDP (Table 
1). Both animal fat and plant oil food types are correlated with prevalence of obesity 
(r=0.581, p<0.001 and r=0.440, p<0.001respectively) and overweight (r=0.803, p<0.001 
and r=0.570, p<0.001 respectively) and mean BMI (r=0.574, p<0.001 and r=0.371, p< 
0.001respectively) in Spearman rank correlation analyses. However, in the succeeding 
partial correlation analysis the significance either does not remain or becomes weak 
except the correlation between animal fats group and prevalence overweight (r=0.358, 
p<0.001). Carbohydrates energy shows the relative significant correlation with 
prevalence of obesity (r=0.230, p<0.01) and overweight (r=0.202, p<0.01) and mean BMI 
(r=0.208, p<0.01), but this relationship becomes slightly negative in partial correlation 
analysis (Table 1).   
Meat and meat protein are in significant correlation with prevalence of obesity (r=0.356, 
p<0.001 and r=0.392, p<0.001 respectively) and overweight (r=0.421, p<0.001 and 
r=0.431, p<0.001 respectively) and mean BMI (r=0.380, p<0.001 and r=0.400, p<0.001 
respectively) when we control for the potential confounders, total calories, GDP and 
physical inactivity in partial analysis (Table 1). Meat availability is also significantly 




and mean BMI (r=0.339, p<0.001) when we controlled for the four other food groups and 
the three potential confounders in partial correlation. We have the similar correlation of 
meat protein to three variables defined by BMI respectively when we controlled for the 
other five macronutrients and the three potential confounders (Table 1).   
Table 1 Spearman and partial correlation between food groups and three variables defined by 
BMI (obesity, overweight and mean BMI) 
  
Variables  




 BMI≥30 BMI≥25 
BMI 
mean 
Food group         
Meat, total   0.666*** 0.800*** 0.656***  0.356*** 0.421***  0.380*** 
Meat, total, all variable controlled+     -   -    -  0.357*** 0.415***  0.339*** 
Fats (plant oil + animal fat)   0.517*** 0.728*** 0.483***    0.077      0.166  -0.005 
Fruits, total    0.467*** 0.521*** 0.461***    0.173 0.197*  0.258** 
Fibers (vegetables + pulses)   0.315*** 0.516*** 0.330***   -0.197*     -0.035  -0.107 
Starch (cereals + starchy root) -0.205** -0.228** -.318***    0.078     -0.011  -0.085 
Macronutrient        
Meat protein  0.673*** 0.793*** 0.660***    0.392***  0.431***  0.400*** 
Meat protein, all variable 
controlled++ 
   -   -    -    0.316***      0.183*  0.299*** 
Animal protein, excluding meat 
protein   
 0.522*** 0.741*** 0.516***  0.017 0.214*   0.029 
Plant protein, total  -0.094 -0.063 -0.094  -0.227*  -0.333***  -0.248* 
Animal fats, total   0.581*** 0.803*** 0.574***    0.196*   0.379***   0.222* 
Plant fats, total   0.440*** 0.570*** 0.371***    0.252*  0.230**   0.201* 
Carbohydrates 0.230**   0.202** 0.208**   -0.193*  -0.324***  -0.166 
Potential confounder        
Calories, total  0.623*** 0.805*** 0.563***  - - - 
GDP PPP  0.642*** 0.808*** 0.610***  - - - 
Physical Inactivity  0.438*** 0.384*** 0.460***  - - - 
Spearman's rho of correlation and partial correlation are reported. Numbers of countries (df) included in the 
two correlation analyses are 161-170 and 115-123 respectively.   * P˂ 0.05, **P˂ 0.01; ***P˂ 0.001.  
BMI≥30 and BMI ≥ 25 are percentages of defined population with a body mass index (BMI) of no less than 
30 kg/m2 and 25 kg/m2 respectively. BMI mean is the mean body mass index (BMI) in kg/m2 of defined 
population. 
Availabilities of food types (meat, fats, fruits, fibers and starch) and macronutrients (meat protein, animal 
protein (excl. meat protein), plant protein, animal fats, plant fats and carbohydrates) are expressed in 
g/capita/day.  
Total calories is in kcal/capita/day. GDP PPP is in per capita USD per year.  Physical inactivity is defined 
as the percent of defined population attaining less than 150 minutes of moderate-intensity physical activity 
per week, or less than 75 minutes of vigorous-intensity physical activity per week, or equivalent. 
+ Partial analysis with controlling for fats (plant oil + animal fat), Fruits, total (total), Fibers (vegetables + 
pulses) and Starch (cereals + starchy root) and the three potential confounders, calories, GDP PPP and 
physical activity.   
++ Partial analysis with controlling for Animal protein (excluding meat protein),   Plant protein (total), Animal 
fats (total), Plant fats (total) and Carbohydrate energy and the three potential confounders, calories, GDP 







We also used scatter plots to show the relationship between prevalence of obesity and 
each food group and macronutrient. See the Supporting Information (Figures S 1 and 2). 
Table 3 shows that generally meat availability is positively correlated with prevalence of 
obesity and overweight and mean BMI can be observed in different country groupings 
regardless of cultural backgrounds, economic levels and geographic locations of the 
clustered countries.  
Table 3 Correlation of meat availability to prevalence of obesity and overweight and mean BMI in 
different country groupings       
Country groupings BMI ≥30 BMI ≥25  BMI, Mean 
Worldwide (n=167) 0.666***            0.800***       0.656*** 
World Bank income classifications  
    Low (n=31)           0.167            0.254       0.196 
    Low middle (n=41)            0.439**            0.537***       0.465** 
    Upper middle (n=47)            0.167            0.149       0.209 
    High (n=48)           0.241            0.631***       0.288* 
WHO regions  
    AFRO (n=40) 0.585*** 0.612***       0.552*** 
    AMRO (n=35) 0.671*** 0.606***       0.546*** 
    EMRO (n=15) 0.857*** 0.879***       0.634* 
    EURO (n=50)          0.429** 0.751***       0.128 
    SEARO (n=10)          -0.267             -0.097       0.322 
    WPRO (n=17)          0.309              0.478       0.447 
Countries grouped based on various factors    
   APEC (n=17)          0.773*** 0.858***       0.789*** 
   Arab World (n=13)         0.687**              0.687**       0.426 
   LAC (n=26)         0.609***              0.519**       0.487** 
   OECD (n=34)         0.243 0.607***       0.285 
    SADC (n=14)         0.890
*** 0.952***       0.802*** 
    ACD (n=26)         0.593
*** 0.720***       0.707*** 
    LA (n=20)         0.557
* 0.675***       0.433 
Spearman's rho of correlation is reported. Number of countries included in the analysis range from 161 to 170.   
* P˂ 0.05, **P˂ 0.01; ***P˂ 0.001 
BMI≥30 and BMI ≥ 25 are percentages of defined population with a body mass index (BMI) of no less than 30 
kg/m2 and 25 kg/m2 respectively. BMI mean is the mean body mass index (BMI) in kg/m2 of defined population.  
Availabilities of food types (meat, fats, fruits, fibers and starch) and macronutrients (meat protein, animal protein 




Based on the WHO region classifications, the positive correlation is observed in every 
region except in SEARO.  
The correlation between meat availability and three variables defined by BMI can also 
be observed in the country groupings of the Arab World (geographically scattered in Asia 
and Africa) and LAC (located in Americas only) featured with the similar cultures 
respectively. The trends also present in two functional alliances, OECD and APEC 
although the former comprises developed countries only and the latter is comprised of 
both developing and developed countries.     
We subtracted grand total protein energy from grand total calories to allow us to obtain 
the energy from grand total fats and carbohydrates in kcal/capita/day [28], which is more 
than the minimum dietary energy requirements in all countries except Haiti (-29.3 
kcal/capita/day) and Zambia (-90.9 kcal/capita/day).  
Discussion 
The worldwide secular trend of increased obesity prevalence likely has multiple 
aetiologies, which may act through multiple mechanisms. By examining the per capita 
availability of the major food groups and macronutrients for 170 countries we have shown 
that populations with the highest availability levels of meat (meat protein) have the 
highest prevalence of overweight and obesity and greatest mean BMI. Meat is most 
significant predictor of prevalence of obesity and overweight and mean BMI at country 
level, and this relationship is independent of total calories availability, GDP and 
prevalence of physical inactivity. Our finding of the relationship between meat availability 
and body weight increase is consistent with data from Belgium [45] and USA [46-48] that 
showed a positive association between obesity prevalence among adults and children 
and meat consumption. Studies in China also showed that high intakes of meat products, 
including red meat were associated with the prevalence of obesity [49, 50]. A survey in 
Ireland showed that young girls avoided meat because they concluded that “‘meat is a 
fattening food” [51]. The association for the Chinese population is particularly striking as 
the changes in dietary patterns and obesity rates have occurred very rapidly [52]. All 
these studies based on the individual level held the view that fat in meat contributed to 
obesity or body weight increase even though fresh meat has been leaner than ever over 
the past few decades due to leaner animals being bred and improved butchery and 
feeding techniques that make fat content fall significantly [53, 54]. The correlation we 
found in this study between the three major macronutrients or their proxy food groups 




modern diet, carbohydrates and fats are digested to satisfy body's energetic needs while 
protein is converted and stored as fat [29].  
The human metabolic system has been adapting to forager diet for millions of years [56], 
and adaptations to an agriculture-based diet only started a few thousand years ago in 
most populations [29, 57]. An evolutionary mismatch between modern dietary 
constituents and the food available prior to the agricultural revolution has long been 
considered a factor in the obesity epidemic [58]. In the Palaeolithic age our ancestors’ 
diet comprised of what could be extracted from natural environments through gathering, 
scavenging and hunting and thus predominately consisted of animal protein [59]. In 
addition to hunting large animals, the main food sources included smaller animals such 
as amphibians, reptiles, invertebrates and their eggs, but also plant products, such as 
tubers, fruits and nuts that could be collected seasonally. In general, there was limited 
availability of animal and plant food, but plant sources were often least available [21]. 
Fats do not occur in large quantities in plants or wild animals. In the foraging situation 
ingested protein was mainly used for energy production as available carbohydrates from 
plants would be too scarce to satisfy human energy needs [56]. This use of protein was 
possible as humans have efficient deaminases that can convert amino acids to carbon 
skeletons that, when broken down to pyruvate can be processed in the citric acid cycle, 
or de novo lipogenesis, or gluconeogenesis [21]. Occasionally, when there was an 
abundant meat source, e.g. a large mammal, surplus ingested protein was efficiently 
stored in the human body as adipose tissue [60]. Thus, the human metabolic system has 
evolved over thousands of years to predominately rely on animal protein and to a lesser 
degree carbohydrate and fats to satisfy our energy needs and to store surplus food intake 
into the adipose tissue [21]. Further support of human adaptation and dependence on 
protein for energy, comes from similarities in total energy intake (standardised by body 
mass) and intestinal tract morphology between modern humans and extant carnivores 
[21].  
In the current study animal products provided less than half (3.1% - 44.5%) of the 
individual daily energy requirement for all countries examined [23], and a majority of 
energy came from plant products. Interestingly, there are a number of different weight 
loss diets that are high in animal and low in plant products such as the Atkins Nutritional 
Approach [61-63]. Although these diets can be effective in reducing weight in the short 
term, energy restriction is difficult to maintain long term and a majority of people regain 
any weight that was lost [15]. Daily energy requirements of modern humans may be 




whereas consumed concurrently animal products, including meat that are more costly 
and slower to digest, will be metabolised into fat and stored [21]. The FAO/WHO currently 
recommends that our dietary protein should make up 10-15 percent of calorie intake [64]. 
It has been reported that consuming an amount of protein above the FAO/WHO 
recommendation may be deleterious for weight maintenance through adult life [65]. In 
support of this, the PANACEA project which used data from the EPIC cohort [66] showed 
that participants consuming more than 22% of energy from protein had 23-24% higher 
risk of becoming overweight or obese than participants consuming a diet low in protein 
(≤14%) [66]. Additionally, a 5% higher proportion of protein at the expense of 
carbohydrates was associated with a 247g weight gain in men (95% CI = (160,334)) and 
a 388g weight gain (296,480) in women after 5 years [66]. Furthermore, increasing the 
proportion of fat by 5% at the expense of carbohydrates during the same period showed 
no association with body weight increase [66].  
Experiments among young males and rats undertaken by Mikkelsen et al. [67] and Toden 
et al. [68] respectively did not show the high meat protein quantity was associated with 
body weight increase. The underlying reasons may be that the used diets contained too 
much meat protein which was over FAO/WHO recommended level and/or that these 
experiments focused on one or two sources of proteins, which did not reflect the actual 
protein metabolism within human body. Two case-controlled studies have shown that 
adults and children consuming vegetarian diets have lower BMI values and a lower 
prevalence of obesity [69, 70]. A medical and performance testing of 46,684 Swiss 
showed that obesity rates were also markedly lower in vegetarian adults [29] and 
epidemiological studies have consistently shown that vegetarians are thinner than 
comparable non-vegetarians [71]. A meta-analysis of adult vegetarian diet studies 
estimated a reduced weight difference of 7.6 kg for men and 3.3 kg for women, which 
resulted in a 2-point lower BMI [69]. Although there are some animal data suggesting 
that diets low in protein may increase the prevalence of obesity [72], evolutionary 
differences between humans and other animal species may explain our different 
metabolic response to dietary protein [73]. Rats [74] and mice [75] model experiments 
have shown that dairy protein rich diet reduces adiposity, which might be interpreted that 
the associations between dairy protein and overweight and obesity are not as strong as 
meat protein in this study. Our results show animal protein (excluding meat protein) is 
associated with the three stages of BMIs, but not as significantly as meat protein does 
may be because protein from dairy [74] and fish products [76] don’t contribute to body 




There is a growing body of evidence which suggests that increased plant protein intakes 
are protective of body weight gain. A longitudinal association study in the US showed 
that people with the highest levels of plant protein intake had a reduced risk of being 
obese [48]. A similar association was found in the Belgian population using a food 
consumption survey [45]. These findings are consistent with the current study which 
showed that plant protein consumption rates were inversely associated with prevalence 
of both overweight and obesity [50] and mean BMI. Plant and meat protein may have 
different effects on body weight [48] because of their differences in amino acid 
composition [77]. Generally, dietary plant protein in food is mixed with indigestible 
carbohydrate (fiber) that can reduce plant protein digestibility. Therefore, plant protein 
varies in its digestibility and may provide considerably less energy compared to meat 
proteins.  
The current study shows an inverse association between starch food group (mixed 
cereals and starchy root) and carbohydrates availability and prevalence of overweight 
and obesity and mean BMI. Cereals and starchy roots are grown in greater quantities 
and provide more food energy worldwide than any other type of crop. Carbohydrates are 
not an essential nutrient in humans [78, 79] even though they are a common source of 
energy. For instance, carbohydrate content in foods provide 70 percent or more of the 
energy intake of the population in the developing countries and about 40 percent in the 
United States and Europe [80]. Humans are the only large mammal that derives a 
majority of its energy by absorbing and metabolising carbohydrate. Because 
carbohydrate metabolism primarily concentrates on the oxidation of carbohydrates in the 
direct production of energy, this rarely produces fat [78, 81]. 
Our results show that both plant oils and animal fats are significantly associated with 
mean BMI, overweight and obesity in Spearman analysis, but the significance of this 
relationship disappears or is reduced because we controlled for total calories, GDP and 
prevalence of physical inactivity in partial correlation analysis. Numerous studies have 
shown increased intakes of dietary fat increase obesity risk/development [82-86]. 
However, a causal relationship between fat intake and obesity prevalence based on 
these studies [87-89] is difficult to demonstrate. Furthermore, the third American National 
Health and Nutrition Examination Survey showed that in the past two decades in United 
States, the prevalence of obesity has increased whereas the fat consumption was 
reduced [90, 91]. Therefore, the increase in obesity cannot be explained by changes in 




A strength of this study is that we used per capita availability data from 170 countries 
which enabled us to examine relationships in food group and macronutrient intake and 
how they may explain differences in the rates of prevalence of obesity and overweight 
and mean BMI at population level. However, there are several limitations in this study. 
Firstly, although we attempted to remove confounding effects of variables such as GDP, 
caloric etc. by means of partial correlation analysis, some confounding factors may still 
influence correlation we found. Secondly, there may be some variables not included in 
our analysis that influence the correlation found in this study. It is however difficult to see 
what such variables may be. Thirdly, we could only use an international food database 
that tracks the general market availability of different food types, not the actual human 
consumption. There are no direct measures of actual human consumption that can 
account for food wastage and provide precise measures of food consumption 
internationally. Fourthly, we were unable to analyze associations of food groups with 
obesity by each individual food item at country level. One of the main reasons is that 
some country may not access some particular food item due to its availability in their 
region, socio-economic status or cultural beliefs. For instance, pig meat (pork) is not 
consumed in Muslim countries or less consumed in countries with Muslim population, 
but they consumed mutton and lamp and other animal meat which share similar 
nutritional properties. Finally, the data analysed are calculated per capita in each country, 
so we can only demonstrate a relationship between food group availability and obesity, 
overweigh and mean BMI at a country level, which does not necessarily correspond to 
the same relationships holding true at the individual level. Prospective cohort studies are 
proposed to explore these associations further.   
Conclusion  
By examining the per capita availability of macronutrients and the major food groups for 
170 countries we are able to identify that countries with dietary patterns that are higher 
in meat have greater rates of obesity and overweight and higher mean BMI. Considering 
the findings of adverse effect of obesity on the risk of other chronic diseases revealed by 
other studies as well as the environmental impact of meat production, the country 
authorities may advise people not to adopt a high-meat diet for long-term healthy weight 
management.  
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Table S1: Food items included in each food group for this study 
The following food groups are based on the major nutrient content and the role of the foodstuffs in human nutrition. 
Food group 
Items included  
This study FAO definition 
Meat Meat, total Beef and veal, Buffalo meat, Pig meat, Mutton and lamb, Goat meat, Horse meat, Chicken meat, Goose meat, Duck meat, 
Turkey meat, Rabbit meat, Game meat and Offal 
Fruits  Fruits  Melons, Watermelons, Apples, Apricots, Avocados, Cherries, Figs, Grapes, Mangoes, Papaya, Peaches, Pears, Persimmons, 
Pineapples, Plums, Quinces, Blueberries, Gooseberries, Raspberries, Strawberries, Kiwi, Dates, Figs (dried), Prunes, 
Currants, Raisins and Other fresh and dried fruits 
Fibers  Vegetables 
Beets, Carrots, Turnips, Rutabagas or swedes, Onions (green), Onions (dry), Artichokes, Tomatoes, Asparagus, Cabbage, 
Cauliflower, Celery, Kale, Lettuce, Spinach, Beans (green), Broad beans (green), Chilli peppers, Garlic, Cucumbers, 
Mushrooms, Eggplant, Peas (green), Pumpkins, Squash, Gourds, Okra, Radishes and Other vegetables 
Pulses  Beans (dry), Broad beans (dry), Peas (dry), Chick peas, Cow peas, Pigeon peas, Lentils, Vetches, Lupins and Other pulses 
Starch  Starchy root  Potatoes, Sweet potatoes, Cassava, Taro, Yams and Other roots and tubers 
Cereals  Wheat, Rye, Barley, Oats, Maize, Rice, Mixed grains, Buckwheat, Sorghum, Millet, Quinoa and Other cereals 
Fats  
Vegetable oil  
Sunflower seed oil, Cottonseed oil, Linseed oil, Hempseed oil, Sesame seed oil, Copra and coconut oil, Palm kernel oil, Palm 
oil, Soybean oil, Olive oil and Maize oil 
Animal fats Butter, Ghee, Fish liver oil, Whale oil and Other animal fats 














Table S4: Countries included in Latin America in our study.   
Based on region primarily speaking romance languages, Latin America contains the 
following countries.    
Argentina, Bolivia (Plurinational State of), Brazil, Chile, Colombia, Costa Rica, Cuba, 
Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Mexico, 
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Contexture Statement 
Sugar is well-established predictor of obesity worldwide because it may cause metabolic 
syndrome and it may provide energy surplus to human body. Our previous study suggested that 
meat protein may have the same mechanism to contribute to body weight increase, thus obesity.  
In this study, we collected the empirical nutrient data at the country level to assess and compare 













Background: The public have been educated that sugar intake should be minimized to avoid 
obesity, but no such recommendation regarding meat exists. We used FAO published comparable 
sugar and meat availability data to examine if they both contribute to obesity prevalence to the 
same extent.    
Methods: Country-specific Body Mass Index (BMI) estimates of obesity and overweight were 
obtained. These were matched with country-specific per capita per day availability of major food 
groups (meat, sugar, starch crops, fibers, fats and fruits), total calories, per capita Gross Domestic 
Product (GDP PPP), urbanization and physical inactivity prevalence. Fisher’s r-to-z 
transformation and Beta (B) range (B ± 2 Standard Error) overlapping were used to test for 
potential differences between correlations and regressions results respectively. SPSS 22.0 was 
used for log-transformed data analysis. 
Results: Pearson correlation showed that sugar and meat availability significantly correlated with 
obesity prevalence to the same extent (r=0.715, p<0.001 and r=0.685, p<0.001 respectively). 
These relationships remained in partial correlation analysis (r=0.359, p<0.001 and r=0.354, 
p<0.001 respectively) when controlling for calories availability, physical inactivity, urbanization 
and GDP PPP. Fisher's r-to-z transformation revealed no significant difference in Pearson 
correlation coefficients (z=-0.53, p=0.60), partial correlation coefficients (z=-0.04, p=0.97) 
between sugar and meat availability with obesity prevalence. 
Multiple linear regression analysis indicated that sugar and meat availability were the two most 
significant predictors of obesity prevalence in both Enter (B=0.455, SE=0.113, p<0.001 and 
B=0.381, SE=0.096, p<0.001, respectively) and Stepwise (B=0.464, SE=0.093, p<0.001 and 
B=0.433, SE=0.072, p<0.001, respectively) models. B ranges overlapping found in the Enter 
(0.289-0.573) and Stepwise (0.294-0.582) models showed sugar and meat availability correlated 
to obesity with no statistically significant difference.   
Conclusion: Sugar and meat availability comparably contribute to global obesity prevalence. 
Dietary guidelines should also advocate to minimize meat consumption to avoid obesity.  
Keywords: Obesity, Sugar, Fructose, Meat, Meat protein, Fats, Insulin resistance, Energy 





Obesity has been considered a major epidemic of the 21st century, and it has become a prelude 
to adverse health and premature death (1). The World Health Organisation (WHO) estimates that 
obesity contributes significantly to the disease burdens of, among others, top causes of diseases, 
such as diabetes (44%), ischaemic heart disease (23%) and carcinogenesis (7-41%) (2). 
Moreover, those considered overweight or obese have been subject to discrimination and 
prejudice (3).  
Obesity and overweight are defined as abnormal or excessive fat accumulation that presents a 
risk to health. A crude population measure of obesity is the body mass index (BMI). A person with 
a BMI of 30 kg/m2 or more is generally considered obese. A person with a BMI equal to or more 
than 25 kg/m2 is considered overweight (http://who.int/topics/obesity/en/).  
Until the invention of food production in the Holocene for several million years, human diet had 
relied on foods that could be found in natural environments. Since humans are unable to extract 
nutrition from cellulose, our food sources were limited to animals, fruits, nuts and tubers. This 
Palaeolithic diet contained large quantities of meat obtained through hunting (4) while it had less 
carbohydrates, especially simple carbohydrates. Besides large game that was hunted or 
scavenged, small vertebrates and invertebrates were gathered, and, where possible, fish were 
caught. Game meat does not contain much fats, so our metabolic system evolved to be efficient 
in using animal protein as a source of energy (5). Deriving Acetyl CoA for use in the citric acid 
cycle from proteins is a complex process using a number of enzymes to obtain peptides, break 
them into separate aminoacids and then deaminate those amino acids to obtain carbon skeletons 
– a source of pyruvates. Any pyruvates not used in the citric acid cycle to obtain energy can be 
converted via de novo lipogenesis into fats and stored. Obtaining pyruvates from carbohydrates 
is a simpler metabolic process, especially when simple carbohydrates that are easily breakable 
into glucose are consumed. Therefore, when simple carbohydrates are available in the diet they, 
soon after their ingestion and absorption, can be used to provide energy in the citric acid cycle 
while additional pyruvates coming later from protein digestion may be surplus to direct need for 
energy, and therefore converted into fat (6). Sucrose, being a compound of glucose and fructose 
provides easily accessible energy from glucose while fructose is not easily digested. Since the 
introduction of agriculture, and especially from the time of industrialised food production, sucrose 
became readily available in large quantities. In traditional agricultural economies meat was 
expensive to produce and thus was consumed in small quantities, rather rarely. Mass animal 
husbandry lowered cost of meat production and now meat is readily available and regularly 
 
139 
consumed in significant quantities in developed economics.Diet patterns have been extensively 
considered as the contributing factor to obesity. Sugar and meat are now two major food groups 
in our daily diet. The prevailing dogma is that we should limit or avoid sugar intake, and eat a 
moderate amount of meat, preferably lean meat since it is a source of essential aminoacids. This 
dogma is supported by various dietary or nutrition guidelines published by the authorities. 
Numerous studies have reported that meat (7) and added sugar (sugar in short hereafter) (8) food 
groups were in significant correlations to obesity and/or body weight increase. However, the 
majority of the studies could not single out total sugar or all meat consumption in our diet for the 
correlation analysis. One of the concrete evidences that sugar consumption was correlated to 
obesity is that sugar-sweetened beverages (SSBs) intake is associated with obesity prevalence 
(9). Despite the correlations between sugar food and beverage products and obesity are 
controversial, SSBs has been mostly consistently correlated to obesity prevalence (8). However, 
sugar consumed via beverage is only part of the dietary sugar intake, and other sugar products, 
such as confectionery and bakery products were not included in the study designs. Similarly, meat 
containing food groups rather than pure meat are considered for example processed meat (10) 
instead of total meat intake (11) have been linked to obesity prevalence. Another issue with meat 
food group is that data used for study may not be able to exclude bias from other food components, 
which may have been linked to body weight increase. For instance, wheat consumption has been 
correlated to obesity (12, 13), and meat food groups containing wheat products (frankfurter and 
sausage) could be associated with obesity and central obesity (11) because of their wheat content. 
Likewise, the correlation between SSBs and obesity prevalence may be biased with other obesity 
associated additives in SSBs, such as preservatives. Therefore, these research results may not 
present the whole picture of the correlation between obesity prevalence and sugar or meat 
consumption. Using these data may not allow us to explore and compare the correlations between 
obesity prevalence and total intake of sugar and meat accurately.  
The Food and Agriculture Organization (FAO) Food Balance Sheet presents the comparative per 
capita availability of major food items during the reference period by country after combining 
sources of supply and its utilization in terms of nutrient value. This study aimed to use empirical, 
macro-level nutrient availability data at the country level to evaluate and compare, from a global 
perspective, the correlation levels of obesity prevalence to sugar and meat availability. 
Materials and Methods 
Data  
The country specific data were collected for this study:  
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1) The WHO Global Health Observatory (GHO) data on estimated prevalence rates of obesity 
and overweight (percent of population aged 18+ with BMI ≥ 30 and 25 kg/m2 respectively) of the 
population aged 18+ by country were obtained for the year 2010 
(http://www.who.int/gho/database/en/).  We did not use the most recent version of body weight 
status in 2014 because of other key variables of interest (described below).  
From GHO, we also captured the estimated prevalence rate of physical inactivity for each country 
for the people aged 18+. The estimated prevalence rate of physical inactivity is defined as percent 
of a given population attaining less than 150 minutes of moderate-intensity physical activity per 
week, or less than 75 minutes of vigorous-intensity physical activity per week, or equivalent.  
2) The FAOSTAT Food Balance Sheet (FBS) data on major food group availability per capita per 
day of: i) sugar (total sugar & sweeteners); ii) total meat; iii) starch crops (mixed cereals and 
starchy root); iv) fibers (vegetables, treenuts and pulses); v) fats (plant oils and animal fats) and 
vi) fruits. We also extracted the per capita per day availability of grand total calories (calories in 
shorted hereafter) as one of the potential confounders of our data analysis. Unfortunately, 
FAOSTAT does not contain data allowing separation of processed meats from “pure meat”. 
Because obesity develops after cumulative exposure to dietary risks (i.e. high intake of risk food 
groups today does not lead to immediate obesity, but a prolonged exposure to high intake of risk 
food type(s) is required (14-16).), we calculated the mean food availability per person per day 
over a 3-year period (2007-2009) in each of food categories to represent typical long-term 
exposure to each of these dietary components. The rationale for this decision is that studies have 
shown that three years is a practical period to develop metabolic syndrome leading to obesity 
after exposure to dietary risks. For instance, high intake of meat today does not lead to immediate 
obesity. Using the mean of three years of nutrients and food groups may also reduce the random 
errors during the data collection and calculation by FAO.  
The food items in each food groups were listed the Additional file 1: Food items in each food 
group.    
3) The World Bank data on per capita GDP PPP (expressed in gross domestic product converted 
to international dollars using purchasing power parity rates) and country specific urbanization (the 
percent of population living in urban areas.  Urbanization has been closely linked to human 
lifestyle change due to its process of modernization and industrialization. 
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How the above variables, such as food types (nutrients) and BMI were data collected and how 
they lead to their robustness and to the subsequent validity of the current analysis have been 
described in details elsewhere (17, 18). 
WHO, FAO and the World Bank are intergovernmental organizations using specialized 
information relevant to their respective fields. Their professional personnel should have evaluated 
these data in consideration of their possible use, e.g. for scientific research and decision making, 
before they were published. Therefore, the data reporting is as free of bias and error as it can be 
with government statistics. This means that errors are reduced but some inaccuracies related to 
reporting quality may still be present in the data. Similar data from the same sources were recently 
used to analyse the relationships between nutrients and obesity (18, 19) and diabetes (20-22) in 
a number of publications.   
We obtained data for 170 countries after we matched the prevalence estimates of obesity and 
overweight to the year-and country-specific food groups and other variables. Each country was 
treated individually as the subject and all their availability for other variables information was 
analysed. Data sources and summary statistics were further described in Additional file 2 Data 
descriptive summary and source.         
For particular analyses, the number of countries included for variables may have differed 
somewhat because all information on other variables was not uniformly available for all countries 
due to unavailability from relevant UN agencies. All the data were extracted and saved in Microsoft 
Excel® for analysis.   
Statistical analyses    
It has been commonly believed that obesity is an affluence related medical condition (23), which is 
generally caused by eating too much (dietary) (24) and moving too little (lifestyle) (25). 
Urbanization is a population shift from rural to urban areas. It causes changes in diet and exercise 
patterns of the population (26). Therefore, in addition to the seven dietary predictors (availability 
of sugar, meat, fats, fruits, fibers, starch and calories), we also incorporated GDP PPP, 
urbanization and prevalence of physical inactivity for data analysis.  
To assess the difference between relationships between obesity prevalence and availability of 
sugar and meat, the analysis proceeded in four steps. 
1. Pearson correlation was used to evaluate the strength and direction of the associations 
between all variables.  
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2. Partial correlation of Pearson moment-product approach was used to find the relationship 
between obesity prevalence and each food group respectively while keeping calories availability, 
GDP PPP, physical inactivity and urbanization statistically constant. In order to show that meat 
and sugar availability contributed to obesity prevalence independent of each other, we controlled 
for availability of the other food groups (starch crops, fibers, fats and fruits) in addition to GDP 
PPP, urbanization, total calories availability, physical inactivity.  
Fisher’s r-to-z transformation was performed to test significance of differences between 
correlation coefficients. The significance was reported when P-value was <0.01.  
We kept sugar and meat availability statistically constant respectively together with all the other 
variables to test if they were correlated to obesity prevalence significantly independent of each 
other in addition to all other variables.  
3. Standard multiple linear regression (Enter) was conducted to describe the relationships 
between obesity prevalence and all independent variables, which include all the dietary, lifestyle 
and socioeconomic predictors.   
Standard multiple linear regression (Stepwise) was also performed to regress multiple variables 
while simultaneously retaining sugar and meat availability as the important predictors of obesity 
prevalence.  
Analysis results of multiple linear regression (Enter and Stepwise) model included both the 
indicative value of beta coefficient (B) and its standard error (SE). The actual B may fall into a 
range determined with its standard error. Therefore, we added twice the standard error (SE) to 
their respective B to obtain the upper bound of the range and subtracted two SEs from B to obtain 
the lower bound of the range. We compared the ranges of B’s of obesity prevalence to sugar and 
meat availability to determine if the relationships were significantly different. If two B ranges have 
overlap, the difference between the B’s would not be considered as significant. If there is no 
overlap, the difference would be considered significant.  
4. We used scatter plots to explore and visualize the correlations between obesity and availability 
of sugar and meat. To compare the two relationships, we reversed x and y axes to allow the two 





Additional variables  
We reassessed our models using overweight (BMI ≥ 25 kg/m2 instead of obesity (BMI ≥ 30 kg/m2) 
in case of sugar and meat availability as a late-stage predictor of obesity. The results were 
reported in tables aligning with those relationships between obesity prevalence and sugar and 
meat availability. To incorporate overweight data for analysis may allow us to reassure the quality 
of data which were used for this study.  
SPSS v. 22 (SPSS Inc., Chicago Il USA) was used for data analysis. Prior to analysis data were 
log-transformed (natural logarithms) to bring their distributions close to normal.  
Results 
Pearson correlation analysis showed that both sugar and meat availability were significantly 
correlated with prevalence of obesity (r=0.715, p<0.001 and r=0.685, p<0.001, respectively) 
(Table 1). Spearman rho values were r= 0.664 (p<0.001) and r=0.664 (p<0.001) respectively. 
Fisher's r-to-z transformation revealed no significant difference in Pearson correlations between 
sugar and meat availability with obesity (z=0.53, p=0.5961). The difference between two 
coefficients’ values was negligible, indicating that both meat and sugar were related to obesity to 
the same extent. 
When we controlled for availability of total calories, prevalence of physical inactivity, urbanization 
and GDP PPP in partial correlation analysis, sugar and meat availability were still in significant 
correlation with prevalence of obesity (r=0.359, p<0.001 and r=0.354, p<0.001, respectively) 
(Table 2). This indicates that it is not just the contribution of sugar and meat to the total caloric 
intake that relates to obesity, but specific contents of these two food groups that influence 
metabolic processes. Fisher's r-to-z transformation revealed no significant difference in partial 
correlations between sugar and meat availability with obesity prevalence based on the 
comparison of two correlations (z=0.04, p=0.9681). This means that both sugar and meat 
availability contributes to obesity to the same extent. 
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BMI 25 Sugar Meat Fats Fruits Fibers  
Starch 
crop 
Calories GDP  Urbanization 
Physical 
Inactivity 
BMI 30 1.000 0.931*** 0.715*** 0.685*** 0.523*** 0.477*** 0.678*** -0.220**  0.619***  0.678***  0.497***  0.448** 
BMI 25  1.000 0.776*** 0.792*** 0.644*** 0.546*** 0.806*** -0.290**  0.748***  0.798***  0.632***  0.458*** 
Sugar   1.000 0.718*** 0.571*** 0.470*** 0.714*** -0.492***  0.650***  0.727***  0.529***  0.437*** 
Meat     1.000 0.614*** 0.520*** 0.826*** -0.431***  0.695***  0.831***  0.565***  0.406*** 
Fats      1.000 0.373*** 0.696*** -0.223**  0.701***  0.684***  0.651***  0.300** 
Fruits      1.000 0.565*** -0.215**  0.499***  0.560***  0.353***  0.230** 
Fibers        1.000 -0.370***  0.779***  0.994***  0.625***  0.439*** 
Starch crop          1.000 -0.029 -0.394*** -0.150* -0.425*** 
Calories           1.000  0.763**  0.643**  0.243** 
GDP PPP           1.000  0.620***  0.437*** 
Urbanization            1.000  0.385*** 
Physical 
Inactivity 
            1.000 
Number of countries included in the analysis range from 126 to 170.   * p<0.05; ** p˂ 0.01, ***P˂ 0.001 
BMI≥30 and BMI ≥ 25 are percentages of defined population with a body mass index (BMI) of no less than 30 kg/m2 and 25 kg/m2 respectively.    
Data sources: Dietary data from the FAO’s FAOSTAT.  BMI (≥30 and ≥25) and Physical Inactivity data from the WHO Global Health Observatory. GDP PPP and urbanization 
data from the World Bank.  
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Table 2 also presented that fats availability was in strong and significant correlation (Pearson) 
with obesity prevalence (r=0.517, p<0.001), but the level of correlation was not retained in partial 
correlation analysis (r=0.057, p=0.537). Starch crops availability was in relative strong correlation 
with obesity prevalence, but this correlation almost disappeared in partial correlation analysis.  
When we controlled for availability of fats, fruits, fibers and starch, prevalence of physical inactivity, 
total calories, urbanization and GDP PPP in partial correlation analysis, both sugar and meat 
availability were still in significant correlation with prevalence of obesity (r=0.431, p< 0.001 and 
r=0.339, p< 0.001, respectively) (Table 2). Fisher's r-to-z transformation did not show a significant 
difference in the correlations between obesity and sugar and meat availability (z=0.81, p=0.4179). 
Therefore, sugar and meat contributions to obesity are independent of the availability of other 
food groups. 
Interestingly, meat and sugar availability significantly correlated with each other in Pearson 
correlation (r=0.718, p<0.001) analysis (Table 1) but this correlation disappeared in partial 
correlation analysis when we controlled for availability of fats, fruits, fibers and starch crops, 
calories, GDP, urbanization and physical inactivity prevalence. Partial correlation coefficient 
became very weak and insignificant (r=0.144, p=0.124, not indicated in Table 2). This means that 
sugar and meat availability may contribute to obesity prevalence independent of each other.  
The further investigation on this independence showed that both sugar (r=0.375, p<0.001) and 
meat (r=0.308, p<0.001) availability were still significantly correlated to obesity prevalence when 
we respectively controlled for sugar and meat availability together with all the other variables (fats, 
fruits, fibers and starch crops, calories, GDP, urbanization and physical inactivity prevalence) for 
testing each other’s relationship with obesity prevalence (Table 2). Fisher's r-to-z transformation 




Table 2 Pearson and partial correlation analysis of different food groups to prevalence estimates of obesity and overweight 












df BMI 30 BMI 25 df BMI≥30 BMI≥25 
Sugar  167 0.715*** 0.776***  118 0.359*** 0.372*** 114 0.431*** 0.399*** 114 0.375*** 0.363*** - - - 
Meat  167 0.685*** 0.792***  118 0.354*** 0.418*** 114 0.339*** 0.370*** - - - 114 0.308*** 0.341*** 
Fats  161 0.523*** 0.644***  118 0.057 0.110 - - - - - - - - - 
Fruits  167 0.477*** 0.546***  118 0.112 0.159 - - - - - - - - - 
Fibers  169 0.678*** 0.806***  118 0.248** 0.269** - - - - - - - - - 
Starch 
crops 





 - - - - - - - - - - - - 






 - - - - - - - - - - - - 
Physical 
Inactivity 
131 0.448*** 0.458***  - - - - - - - - - - - - 
* p<0.05, ** P˂ 0.01, ***P˂ 0.001. -, controlled variable.  
BMI≥30 and BMI ≥ 25 are percentages of defined population with a body mass index (BMI) of no less than 30 kg/m2 and 25 kg/m2 respectively.   
Data sources: Dietary data from the FAO’s FAOSTAT.  BMI (≥30 and ≥25) and Physical Inactivity data from the WHO Global Health Observatory. GDP and urbanization 




Table 3 presented the results of multiple linear regression analyses to identify dietary, 
lifestyle and socioeconomic predictors of prevalence estimates of obesity and overweight. 
We found that both sugar and meat were the significant predicators of estimates of 
obesity (B=0.455, SE=0.113 and B=0.381, SE=0.096, respectively) at the same 
significance level of p<0.001. The B ranges between obesity prevalence and availability 
of sugar (0.229-0.681) and meat (0.189-0.573) overlapped each other greatly (0.229-
0.573). This meant that meat availability was no different from sugar availability to predict 
the estimates of prevalence of obesity.   
Table 3 Results of enter multiple linear regression analyses to identify dietary, lifestyle and 
socioeconomic predictors of prevalence estimates of overweight and obesity  
 Obesity prevalence (%)  Overweight prevalence (%) 
 Model 1 (Enter), R2= 0.656  Model 1 (Enter), R2=0.823 
Predictors B SE p B range  B SE p B range 
Sugar  0.455 0.113 <0.001 0.229-0.681  0.315 0.066 <0.001 0.183-0.447 
Meat   0.381 0.096 0.001 0.189-0.573  0.307 0.056 <0.001 0.195-0.419 
Fats   0.053 0.095 0.565 -  0.056 0.055 0.391 - 
Fruits   0.034 0.070 0.633 -  0.054 0.041 0.290 - 
Fibers    -0.170 0.314 0.777 -  0.214 0.182 0.618 - 
Starch crops   0.349 0.215 <0.001 -  0.164 0.124 0.008 - 
GDP PPP  0.370 0.272 0.525 -  0.002 0.157 0.997 - 
Urbanization -0.040 0.119 0.635 -  0.054 0.069 0.368 - 
Physical Inactivity 0.163 0.098 0.015 -  0.081 0.057 0.090 - 
Calories  -0.147 0.544 0.233 -  0.069 0.315 0.434 - 
B, Beta; SE, Std. Error; p, Sig.  
BMI≥30 and BMI ≥ 25 are percentages of defined population with a body mass index (BMI) of no less than 30 
kg/m2 and 25 kg/m2 respectively.   
Data sources: Dietary data from the FAO’s FAOSTAT.  BMI (≥30 and≥25) and Physical Inactivity data from the 
WHO Global Health Observatory. GDP and urbanization data from the World Bank. 
 
Table 4 indicated that sugar (B=0.464, SE=0.093, p<0.001) and meat (B=0.433, 
SE=0.072, p<0.001) availability stood out as the significant predictor of obesity 
prevalence simultaneously in stepwise multiple linear regression analyses. Two 
overlapping B ranges (0.294-0.582) indicated that there was no difference between 
sugar and meat availability to predict obesity prevalence.     
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One of the highlights in our data analysis with linear regression was that fats availability 
was a minor predictor of obesity prevalence in both Enter method (B=0.053, SE=0.095, 
p=0.565) (Table 3) and Stepwise method (fats availability was a removed variable) 
(Table 4).  
Table 4 Results of stepwise multiple linear regression analyses to identify dietary, 
lifestyle and socioeconomic predictors of prevalence estimates of overweight 
and obesity  
 Obesity prevalence (%)  Overweight prevalence (%) 
 Model 4 (Stepwise), Adjusted R2= 0.630  Model 4(Stepwise), Adjusted R2=0.802 
Predictors  B SE p B Range  B SE p B Range 
Sugar  0.464 0.093 <0.001 0.278-0.650  0.363 0.059 <0.001 0.245-0.481 
Meat   0.438 0.072 <0.001 0.294-0.582  0.340 0.055 <0.001 0.230-0.450 
Fats   - - -   - - - - 
Fruits   - - -   - - - - 
Fibers    - - -   0.359 0.034 <0.001 - 
Starch crops   0.464 0.171 <0.001   0.187 0.097 <0.001 - 
GDP PPP  - - -   - - - - 
Urbanization - - -   - - - - 
Physical Inactivity 0.171 0.094 0.008   - - - - 
Calories  - - -   - - - - 
B, Beta; SE, Std. Error; p, Sig.; -, removed variable  
BMI≥30 and BMI ≥ 25 are percentages of defined population with a body mass index (BMI) of no less than 30 
kg/m2 and 25 kg/m2 respectively.   
Data sources: Dietary data from the FAO’s FAOSTAT.  BMI (≥30 and ≥25 mean) and Physical Inactivity data 
from the WHO Global Health Observatory. GDP and urbanization data from the World Bank. 
 
Figure 1 showed the unadjusted correlation between prevalence estimate of obesity and 
sugar and meat availability. The scatterplots are very similar. The relationships were 
noted to be best described by polynomial regression equations with strong correlation at 





 1. Sugar and meat consumptions may be two significant determinants of obesity 
prevalence. 
 2. The consumption of sugar and meat have statistically significant relations to obesity 
independent of the effect of other major food groups, socioeconomic and lifestyle 
factors.  
 3. Availability of sugar and meat availability are correlated to obesity prevalence 
independent of each other.   
 4. Statistically, there was no significant difference between sugar and meat relationship 
to global obesity prevalence at a population level.    
Values of Pearson correlation coefficients may be influenced by non-homoscedasticity 
of distribution of correlated variables. We have tried to minimize such possibility by using 
logarithmically transformed data. Comparison of the values of Pearson correlation 
coefficients with Spearman rho values shows that effects of distributions are negligible. 
Thus, our partial correlation analysis produced acceptable results.       
There is ample research on foods and diet patterns that contribute to body weight 
increase. Using the similar source of data, Siervo et al. reported that both meat and sugar 
availability were correlated to global obesity prevalence (18). However, their study did 
not conduct in-depth investigation to compare the correlation levels of meat and sugar 
availability to obesity prevalence.  
There are two similar mechanisms that may explain why sugar and meat availability 
contribute to obesity comparably.     
1. Fructose and meat protein may produce energy surplus due to their slower digestion 
process.  
Sucrose and high-fructose corn syrup (HFCS; 42% or 55% fructose) are two primarily 
consumed sugars, and they are very similar in their composition. HFCS is only consumed 
in the U.S., Canada, Japan, and some parts of Europe, while the rest of the world 
primarily consumes sucrose (50% fructose). Sucrose contains 50% fructose and 50% 
glucose. HFCS in common usage within the food industry comprises similar percentages 
(40-55%) of glucose and fructose, water and other carbohydrates which are readily 
hydrolysable polymers of glucose. Fructose, as the major component of sugar, is slow 
to absorb (27) and hard to assimilate and it can only be metabolized by the liver to have 
glycogen most of which may be converted into fat for storage (28-30).  
Meat is mainly composed of protein, fat and water. The absolute energy value of meat 
is determined by the protein and fat content (31). Because meat of domesticated animals 
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contains relatively large amount of fat, a number of studies have considered meat 
consumption as a higher risk of obesity and waist circumference (WC) (11, 32). Studies 
have already shown that dietary fat may not be a major determinant of obesity (33, 34). 
Animal breeding and butchering techniques in modern agriculture have significantly 
reduced meat fat content and increased protein content in the past few decades, so 
dietary meat is much leaner than ever (35, 36). The macronutrient energy values are 9.0 
kcal/g for fat, 4.0 kcal/g for protein and carbohydrates (37). Therefore, meat is not high 
in “energy and fat content” because it contains less fat and higher meat protein due to 
modern agriculture techniques.  
Despite energy value of protein is not high (4.0 kcal/g), it has been postulated to 
contribute to the development of obesity because it may only be digested later than fats 
and carbohydrates (17, 38, 39). Modern agriculture has been bringing the cost of 
availability of carbohydrates rich crops, such as cereals and starchy roots, and fat (oil), 
such as rape and soy significantly down. Cheap carbohydrates and fats in a meal can 
easily supply enough energy to meet human needs. This may make the energy from 
slow digested protein a surplus and stored as fat (17, 38, 39). This postulation was 
supported by our data analysis result (Table 2) with the changes of correlations between 
food groups (fats and starch crops correlated to obesity and prevalence in Pearson r 
correlation, but not in partial correlation) and obesity and overweight in Pearson and 
partial correlations. In modern diet, foods rich in carbohydrates and fats have been able 
to provide enough energy to meet human daily energy requirements, so meat protein 
has been postulated to produce energy surplus, thus contributing to obesity may support 
our hypothesis in this study (17).   
Plant protein is always mixed with fiber which makes it difficult to digest. Therefore, meat 
protein as the major source of digestible protein may contribute to the “energy surplus” 
significantly.   
2. Sugar and meat consumption may cause insulin resistance, a metabolic syndrome 
contributing to obesity.  
Insulin is an anabolic hormone in human body. It encourages the synthesis of 
carbohydrate, fat and protein, inhibits the production of glucose by the liver (40). Insulin 
also increases the storage of fat in fat cells and prevents fat cells from releasing fat for 
energy (41-44). The cells in insulin resistance patient become “resistant” to insulin, and 
sugars in blood cannot enter cells for calories production (45-50), but are metabolized 
into glycogen in their liver, which may be forced by insulin to metabolise into fat (28, 51) 
and accelerates body weight gain (52) independent of excessive energy intake (53). 
Insulin resistance is a major underlying cause of excess weight and obesity (54, 55). 
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Many studies showed that sugar consumption is linked to insulin resistance in both 
children and adults, especially when it is consumed in large amounts (45, 46). High-dose 
fructose feeding can also cause insulin resistance in normal healthy human in as little as 
a week (56) and it can exacerbate insulin resistance in overweight and obese people 
(57). 
Likewise, a number of studies have associated meat consumption as a risk factor for 
insulin resistance because: 1) Meat fat enhances intracellular lipid storage and impairs 
insulin metabolism (58, 59); 2) Heme iron from meat may damage pancreas cells (60, 
61) and 3) Meat sourced nitrites and sodium may impair the function of the pancreatic 
beta cells (62).   
Leptin is a hormone made by adipose cells that helps to regulate energy balance by 
inhibiting hunger. A number of studies reported that sugar consumption was correlated 
to production of leptin, but the results were controversial (63, 64).  
The role of sugar consumption in the development of overweight and obesity has overly 
received scientific and policy attention. There are literally thousands of postings on the 
internet related to putative healthy diet guideline links between sugar and body obesity 
as well as insulin resistance. For instance, Te Morenga et al.  concluded that intake of 
sugar is a determinant of body weight after assessment of 6,557 relevant academic 
publications (8). Some authorities have taken action to limit young students’ access to 
sugar products. Furthermore, taxation of sugar has been advocated or implemented in 
some countries/areas as a potential public health strategy to curb the obesity epidemic.  
Meat, by contrast, has not been singled out as one of the worst dietary offenders. In 
terms of balanced diet components, what the public have been told overwhelmingly is 
that a moderate amount of meat (lean meat preferred) should be included in our daily 
diet as it contains essential protein and minerals. Although meat protein is nutritious and 
integral to our health, protein halo should not be prevailing. While recognizing that the 
evidence of harm to health against meat is statistically as strong as sugar, we should 
avoid the trap of waiting for absolute proof before allowing public health action to be 
taken. A survey of approximately 100,000 North American members of the Seventh Day 
Adventist Church (65) indicated that vegan members had the lowest BMI values, while 
mean BMI increased gradually with increasing amounts of animal protein consumed by 
lacto-ovo vegetarians, pesco-vegetarians and semi-vegetarians reaching the highest 
value in non-vegetarians.  
A strength of this study is that we used comparable per capita availability data from 170 
countries which enabled us to examine and compare relationships between obesity 
prevalence and different food groups (sugar and meat) at population level. However, 
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there are several limitations in this study. Firstly, although we attempted to remove the 
potential confounding effects of variables such as GDP, caloric etc. by means of partial 
correlation analysis, some confounding factors may still influence correlations we found. 
Secondly, there may be some variables not included in our analysis that influence the 
correlation found in this study. It is however difficult to see what such variables may be. 
Thirdly, we could only use an international food group database that tracks the general 
market availability of different food types, not the actual human consumption. There are 
no direct measures of actual human consumption that can account for food wastage and 
provide precise measures of food consumption internationally. The database did not 
contain sufficient information to separate effects of “pure meat” from meat products that 
may contain other nutrients. Finally, the data analysed are calculated for per capita in 
each country, so we can only demonstrate a relationship between food group availability 
and obesity at a country level, which does not necessarily correspond to the same 
relationships holding true at the individual level. Prospective cohort studies are proposed 
to explore these associations further.   
Conclusion  
Both sugar and meat availability are correlated to obesity prevalence worldwide, and 
there is no significant difference between the levels of two correlations. Similar to the 
public campaign against excessive sugar consumption, considering the findings of 
adverse effects of meat on obesity and the environmental impact of meat production, the 
country authorities should also advise the public not to adopt a high-meat diet for long-
term healthy weight management.  
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Additional file 1: Food items in each food group 
Food group 
Items included  
This study FAO definition 
Meat Meat, total Beef and veal, Buffalo meat, Pig meat, Mutton and lamb, Goat meat, Horse meat, Chicken meat, Goose meat, Duck meat, 
Turkey meat, Rabbit meat, Game meat and Offal 
Fruits  Fruits  Melons, Watermelons, Apples, Apricots, Avocados, Cherries, Figs, Grapes, Mangoes, Papaya, Peaches, Pears, Persimmons, 
Pineapples, Plums, Quinces, Blueberries, Gooseberries, Raspberries, Strawberries, Kiwi, Dates, Figs (dried), Prunes, 
Currants, Raisins and Other fresh and dried fruits 
Fibers  Vegetables 
Beets, Carrots, Turnips, Rutabagas or swedes, Onions (green), Onions (dry), Artichokes, Tomatoes, Asparagus, Cabbage, 
Cauliflower, Celery, Kale, Lettuce, Spinach, Beans (green), Broad beans (green), Chilli peppers, Garlic, Cucumbers, 
Mushrooms, Eggplant, Peas (green), Pumpkins, Squash, Gourds, Okra, Radishes and Other vegetables 
Pulses  Beans (dry), Broad beans (dry), Peas (dry), Chick peas, Cow peas, Pigeon peas, Lentils, Vetches, Lupins and Other pulses 
Starch  Starchy root  Potatoes, Sweet potatoes, Cassava, Taro, Yams and Other roots and tubers 
Cereals  Wheat, Rye, Barley, Oats, Maize, Rice, Mixed grains, Buckwheat, Sorghum, Millet, Quinoa and Other cereals 
Fats  
Vegetable oil  
Sunflower seed oil, Cottonseed oil, Linseed oil, Hempseed oil, Sesame seed oil, Copra and coconut oil, Palm kernel oil, Palm 
oil, Soybean oil, Olive oil and Maize oil 
Animal fats Butter, Ghee, Fish liver oil, Whale oil and Other animal fats 
  Source: http://www.fao.org/docrep/003/x9892e/x9892e02.htm  
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source Statistic Statistic 
Std. 
Error 
BMI≥30,18+,2010 170 1.7 41.8 16.670 8.9937 0.06 0.19 WHO 
BMI≥25,18+, 2010 170 9.7 72.8 43.021 19.4304 -0.37 0.19 WHO 
BMI mean,18+, 2010 170 20.3 31.4 25.258 2.1433 -0.26 0.19 WHO 
Meat, total 2007-09 
mean (g/capita/day) 
167 10.73 337.26 129.57 82.53 0.42 0.19 FAO 
Fat (plant oil+ animal 
fat) (g/capita/day) 07-09 
161 4.63 137.87 42.55 26.83 1.10 0.19 FAO 
Fruits (g/capita/day) 
2007-09 mean 
167 15.26 964.69 229.70 142.71 1.39 0.19 FAO 
Fiber (Vegetables + 
Pulses) (g/capita/day), 
2007-09 mean 
167 35.59 873.12 251.97 164.61 1.32 0.19 FAO 




167 219.53 1345.32 573.11 176.81 1.23 0.19 FAO 
Meat protein 
(g/capita/day), 2007-09  
mean 
167 1.53 40.83 16.37 10.21 0.49 0.19 FAO 




167 1.87 65.30 18.94 11.71 0.90 0.19 FAO 
Plant protein 
(g/capita/day) 2007-09  
mean 
167 23.88 77.56 43.50 9.08 0.85 0.19 FAO 
Animal Fat Total 
(g/capita/day), 2007-09  
mean 
167 4.58 105.35 37.45 24.94 0.62 0.19 FAO 
Plant oil total 
(g/capita/day),2007-09  
mean 




167 303.47 627.64 431.23 55.46 0.29 0.19 FAO 
Calories Total 
(kcal/capita/day) 07-09  
mean 




167 1690 2000 1852.40 87.655 -0.05 0.19 FAO 
Prevalence of physicak 
inactivity %, 18+, 2010 
131 4.1 63.6 25.302 11.4495 0.73 0.21 WHO 
GDP PPP (current 
US$), 2010 
165 619.47 84200.57 15224.06 15714.26 1.70 0.19 World 
Bank 
Valid N (listwise) 123        
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Contexture Statement  
Meat types (red meat, instead of white meat) and levels of doneness have been 
constantly associated with prostate cancer (PC61). However, there has been no 
substantial research into the real difference between red meat and white meat in terms 
of their detrimental health effects. Contrarily, studies have suggested that white meat 
and red meat contribute to body weight at the similar level. Red meat with high level of 
doneness may have been well-known to PC61 patients to contribute to their cancer 
initiation. Therefore, it is easy for them to exaggerate how much red meat and level of 
doneness of red meat they had before they were diagnosed with PC61.   
Total fresh meat, regardless of meat types and levels of doneness, may be an objective 
measure for meat consumption. We postulated and assessed the correlation between 







Objective: To examine the association of total meat (flesh of animals) consumption to 
Prostate Cancer incidence (PC61) at population level.   
Subjects and Methods: Data from 172 countries were extracted for analysis. 
Associations between country specific per capita total meat intake and PC61 incidence 
at country level were examined using Pearson’s r and Spearman rho, partial correlation, 
stepwise multiple linear regression analyses with ageing, GDP, Is (index of magnitude of 
prostate cancer gene accumulation at population level), obesity prevalence and 
urbanization included as the confounding factors. Countries were also grouped for 
regional association analysis. The data were log-transformed for analysis in SPSS. 
Microsoft Excel, and ANOVA Post hoc Scheffe tests were applied to calculate and 
compare mean differences between country groupings.  
Results: Worldwide, total meat intake was strongly and positively associated with PC61 
incidence in Pearson’s r (r= 0.595, p<0.001) and Spearman rho (r= 0.637, p<0.001) 
analyses. This relationship remained significant in partial correlation (r= 0.295, p<0.001) 
when ageing, GDP, Is, obesity prevalence and urbanization were kept statistically 
constant. GDP was weakly and insignificantly associated with PC61 when total meat 
intake was kept statistically constant. Stepwise multiple regression identified that total 
meat was a significant predictor of PC61 with total meat intake and all the five 
confounders included as the independent variables (R2=0.417). GDP was not identified 
as the statistically significant predictor of PC61 in either of the models including or 
excluding total meat as the independent variable. Post hoc Scheffe tests revealed nine 
significant mean differences of PC61 between the six WHO regions, but all disappeared 
when the contributing effect of total meat on PC61 incidence rate was removed.  
Conclusions: Total meat intake is an independent predictor of PC61 worldwide, and the 
determinant of regional variation of PC61. The longitudinal cohort studies are proposed 
to explore the association further. 
Keywords: Total meat (flesh of animals), Prostate cancer, Carcinogen, Regional 
variation           
Introduction 
Prostate cancer (PC61) is the second most common cancer among men in the world 
[1]. It has become an enormous public health concern in most developed countries and 
an emerging public health problem in developing countries [2, 3]. Globally, an estimated 
0.9 million men in 2008 were diagnosed with prostate cancer worldwide [4], but, in 2012, 
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the number increased to 1.1 million [5] and the majority of cases (almost 70%) occur in 
developed countries [5].   
A complete understanding of the aetiology of PC61 remains elusive to the public and 
professionals [6, 7]. Genetic background is the well-established risk factor through 
studies of PC61 in family histories [8, 9], and this background may be have been 
accumulated in human population due to the reduced natural selection [10-12]. 
Researches into the relationship between ageing and PC61 have revealed that, 
essentially, ageing process leads to the acquisition of mutations and the formation of a 
molecular and cellular environment which favours carcinogenesis [13-15]. Recent 
studies have shown that people who are obese may have more exposure to PC61 risk 
because they have the increased blood levels of insulin and insulin-like growth factor-1 
(IGF-1) [16, 17]. Urbanization has been closely linked to human lifestyle change, such 
as more meat intake [18, 19] and less physical exercise [20], due to its process of 
modernization and industrialization. Therefore, it has been postulated as the risk factor 
of PC61 [21].  
PC61 epidemiology has revealed that its incidence varies more than 25-fold worldwide 
[22]. In the past years, researchers from the International Agency for Research on 
Cancer (IARC) as the specialized cancer agency of the World Health Organization (WHO) 
published several articles/reports associating the regional variation of PC61 incidence 
with regional socioeconomic levels [1, 5].   
Diet pattern plays a very important role in causing a large percentage of cancers [23, 24]. 
Plant sourced food products, such as vegetables [25], fruits [25] and grains [26], have 
been reported as not associated with prostate cancer.  
In the last decades, a number of large cohort and case-control studies have 
controversially and circumstantially linked red meat intake to the development of PC61 
[27-30]. It has been suggested that there was no substantial difference between “red 
meat” and “white meat” in terms of the nutrient components [19, 31]. Therefore, both red 
meat and white meat might contribute to PC61 together when people had diets which 
usually include the combination of red meat and white meat. Researches, which simply 
correlated red meat intake and PC61 risk, may have a defect in the study designs 
because the contributing effects of white meat intake to PC61 was not removed. 
Statistically, we may say that white meat intake was not kept constant when the 
correlation of red meat intake to PC61 was analysed [32, 33].  
It is proposed to use ecological study for ascertaining a new association between total 
meat (flesh of animals) intake and PC61 risk at population level. We examined this 
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relationship with the country specific data on total meat intake and PC61 incidence rate 
published by the United Nations (UN) agencies. 
Materials and Methods 
Data Collection and Selection   
The country specific data were collected for this study:  
The most recent IARC data on estimated PC61 incidence rate in 2012 for the adult (aged 
15+ years old) part of each population were extracted as the dependent variable [1].     
Total meat intake (expressed in kg/capita/year) in 2011 from the FAOSTAT Food 
Balance Sheet (FBS) [34] was obtained as the independent predictor of PC61. FAO 
defined total meat as “flesh of animals used for food”, which includes beef and veal, 
buffalo meat, pig meat, mutton and lamb, goat meat, horse meat, chicken meat, goose 
meat, duck meat, turkey meat, rabbit meat, game meat and offal [34]. For the interest of 
discussing the relationships between PC61 and white meat intake and red meat intake, 
we extracted poultry meat (flesh) as white meat (expressed in kg/capita/year). We 
calculated red meat intake by subtracting white meat intake from the total meat intake.   
We extracted the following data as the confounding variables as they have been 
postulated as the risk factors of PC61.   
Ageing, expressed with the percentage of males age 65 and above in each country in 
2011 was extracted from the World Bank [35].  
The World Bank data on per capita GDP PPP (gross domestic product converted to 
international dollars using purchasing power parity rates) in 2011 [35]. Ferlay et al. 
indicated that the PC61 incidence rate varies significantly largely because of how 
widespread the prostate specific antigen (PSA) testing and subsequent biopsy are in 
practice in those countries and regions [1]. The testing depends on the GDP because of 
funding for medical services. GDP PPP was incorporated as the confounding factor to 
reduce/remove the bias on PC61 incidence in addition to other socioeconomic level 
related factors which may affect the association between meat intake and PC61 
incidence.   
Country-specific index of the total opportunity for natural selection in modern populations 
(Is) was extracted from previous studies [10-12]. An Is value signifies here the magnitude 
of the country to accumulate the PC61 genes [10-12]. The calculation methods and 
significance of Is recently used by You and Henneberg [10, 36] is based on the Biological 
State Index as described in Henneberg [37] and Henneberg and Piontek [38]. PC61 has 
strong genetic background which is heritable [3, 39]. Therefore, Is was chosen as the 
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confounding factor to remove the confounding effect of country-specific PC61 genetic 
background on the association between meat intake and PC61 incidence [10-12, 40].       
The WHO Global Health Observatory (GHO) data on the estimated prevalence rate of 
obesity (percent of population aged 18+ with BMI ≥ 30 kg/m2) of the male population in 
2010 [41].  
The World Bank data on urbanization (the percent of males living in urban areas in each 
country in 2011 [35].   
We simply extracted the country-specific meat intake data from the FAO Food Balance 
Sheet for 172 countries, that is all countries of the world for which these data were 
available. And then, we matched the other variables with the meat intake data. All the 
independent variables were backdated 1-2 years to reflect the exposure with delayed 
presentation of PC61. 
Each country was treated as the individual subject for data analysis in this study. For 
particular analyses, the number of countries included for variables may have differed 
somewhat because all information on other variables was not uniformly available for all 
countries due to unavailability from relevant UN agencies. All the data were extracted 
and saved in Microsoft Excel® for performing the data analysis.   
Statistical analyses    
To assess the relationship between PC61 incidence rate and total meat intake, the 
analysis proceeded in six steps. 
1. Scatter plots was produced with the original data in Microsoft Excel® to explore and 
visualize the strength, shape and direction of association between meat intake and PC61 
incidence at the global level.  
We also calculated and compared the means of PC61 of the 10 countries with highest 
and lowest meat intake in the Excel to show how meat consumption changes average 
incidence rates of PC61  
For the data analysis in SPSS (Steps 2 -5), the original data were log-transformed 
(natural logarithms) to bring their distributions closer to normal, which may increase 
homoscedasticity of data distributions.  
2. Bivariate correlation (Pearson’s and Nonparametric) was used to evaluate the strength 
and direction of the associations between both dependent variable (PC61 incidence) and 
all independent variables (Meat intake, Ageing, GDP PPP, Obesity and Urbanization).  
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3. Partial correlation of Pearson moment-product approach was used to find the 
relationship between PC61 incidence and meat intake while keeping ageing, GDP PPP, 
obesity and urbanization statistically constant.  
The independent relationships between PC61 and each of the five variables were 
explored with partial correlation of Pearson’s moment-product approach while we kept 
the meat intake statically constant. This allows us to identify how strongly the meat intake 
affects the association between PC61 and each of the five variables.  
A number of previous ecological studies [18, 19, 42, 43] revealed that meat intake was 
in significant and strong correlation to GDP. We alternated GDP and meat intake as the 
predictor and confounding factor for the partial correlation analysis.  
4. Stepwise multiple linear regression modelling was performed to identify and rank 
predictors (independent variables) of PC61. We included and excluded meat intake as 
the one of the predictors in the two analyses to observe how strongly the meat intake 
affected the predictor ranking in Stepwise linear analysis.   
5. Pearson’s r was calculated to investigate the regional correlation between meat intake 
and PC61 incidence. Fisher’s r-to-z transformation was performed to test significance of 
differences between correlation coefficients. We did this analysis because meat intake 
varies in human diet patterns due to the availability and affordability in different regions, 
and also because the WHO and its agent the IARC reported that PC61 incidence varies 
in different regions [1, 3]. The 173 countries were grouped as per WHO region division 
[44] and the World Bank income classifications [45] for correlation analyses.  
6. Post hoc Scheffe (Oneway ANOVA) testing was performed to compare the mean 
difference of meat intake (original data), PC61 incidence (original data), and residual of 
PC61 incidence standardized on meat intake (original data) between six WHO regions. 
This may allow us to investigate the importance of meat intake in determining the 
regional variation of PC61.  
The equation (y = 0.7643x + 1.1864) of the best fitting trendline obtained in the scatter 
plots analysis of correlation between meat intake and PC61 incidence was used to 
calculate and remove the contributing effect of total meat intake on PC61 incidence rate. 
Thus, we created a new dependent variable, “PC61 incidence standardized on meat 
intake” and subsequently “Residual of PC61 incidence standardised on meat intake” 
after subtracting the “PC61 incidence standardized on meat intake” from the PC61 
incidence rate.  
The means of PC61 and meat intake of the six WHO regions were compared and the 




selection to include them as the confounding factors in exploring the correlation between 
meat intake and PC61 incidence.  
 
Table 1 Pearson’s r and nonparametric correlation matrix between all variables involved in this 
study 
 PC61 Meat   Ageing GDP PPP Is Obesity %  Urbanization 
PC61 
1 0.595*** 0.555*** 0.529*** -0.480*** 0.489*** 0.470*** 
Meat  0.637*** 1 0.648*** 0.810*** 0.674*** 0.761*** 0.588*** 
Ageing  0.587*** 0.699*** 1 0.706*** 0.686*** 0.596*** 0.498*** 
GDP 0.573*** 0.833*** 0.750*** 1 0.738*** 0.717*** 0.664*** 
Is -0.565*** 0.794*** 0.864*** 0.871*** 1 0.708*** 0.505*** 
Obesity % 0.501*** 0.737*** 0.630*** 0.729*** 0.745*** 1 0.671*** 
URBAN 0.516*** 0.635*** 0.563*** 0.737*** 0.665*** 0.735*** 1 
Pearson r (above diagonal) and nonparametric (below diagonal) correlations were reported. Significance levels: 
* P <0.05, ** P< 0.01, *** P< 0.001. Number of country range, 157-172.  
Meat intake (kg/capita/year) sourced from the Food and Agriculture Organization; Ageing (percent of males 
ages 65 and above) and GDP PPP (gross domestic product converted to international dollars using purchasing 
power parity rates) and urbanization (the percent of males living in urban areas) were sourced from the World 
Bank. Male obesity prevalence (percent of males aged 18+ with BMI ≥ 30 kg/m2); Is was extracted from 




These bivariate correlations were also reflected in the WHO regions showing increased 
correlation of meat intake with PC61 (Table 2). AFRO region was the exception. In 
general, the bivariate correlations were also true in country groupings based on economy 










Table 2 Correlation of meat availability to each level of in different country groupings 
 
Country groupings Pearson r p  nonparametric p 
Worldwide (n=163) 0.595 <0.001  0.637 P<0.001 
World Bank income classifications      
    High Income, n=47 0.528 <0.001  0.346 <0.05 
    Low Income, n=26 0.429 <0.05  0.372 0.061 
    Low Middle Income, n=43 0.305 <0.05  0.216 0.164 
    Upper Middle, n=47 0.402 <0.01  0.419 P<0.003 
WHO regions     
    AFRO, n=38 0.180 0.280  0.049 0.771 
    AMRO, n=29 0.570 <0.001  0.555 <0.01 
    EMRO, n=18 0.524 <0.05  0.556 <0.05 
    EURO, n=50 0.723 <0.001  0.654 <0.001 
    SEARO, n=10  0.549 0.101  0.661 <0.05 
    WPRO, n=18 0.591 <0.01  0.513 <0.05 
         Pearson r and nonparametric correlations within country groupings were reported.  
     Meat intake (kg/capita/year) sourced from the Food and Agriculture Organization; 
 
Partial correlation analysis revealed that meat intake was a strong and significant 
predictor of PC61 independent of ageing, GDP PPP, obesity and urbanization (r=0.295, 
p<0.001, Table 3). When meat intake was stabilised as a confounding factor in partial 
correlation analysis, it was revealed that: 1) ageing was identified as a significant 
independent predictor (r=0.277, p<0.001) of PC61 incidence; 2) urbanization showed 
weak and significant correlation to PC61 incidence (r=0.185, p<0.05); and 3) GDP, Is 
and Obesity showed barely a correlation to PC61 incidence (Table 3). This suggested 
that meat intake had great confounding effects on the correlation between PC61 
incidence and GDP PPP, Is, obesity and urbanization respectively.  
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Table 3 Partial correlations between prostate cancer incidence and independent variable 
when meat was included as the independent and confounder respectively   
 Variables 
Partial Correlation to PC61  Partial Correlation to PC61 
r p df  r p df 
Meat  0.295 <0.001 150  - - - 
Ageing  - - -  0.277 <0.001 160 
GDP - - -  0.100 0.209 160 
Is - - -  -0.041 0.608 158 
Obesity  - - -  0.070 0.382 158 
Urbanization   - - -  0.185 P<0.05 160 
Partial correlations were reported.  
Meat intake (kg/capita/year) sourced from the Food and Agriculture Organization; Ageing (percent of males 
ages 65 and above) and GDP PPP (gross domestic product converted to international dollars using 
purchasing power parity rates) and urbanization (the percent of males living in urban areas) were sourced 
from the World Bank. Male obesity prevalence (percent of males aged 18+ with BMI ≥ 30 kg/m2); Is was 
extracted from previous publications.   
- Included as the confounding factor  
 
When meat intake was excluded as the PC61 predictor, ageing and urbanization were 
selected as the significant predictors of PC61 with R2 = 0.354 in the standard multiple 
linear regression (Stepwise) analysis. When meat intake was incorporated as an 
independent variable, it was placed first as the major predictor of PC61 with increasing 
R2 to 0.417. GDP was not selected as the major predictor of PC61 in Stepwise linear 
regression. Additionally, it was not in strong or significant correlation to PC61 incidence 
in partial correlation (Table 2). This may suggest that GDP PPP may not be the strong 
predictor of PC61, but meat intake is. 
Table 4 Results of Stepwise multiple linear regression analyses to sort significant predictors of 
Prostate Cancer incidence    
 Excluding meats   Including meat  
Rank Variables Entered Adjusted R Square  Rank Variables Entered Adjusted R Square 
1 Ageing 0.310  1 Meat  0.332 
2 Urbanization 0.354  2 Ageing 0.386 
3 Ibs  Not a major predictor  3 Is  0.404 
4 GDP PPP  Not a major predictor  4 Urbanization  0.417 
5 Obesity % Not a major predictor  5 GDP PPP Not a major predictor 
    6 Obesity Not a major predictor 
Stepwise multiple linear regression modelling is reported. Contribution of variables is listed in order of how much they 
contribute to prostate cancer incidence.    
Meat intake (kg/capita/year) sourced from the Food and Agriculture Organization; Ageing (percent of males ages 65 and 
above) and GDP PPP (gross domestic product converted to international dollars using purchasing power parity rates) and 
urbanization (the percent of males living in urban areas) were sourced from the World Bank. Male obesity prevalence 




Table 5 showed the calculated means of meat intake and PC61 incidence rates in all the 
six WHO regions. In general, at country grouping level, meat intake was in strong 
correlation to PC61 incidence based on the best fit trendline (r=0.832, p<0.05). This is 
consistent with the correlation between meat intake and PC61 incidence at the individual 
country level (r=0.684, p<0.001) (Table 5).  
A post hoc Scheffe analysis conducted on the multiple mean comparisons revealed that 
there were numerous significant mean differences in PC61 incidence rates between 
different WHO regions (Table 5). Mean of PC61 incidence in Africa was significantly 
lower than that in Americas and Europe. Mean of PC61 incidence in the Eastern 
Mediterranean was significantly lower than that in Americas and Europe. The mean 
PC61 incidence in South-Eastern Asia was significantly lower than that in Americas and 
Europe.   
A subsequent ANOVA with post hoc Scheffe procedure performed on the means of 
“Residual of PC61 standardised on meat intake” in different WHO regions showed no 
significant differences among and between regions (Table 5). The results from post hoc 
Scheffe tests conducted on mean comparison between the WHO regions suggested that 
regional variations of PC61 incidence may only reach statistically significant levels if the 
contribution of their respective meat intake was included. This result was supported by 
the findings identified in our previous bivariate and partial correlation (Table 3) and 
multiple linear regression (Table 4) that meat intake is the major risk factor of PC61 






The results from our study suggested, at population level, total meat (flesh) intake was 
strongly and significantly associated with incidence rate of PC61 globally and regionally. 
Worldwide, total meat intake may be a major predictor of PC61 regardless of the 
influence from other risk factors, such as ageing, GDP, Is, obesity and urbanization. Our 
results also suggested that meat consumption, instead of GDP, may be a determinant of 
the regional variation of PC61.  
Red and processed meat increasing risk of PC61 has been a central dogma reported in 
the majority of the studies into relationship between meat intake and PC61. The dogma, 
which is supported by the IARC [46], stipulates multiple etiologies through which red and 
processed meat intake contributes to PC61 risk [47]:  
1) Carcinogens such as heterocyclic amines (PhIP), 2-amino-3,8-dimethylimidazo-[4,5-
b] quinoxaline (MeIQx), and 2-amino-3, 4,8-trimethylimidazo-[4,5-f] quinoxaline 
(DiMeIQx), and polycyclic aromatic hydrocarbons may be formed when meat is cooked 
at high-temperature [48-53].  
2) N-nitroso compounds (NOCs) may be produced endogenously from meat itself or 
preservatives added to processed meats [54-56].  
3) Heme iron has catalytic effects on (i) the endogenous formation of carcinogenic N-
nitroso compounds and (ii) the formation of cytotoxic and genotoxic aldehydes by 
lipoperoxidation [54, 57-61]. 
4) Meat may cause metabolic syndrome (MetS) [62], which play a role in the 
development of PC61 [63].  
Recent studies reported that meat protein from both red meat and white meat may be 
digested slowly and later than other maco-nutrients, such as carbohydrates and fat [18, 
19]. This may highlight the role of meat in contribute to PC61. However, the results from 
these studies may not be rigorous as they only focused on the relationship between red 
meat intake, instead of total meat intake, and PC61. It may not be wise to exclude white 
meat from the studies because: 1) The contents of red meat and white meat are quite 
similar although the quantities of the specific compounds are different. 2) Both red and 
white meat can produce the same mutagens or carcinogens when they are cooked at 
high temperature [64-66]. 3) Fat [33] and heme iron [58] [59-61] in red meat have been 
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postulated as the carcinogen. However, red meat has been leaner than ever over the 
past few decades due to leaner animals being bred and improved butchery and feeding 
techniques that make fat content fall significantly [67, 68]. Blood, which contains lots of 
heme iron, has been extensively consumed in Asian cuisines for thousands of years, but 
the PC61 incidence in Asia (9.4 per 100,000) is much lower than in other continents, 
such as Africa (23.2 per 100,000), Americas (75.0 per 100,000), Europe (61.3 per 
100,000) and Oceania (101.9 per 100,000) [69]. Additionally, The National Pork Board 
of the United States used to classify pork, a major “red meat”, as “the other white meat” 
[70]. Therefore, the contribution of white meat to PC61 may not be ignored in those 
studies. However, those studies into the relationship between red meat and PC61 did 
not remove the influence of white meat on PC61. In other words, statistically, there may 
be a defect in these studies as they did not establish the relationship independent of 
white meat consumption.    
Some studies do not support that red meat should be the only meat category to be 
associated with PC61. Globally, the overall consumption of white meat (poultry in per 
capita per year) between 1990 and 2009 has increased by 76.6% [71]. Accompanying 
this process, the PC61 incidence keeps increasing [2-5] worldwide. At the specific 
country level, for instance, in Australia, between 1982 and 2009, poultry meat has 
increased by 105%, but red meat has decreased by 22%. However, during this period, 
the PC61 incidence rate increased from 79.4 (per 100,000) in 1982 to 193.9 (per 100,000) 
in 2009 [72].  
Our data showed that both white meat intake and red meat intake were in strong and 
significant correlation to PC61 in Pearson r (r=0.515, p<0.001 and r=0.531, p<0.001 
respectively) and non-parametric correlations (r=0.560, p<0.001 and r=0.551, p<0.001 
respectively) (Table 6). However, only white meat intake, instead of red meat was 
significantly correlated to PC61 when ageing, GDP, Is, obesity and urbanization were 
statistically kept constant (r=0.337, p<0.001) (Table 6). Interestingly, when we 
incorporated red meat as the confounding factor, white meat intake was still significantly 
correlated to PC61 (r=0.384, p<0.001) (Table 6). This suggested that, if we consume 
both white and red meat, white meat may be able to contribute to PC61 when we remove 
the influence of red meat intake on PC61. To the best of our knowledge, statistically, this 
finding has not been reported by other studies.  
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Table 6 Pearson r, nonparametric and partial correlations of prostate cancer incidence to white 
and red meat respectively  
 Pearson r  Spearman rho  Partial    Partial   
 r n  r n  r n  r n 
White meat 0.515*** 163  0.560*** 163  0.337
*** n=150  0.3484*** n=149 
Red meat 0.531*** 163  0.551*** 163  0.092 n=150  - - 
Ageing 0.555*** 163  0.587*** 163  - -  - - 
GDP 0.529*** 157  0.573*** 157  - -  - - 
Is 0.274
*** 161  0.565*** 161  - -  - - 
Obesity % 0.489*** 161  0.501*** 161  - -  - - 
URBAN 0.470*** 163  0.516*** 163  - -  - - 
Pearson r, nonparametric and partial correlations were reported. Significance levels: * P <0.05, ** P< 0.01, *** P< 0.001.  
 
White meat (poultry) intake (kg/capita/year) sourced from the Food and Agriculture 
Organization, and red meat intake (kg/capita/year) was calculated through subtracting 
white meat from total meat intake; Ageing (percent of males ages 65 and above) and 
GDP PPP (gross domestic product converted to international dollars using purchasing 
power parity rates) and urbanization (the percent of males living in urban areas) were 
sourced from the World Bank. Male obesity prevalence (percent of males aged 18+ with 
BMI ≥ 30 kg/m2); Is was extracted from previous publications.   
White meat intake was placed second increasing R2 to 0.363 from 0.315 with ageing 
selected as the variable having the greatest influence on PC61 (R2 = 0.315) in Stepwise 
multiple regression analysis. When we replaced white meat intake with red meat intake 
as the independent variable, red meat was not selected as the most influential predictor 
of PC61.  
Although, statistically, we found that white meat intake may be a major predictor of PC61, 
it may not be proper to conclude that white meat intake is a major predictor of PC61, 
while red meat intake is not, considering the similarities between white meat and red 
meat (see above for details) and the controversial and circumstantial findings in previous 
studies.  
A cohort study based on the dietary habits of 917 subjects with PC61 concluded that 
there were no association between chicken intake and the risk of aggressive prostate 
cancer [73]. This result may not conflict with our finding that white meat was a major and 
independent predictor of PC61 because of a couple differences in study designs: 1) Only 
chicken which is main component, but not all, of white (poultry) meat. Our study included 
all the meat from poultry. 2) The research subjects in this study were PC61 patients, but 
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our study chose all the males. 3) Cooked chicken was used as the independent variable 
in the previous study, but poultry flesh was included as the independent variable in our 
study.  
The association between processed meat intake and PC61 has been tentative [32, 74]. 
Processed meat is usually composed of both red meat and white meat [75]. Therefore, 
this may support that white meat also contributes to PC61. There may be several issues 
with those studies. Firstly, the cariogenic effects of processing aids, such as sodium 
nitrite (E250) on PC61 were (or could) not be removed from the association between 
processed meat intake and PC61. Secondly, the total processed meat, such as hotdogs 
and sausages, instead of pure meat were included for study. Therefore, the quality of 
the data may be questionable. Similarly, statistically, the influence of unprocessed meat 
intake on PC61 was not removed from the association between processed meat and 
PC61. This may be the defect in these studies as well.   
A recent study conducted by Murphy et al. concluded that, due to similarities between 
pork, beef and chicken diets, people on these three diets for three months did not have 
different changes of the Body Mass Index (BMI) or any other marker of adiposity [31]. 
Similarly, another study did not deem that it was necessary to differentiate meat into 
different categories for investigating the relationship between meat intake and obesity 
[19].  
Categorizing meats and associating some meat types, such as red meat and processed 
meat, with detrimental health effects in the different circumstances is not supported by 
the health eating guideline published by the authorities from different country 
governments, such as Australia [76, 77], Canada [78], Europe [77] and United States 
[79]. One of the reasons may be that the conclusions from these studies are still 
controversial and not convincing enough.    
We have to point out a strong advantage of this study. This study does not list any 
circumstance for the existing relationship between total meat intake and PC61. The 
majority of the previous studies categorized meats for investigating the association 
between specific meat groups, such as red meat, and PC61 in the specific circumstances 
[80]. However, generally, people do not eat individual meats but rather meats in 
combination in broad circumstances [19, 81]. We used the total meat intake, defined as 
the “flesh of animals used for food”, as the independent variable in this study [68, 82]. 
The cooking methods, processing methods or nutritional function were not used to 
differentiate meat types. However, previous studies always listed one or more 
circumstances (categorizing meat) when the relationship between meat intake and PC61 
was investigated. The circumstances may include, but limited to, level of doneness [53, 
 
179 
64, 66, 80], myoglobin content (red and white meat) [46, 83, 84], modification methods 
(processed meat) [83, 85], ethnicity [85-87] and stage of the PC61 [80, 84, 85]. The 
definitions of these circumstances varied greatly and were not crystal clear. These 
ambiguous circumstances may have produced the controversial relationships between 
specific meat intake and PC61 [87]. Without any circumstance, the relationship between 
total meat intake and PC61 identified in our study may offer the new insight into the study 
of the adverse health effects of meat intake [81].  
There have been a couple of investigations into the relationship between total meat 
intake and PC61 risk. John et al. concluded that total meat intake was not associated 
with the risk of advanced prostate cancer [85]. Compared with our findings, the 
relationship in this study is very circumstantial because the results were based on the 
specific ethnicity (Non-Hispanic White and African-American men) and specified cooking 
methods and degree of doneness and stage of PC61 (advanced). In addition to the 
multiple circumstances included in this study, the data on total meat intake may be 
biased because newly diagnosed PC61 patients were included as the main research 
subjects in this study. These patients may more easily recall the negative life events 
(total meat intake) which have been considered as PC61 risks [88-92]. Our results were 
in agreement with the findings reported by Koutros et al. that total meat was in weak 
association with the increased risk of incident PC61 and increased risk of advanced 
PC61 although in this study “well or very well done total meat” was indicated as the 
independent variable [80].    
Several limitations in this study need to be declared. Firstly, the total meat intake data 
analysed were calculated for per capita in each country. Therefore, the relationship 
between meat intake and PC61 may only be demonstrated at a country level, which does 
not necessarily correspond to the same relationship holding true at the individual level. 
Furthermore, the general market availability of total meat, not the actual human 
consumption, were tracked for this study. We could not be able to access the direct 
measures of actual meat consumed by humans as we did not have the data to measure 
food wastage and provide actual meat intake at country level. Secondly, we included 
ageing, GDP, magnitude of PC61 accumulation, obesity and urbanization as the 
potential confounding variables in partial correlation analysis, but other confounding 
factors may still have influenced the associations reported in this study. For instance, 
meat intake varies worldwide due to availability, cultural beliefs or religious preferences. 
However, we could not locate and include other variables as the confounding factor in 
this study. Thirdly, the PC61 incidence rate was extracted from the GLOBOCAN 
database. It is probable that datasets from developing countries are less complete than 
those from developed countries due to issues of underdiagnoses. We attempted to 
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remove the different levels of PC61 diagnoses through controlling for GDP and 
urbanization, but this removal might not be sufficient.  Fourthly, total meat (“flesh of 
animals”) was used as the independent predictor of PC61 in this study. However, it is 
constantly reported that specific types, cooking methods, doneness levels and 
processing methods of meat may be the factors which make meat contribute to PC61.  
Conclusion  
Per capita total meat (flesh of animals) consumption may be an independent predictor of 
PC61 incidence at a global level. Major shifts in dietary habits featured with more meat 
intake should be investigated globally to determine its adverse health effects. It is novel 
to include total meat as the predictor of the worldwide non-communicable disease 
epidemic. This study creates avenues for further study into the subject with exposure 
based longitudinal cohort studies.   
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Contextual Statement 
Wheat protein (gluten) has been associated with metabolic syndrome, which may 
increase body weight. Wheat, rice and maize are the three major cereal crops. Rice and 
maize have already been advocated as the body weight control dietary components. 
However, cereals, including wheat, have also been suggested as the healthy food group 
in terms of body weight management.  
We postulated and tested that wheat consumption may have been contributing to obesity 
worldwide in a hidden way because wheat’s contributing effects may have been 
balanced by the other two cereal crops, rice and maize, which are beneficial for body 







Background: Cereals have been extensively advocated as the beneficial food group in 
terms of body weight management, but each staple cereal crop may contribute in 
different ways. Studies of the association between wheat availability and risk of obesity 
are controversial. This study aimed to test the global and regional association between 
wheat availability as reported by FAO and obesity prevalence at a population level. FAO 
does not distinguish between whole grain wheat and refined wheat.   
Methods: Population-specific data from 170 countries on prevalence of obesity, 
availabilities of mixed cereals, wheat, rice, maize, meat, sugar, fat, soy and calories and 
GDP are obtained from the UN agencies. All variables were measured as per capita per 
day (or per year). Each country is treated as an individual subject. SPSS v. 22 is used to 
analyse these data for all the 170 countries and official country groupings (regions) using 
non-parametric and parametric correlations, including partial correlation analysis.  
Results: Pearson’s correlation coefficient analysis showed that obesity prevalence was 
positively associated with wheat availability (r=0.500, p<0.001), but is inversely 
associated with availabilities of total cereals (r=-0.132, p=0.087), rice (r=-0.405, p<0.001) 
and maize (r= -0.227, p=0.004). These associations remain in partial correlation model 
when we keep availabilities of meat, fat, sugar, soy and caloric intake and GDP 
statistically constant. Overall, positive association between wheat availability and obesity 
prevalence remain in different regions. Maize and mixed cereal availabilities do not show 
independent associations with the obesity prevalence.  
Conclusions: Our study suggests that wheat availability is an independent predictor of 
the obesity prevalence both worldwide and with special regard to the regions of Africa, 
Americas and Asia.      
Key Words: Rice, Maize, Correlation, Cereals, Ecological Study  
Background  
Obesity is a serious global public health problem that needs to be urgently addressed 
among all populations (1-3). Obesity increases mortality and morbidity risk from various 
chronic diseases, such as cardiovascular diseases, diabetes, certain types of cancers 
and musculoskeletal disorders (4). Despite progress in knowledge of reasons of obesity, 
some causes for the obesity epidemic and the disparities between population groups are 
still unclear.  
Obesity is caused by a complex interaction between the environment, genetic 
predisposition and human behaviour (5). Diet habits have been implicated in the 
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development of obesity as they may bring environmental factor exposures to people, and 
this relationship between environmental factor exposure and obesity is complex and not 
completely understood (2, 6). Food components such as soy products and sugar in our 
diets were postulated to contribute to obesity (7) and diabetes (8, 9) respectively in 
additioon to a number of factors, such as physical activities, diet composition and 
genetics. Mixed cereals are important sources of many nutrients including dietary fiber, 
resistant starch, oligosaccharides, trace elements, vitamins, and other compounds of 
interest in disease prevention, including phytoestrogens and antioxidants (10). Dietary 
guidelines recommend the consumption of mixed cereals to prevent chronic diseases 
and/or their risk factors. For instance, whole-grain? mixed cereals, instead of the 
individual cereal crop, have been extensively advocated as the major food group for 
healthy body weight management (11-17), and have been shown their protective role of 
mixed cereals in reducing the risk of chronic diseases (18) including cancer (19, 20), type 
2 diabetes (16, 17) and cardiovascular disease (16, 17).     
Wheat makes up a substantial part of the human diet and is the most important food 
cereal source for humans (21). Due to the adoption of western-style diets, its demand 
for human consumption is increasing globally, including countries which are climatically 
unsuited for wheat production (22). In the recent years, the association between wheat 
intake and body weight management has been debated (17, 22-31). Wheat is provided 
for human consumption in different forms, principally unrefined or refined. The different 
forms of wheat products may have different health effects. It has been argued that whole 
wheat is beneficial for human health (17, 18).  A number of studies suggested that wheat 
consumption contributes to obesity prevalence in several ways including its use in energy 
dense and refined products. It has been suggested that wheat protein (gluten) may 
develop metabolic syndrome which may lead to body weight increase (25, 27, 32). In this 
study, we tested the association between the prevalence of obesity (expressed in 
percentage of defined population with a body mass index (BMI) of 30 kg/m2 or higher) 
and wheat availability at the population level on the basis of most recent complete data 
published by the United Nations (UN) agencies.  
Methods and Materials  
Data sources:  
The country specific data were collected for this ecological study:  
1) The WHO Global Health Observatory (GHO) data on the estimates of prevalence of 
adult obesity (percentage of BMI ≥ 30 kg/m2 in country population, 2014).  
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The GHO is an initiative of the WHO to share data on global health, including statistics 
by country and information about specific diseases and health measures. The GHO 
specifically assembles prevalence data of the biological risk factors, including obesity for 
WHO Member States using standardized protocols 
(http://www.who.int/gho/ncd/methods/en/).  
2) The FAOSTAT data on food availability per capita per day in 2011 of mixed cereals 
(excluding beer), wheat and products, rice (paddy equivalent), maize and products, total 
meat, sugar and sweeteners, grand total fat, soy products and grand total calories. These 
data were abbreviated as cereals, wheat, rice, maize, meat, sugar, fat, soy and total 
calories respectively in this paper.  
The FAOSTAT database disseminates statistical data collected and maintained by the 
FAO. FAOSTAT data are provided as a time-series from 1961 in most domains through 
the Food Balance Sheet (FBS, http://faostat3.fao.org/home/E). The FBS presents a 
comprehensive picture of the pattern of a country's food supply during a specified 
reference period. The FBS shows for each food item i.e. each primary commodity 
availability for human consumption which corresponds to the sources of supply and its 
utilisation. The total quantity of foodstuffs produced in a country added to the total 
quantity imported and adjusted to any change in stocks that may have occurred since 
the beginning of the reference period gives the supply available during that period. On 
the utilisation side a distinction is made between the quantities exported, fed to livestock 
+ used for seed, losses during storage and transportation, and food supplies available 
for human consumption. The per capita supply of each such food item available for 
human consumption is then obtained by dividing the respective quantity by the related 
data on the population actually partaking in it (33). Unfortunately, no separate data on 
consumption of refinded and unrefined of wheat products are available.  
3) The World Bank data on GDP per capita (USD per year, 2011)  
The World Bank dataset measures progress on aggregate outcomes for member 
countries for selected indicators. GDP per capita is gross domestic product divided by 
midyear population (http://data.worldbank.org/indicator/NY.GDP.PCAP.CD). GDP is the 
sum of gross value added by all resident producers in the economy plus any product 
taxes and minus any subsidies not included in the value of the products. It is calculated 
without making deductions for depreciation of fabricated assets or for depletion and 
degradation of natural resources.  
WHO, FAO and the World Bank are intergovernmental organizations using specialized 
information relevant to their respective fields. Their professional personnel should have 
evaluated these data in consideration of their possible use, e.g. for scientific research 
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and decision making, before they were published. Therefore, the data reporting is as free 
of bias and error as it can be with government statistics. This means that errors are 
reduced but some inaccuracies related to reporting quality may still be present in the 
data. Similar data from the same sources were recently used to analyse the relationships 
between nutrients and obesity (7, 34) and diabetes (8, 9, 35) in a number of publications.   
Criteria for data inclusion 
The data were selected in consideration of their fulfilment of 1) completeness of data 
across all analysed variables, 2) the most updated and recent datasets available, 3) 
major food types that were indicated in the literature to have relationships with obesity, 
specifically: wheat, rice, maize, meat, fat and sugar. For instance, barley and rye also 
contain gluten like wheat (36), but we did not include them in our study due to their 
extremely low availabilities in limited areas in the world. Following these conditions, 
country-level data on obesity prevalence in 2014, cereal availability in 2011 (mixed 
cereals, wheat, rice, and maize), and potential confounders (meat, sugar, fat, soy, total 
calories and GDP) in 2011 were matched. We backdated variables and potential 
confounders to 2011 to reflect exposure with delayed obesity presentation in 2014. The 
rationale for this decision is that studies have shown that three years is a practical period 
to develop obesity and metabolic syndrome after exposure to dietary risks (i.e., high 
intake of wheat today does not lead to immediate obesity) (37-39). 
In order to contrast the association between wheat availability and obesity prevalence 
and availability of other cereal crops, we used the availability data of mixed cereals and 
the other two staple food cereal crops, rice and maize for comparative analysis.  
All the aforementioned data were freely downloaded from the UN agencies websites. No 
ethical approval or written informed consent for participation was required.   
Data analysis 
We obtained data for 170 countries that had information required for both obesity and 
wheat availability in a uniform format. Each country was treated individually and all their 
availability for other variables information was analysed. In this paper the variables and 
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confounders were only referred to with their abbreviations instead of full names followed 
by their units. For particular analyses, the number of countries included may have 
differed somewhat because all information on other variables was not uniformly available 
for all countries due to unavailability from relevant UN agencies. The minimum sample 
size is 148 for correlation with soy availability. All the data were extracted and saved in 
Microsoft Excel® for analysis.   
Human diet patterns varying in different food components may be affected by the types 
of food availability in a particular region, socio-economic status and cultural beliefs. In 
order to demonstrate that association between obesity prevalence and wheat availability 
is universal regardless of these factors, countries were grouped for correlation analyses. 
The criteria for grouping countries are UN macro geographical regions, the World Bank 
income classifications, WHO regions, countries sharing specific characteristics like 
geography, culture, development role or socio-economic status, like Latin America and 
the Caribbean (LAC), Organisation  for  Economic  Co-operation  and  Development 
(OECD), Asia-Pacific Economic  Cooperation (APEC), Southern  African Development 
Community (SADC), the Arab World, Latin America (LA), European Union (EU) and Asia  
Cooperation  Dialogue (ACD). All the country listings are sourced from their official 
websites for matching except LA which is self-classified based on region primarily 
speaking romance languages. Countries included in LA are Argentina, Bolivia 
(Plurinational State of), Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, 
Ecuador, El Salvador, Guatemala, Haiti, Honduras, Mexico, Nicaragua, Panama, 






Table 1 Sources of country grouping criteria and correlation between obesity prevalence and 
wheat availability in different country groupings   
Country groupings 
 Pearson’s  Nonparametric 
  Source of country grouping criteria  r Sig. rho Sig. 
Worldwide (n=170) 0.500 <0.001  0.555 <0.001 
  http://who.int/en & 
http://faostat3.fao.org 
UN macro geographical regions      
     Africa (n=47) 0.790 <0.001  0.767 <0.001   http://unstats.un.org 
     Americas (n=35)    0.518 0.001  0.604 <0.001   http://unstats.un.org 
     Asia (n=42) 0.616 <0.001  0.639 <0.001   http://unstats.un.org 
     Europe (n=39)  0.222 0.174  0.222 0.173   http://unstats.un.org 
     Oceania (n=7)    -0.053 0.911  0.214 0.645   http://unstats.un.org 
  Sub-continents within UN macro geographic regions  
 Sub-Africa: SADC (n=14) 0.633 0.015  0.770 0.001   http://www.sadc.int 
Sub-Asia: ACD (n=26) 0.592 0.001  0.729 <0.001   http://www.acddialogue.com 
Sub-Americas: LA (n=20) 0.567 0.009 
 0.502 0.024 Self-classified based on region 
primarily speaking romance 
languages 
Sub-Europe: EU (n=28) 0.283 0.144  0.298 0.124   http://europa.eu 
World Bank income classifications 
    
    Low (n=32) 0.219 0.228  0.196 0.282   http://data.worldbank.org 
    Low middle (n=42)  0.307 0.048  0.544 <0.001   http://data.worldbank.org 
    Upper middle (n=48)  0.257 0.078  0.196 0.181   http://data.worldbank.org 
    High (n=48) 0.196 0.181  0.076 0.608   http://data.worldbank.org 
WHO regions 
    
    AFRO (n=40) 0.679 <0.001  0.745 <0.001   http://www.afro.who.int  
    AMRO (n=35) 0.518 0.001  0.604 <0.001   http://www.paho.org/hq  
    EMRO (n=15) 0.285 0.252  -0.010 09.68   www.emro.who.int  
    EURO (n=50) -0.002 0.989  0.012 0.933   www.euro.who.int  
    SEARO (n=10)  0.408 0.241  0.413 0.235   www.searo.who.int  
    WPRO (n=17) 0.455 0.067  0.613 0.009   www.wpro.who.int  
Various economic and cultural country groupings 
   APEC (n=17) 0.640 0.006  0.689 0.002  http://www.apec.org 
   Arab World (n=17) 0.427 0.087  0.140 0.593  http://data.worldbank.org 
   LAC (n=32) 0.481 0.013  0.583 <0.001  http://www.unesco.org 
   OECD (n=34) 0.316 0.069  0.176 0.320  http://www.oecd.org 
Pearson correlation coefficients and Nonparametric Correlations are reported.   
Obesity prevalence is expressed in percentage of defined population with a body mass index (BMI) of 30 
kg/m2 or higher. Wheat availability is in g/capita/day.  
Abbreviations: LAC, Latin America and the Caribbean, OECD, Organisation for Economic Co-operation and 
Development; APEC, Asia-Pacific Economic Cooperation; SADC, Southern African Development 
Community; LA, Latin America; EU, European Union; ACD, Asia Cooperation Dialogue.    
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SADC, ACD, LA and EU are included as the sub macro UN continents of Africa, Asia, 
Americas and Europe respectively to further investigate the correlation within the 
succeeding macro areas. We could not select any small international organization within 
Oceania due to very limited number of countries for us to access data. In our analysis, 
we only included those countries for which we could access the data for the specific 
groupings.  
We calculated the standard deviations of wheat availability and obesity prevalence in 
United Nations macro continents to explore the variation in Pearson coefficients between 
wheat availability and obesity prevalence due to the different geographic distributions of 
country groupings.  
Pearson’s correlation coefficient, non-parametric correlation coefficient (rho) of 
Speaman were calculated between all selected variables and partial correlation analyses 
keeping some variables statistically constant were conducted using SPSS v. 22 (SPSS 
Inc., Chicago Il USA). In this study, significance was kept at the 0.01 level (2-tailed).  
Results  
In general, obesity prevalence is in significant positive association with wheat availability 
(r=0.500, p<0.001), but inversely with rice availability (r=-0.405, p<0.001) (Table 2). It is 
also inversely associated with maize availability (r=-0.227, p=0.004) and mixed cereals 
availability (r=-0.132, p=0.087) (Table 2).  
We subsequently performed nonparametric correlations in SPSS (Spearman’s “rho”) 
with the same set of data to test whether the Pearson’s correlations between obesity 
prevalence and all variables differ due to potentially abnormally distributed variables 
(Table 2).  
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Table 2 Correlation analysis between obesity prevalence and all variables 
  
BMI≥30 Total 
Cereals Wheat Rice Maize Meat Total Fat  Sugar Total Calories  GDP Soy 
BMI≥30 1     -0.132  0.500*** -0.405***     -0.227** 0.624*** 0.589***    0.660***    0.593***   0.339***     0.252*** 
Cereals -0.172* 1  0.406*** 0.164*      0.216** -0.336***    -0.230** -0.167* 0.147 -0.234** -0.025 
Wheat   0.555***  0.288*** 1  -0.465***     -0.347*** 0.293***  0.429***   0.380***    0.574*** 0.224**  0.063 
Rice -0.252*** 0.052 -0.473*** 1     -0.145 -0.349***  -0.392***  -0.308***   -0.280*** -0.246***  0.029 
Maize   -0.300*** 0.116  -0.418***     -0.021 1 -0.313***  -0.381***  -0.260***   -0.302*** -0.291*** -0.038 
Meat  0.637*** -0.325*** 0.420***  -0.321***    -0.321*** 1  0.811***   0.627***    0.666***  0.648***     0.314*** 
Total Fat   0.631*** -0.210**   0.550***  -0.363***    -0.437***  0.807*** 1   0.613***    0.818***  0.731***     0.270*** 
Sugar   0.664*** -0.182*   0.466*** -0.250***    -0.337***   0.636***   0.641*** 1    0.624***  0.480***    0.343*** 
Total Calories   0.603*** 0.095 0.635*** -0.338***    -0.314*** 0.679*** 0.823*** 0.627*** 1  0.615***    0.313*** 
GDP   0.657*** -0.243**   0.513***  -0.287***    -0.388***  0.833***  0.819*** 0.704***  0.757*** 1  0.188* 
Soy  0.339*** -0.052  0.099 0.072    -0.034         0.317***       0.317*** 0.358***  0.319***     0.428*** 1 
Pearson correlation coefficients and non-parametric correlation coefficients (rho) are reported. Number of countries included in the analysis range from 148 to170.   *P˂ 0.05; **P˂ 
0.01; ***P˂ 0.001 
BMI≥30 is for obesity prevalence which is expressed in percentage of defined population with a body mass index (BMI) of 30 kg/m2 or higher. Availabilities of wheat, rice, maize, meat, 




Figure 1 presents the relationships between obesity prevalence and each cereal food 
type.  Relationships between obesity prevalence and availabilities of total cereals, rice 
and maize are linear, and wheat availability shows power relationship with obesity 
prevalence.  
 








When the potential confounders which are the availabilities of meat, sugar, fat and soy, 
the intake of calories and GDP are controlled for partial correlation analysis, obesity 
prevalence is still in strong positive association with wheat availability (r=0.368, p<0.001) 
(Table 3). The association between obesity prevalence and rice availability is relatively 
strong, but negative (r=-0.276, p=0.001). No association between cereals availability 
(r=0.065, p=0.436) or maize availability (r=-0.004, p=0.963) is observed (Table 3).  
 
Table 3: Global association between obesity prevalence and total cereals and each cereal 
food availabilities controlled for several confounders in partial correlation 
analysis   
Correlation Cereals Wheat Rice    Maize 
  Partial correlation (r) -0.065 0.368            -0.276    0.004 
  Significance 0.436           <0.001 0.001    0.963 
  df 145 145 145   145 
Partial correlation coefficients are reported. Keeping intake of meats, total fats, sugar, soy, total calories 
and GDP constant.  
Obesity prevalence which is expressed in percentage of defined population with a body mass index (BMI) 
of 30 kg/m2 or higher. Availabilities of wheat, rice, maize, meat, soy, cereals, sugar and total fat are 
expressed in g/capita/day. GDP is in per capita USD per year. Total calories is in kcal/capita/day. 
 
The correlation of wheat availability to obesity prevalence in different country groupings 
is also observed (Table 1). Within the UN macro geographical regions, Africa (r=0.790, 
p<0.001), Americas (r=0.518, p=0.001) and Asia (r=0.616, p<0.001) have a significant 
positive association with wheat availability. The association based on Europe region is 
positive, but not significant. These trends are also observed in Africa sub-grouping 
(SADC), Americas sub-grouping (LA), Asia sub-grouping (ACD) and Europe sub-
grouping (EU) respectively (Table 1).   
For the UN macro region of Oceania (Table 1), sample size is small and variation of 
wheat availability is limited. This renders correlation coefficients uninformative (Table 4).  
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Table 4 Standard deviations of obesity prevalence and wheat availability in UN macro continents 
 Obesity prevalence  Wheat availability  
Continents  
Mean Std. Deviation 
 
Mean Std. Deviation 




  Americas (n=35)    
24.49 5.26 
 
 154.54 65.06 
  Asia (n=42) 
14.97        11.07 
 
  241.24 163.16 








Obesity prevalence is expressed in percentage of defined population with a body mass index (BMI) of 30 kg/m2 or 
higher. Wheat availability is in g/capita/day.  
 
The association between obesity prevalence and wheat availability exists in all the 
country groupings categorized by the World Bank based on per capita GDP.     
Based on the WHO region classifications, AFRO (r=0.679, p<0.001) and AMRO (r=0.518, 
p=0.001) have the significant correlation between obesity prevalence and wheat 
availability. However, there is nearly no association in Europe. The similar correlation 
can be observed in Africa sub-grouping (SADC), Americas sub-grouping (LA) and 
Europe sub-grouping (EU) respectively. Wheat availability is also positively correlated to 
obesity prevalence in EMRO and SEARO.  Lack of correlation in Europe is a result of 
small variation in obesity prevalence and wheat availability (Table 4).  
The general trend that obesity prevalence is positively associated with wheat availability 
can be observed in country groupings regardless of cultural backgrounds, economic 
levels and geographic locations of the clustered countries. The trends are also present 
in two functional alliances, OECD and APEC although the former comprises developed 
countries only and the latter is comprised of both developing and developed countries.          
Discussion  
The worldwide secular trend of increased obesity prevalence likely has multiple 
etiologies, which may act through multiple mechanisms. By examining the data collected 
for 170 countries, we have shown that globally obesity prevalence is significantly 
associated with wheat availability independent of other food components (total fat, soy 
products, sugar and meat), total calories and GDP. Although results of ecological 
analysis must be treated cautiously, our results indicated relationship similar to those 
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found in three recent empirical surveys in children (31), young women (24) and general 
adults (23).  
Early in history, barley and rye were much more prominent as dietary grains. However, 
during agriculture modernization and evolution of our culture, wheat has been recognized 
as the finest grain (40). Wheat has a pleasant flavour, an extensive shelf life and unique 
properties because of gluten-forming proteins (40). About 95% of the wheat that is grown 
and consumed globally is bread wheat (Triticum aestivum). Bread wheat is a relatively 
new species, having arisen in southeast Turkey about 9,000 years ago (21, 41). 
Extensive wheat breeding by modern agricultural techniques, such as seed selection, 
hybridization and radiation, has aimed to increase crop yield, improve quality, diversify 
the strains and develop disease and insect resistance and tolerance to abiotic stresses. 
Modern agriculture techniques have made hereditary factor of wheat changed. These 
changes of genetic material may have brought new substances in modern wheat in 
comparison to those from wheat decades ago (25, 30).  
Wheats are subjected to many different processes during their preparation for human 
consumption. Whole wheat products have been generally accepted as food groups that 
are rich in fiber, micronutrients and minerals. Therefore, it has been argued that whole 
wheat consumption is beneficial to human health (17, 18). Refined wheat products have 
been considered as desired food in the past due to its purity, but it contains practically 
only carbohydrates, which is less beneficial nutritionally (42). Due to their appearance 
and good taste, food items containing refined wheat may be over consumed. Since we 
could not obtain separate data on whole wheat and refined wheat consumption, their 
respective contributions to obesity should be subject of separate study. There are many 
varieties of wheat gluten proteins which may have structural, metabolic, protective or 
storage functions (43). Analysis of proteins expressed by a wheat hybrid compared to its 
two parent strains have demonstrated that 5% of proteins in general (44) and 14% in 
gluten proteins (45) were present in either parent. From the evolutionary perspective, 
new types of crops or food components, such as soy (7), when massively introduced into 
human diet, may be able to change human nutritional environment with the consequence 
of contributing to obesity prevalence (46).  
Gluten proteins are the major storage components in wheat and may account for up to 
80% of the total cereal protein (47, 48). Anti-nutrients are natural or synthetic compounds 
that interfere with nutrient absorption. The gluten complex has been considered as one 
of the anti-nutrients causing inflammation (25, 30, 32) which has been associated with 
body weight increase in a number of studies in humans (25, 27, 30) and animals (28). A 
couple of studies found that gluten consumption was inversely correlated with BMI 
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increase (27, 49), but the two cohorts in the studies had been under clinical treatments 
due to celiac disease and Crohn’s disease respectively.  
In this ecological analysis, wheat contributes to obesity. Wheat has greater energy 
density than another staple food, rice (23). For instance, eaten in Asia steamed wheat 
bread doubles the energy from the same amount of steamed rice (50). It has been well 
established that energy-dense diets increase risk of obesity because they tend to 
increase total energy intake (51, 52).  Since we do not have data on whole wheat and 
refined wheat availability. It can only be suggested that the observed correlation may be 
a result of refined grain consumption (53).   
European countries are culturally and socio-economically relatively homogenous. In 
Europe, the correlation coefficient between per capita wheat availability and obesity 
prevalence does not reach the significant level, though it is still positive in our study. This 
is most likely due to small variances of wheat availability and obesity prevalence in this 
region (SD of wheat availability= 62.19, SD of obesity prevalence=2.92, Table 4) that 
may reduce the co-variance. It may also be that types of wheat products consumed in 
Europe differ from those consumed in other parts of the world.    
Although the association between wheat availability and the obesity prevalence is not 
significant in the South East Asia (WHO region), it is significant in macro Asia (both UN 
and WHO definitions) and the Asia sub-ACD. It may be because the obesity prevalence 
in South East Asia should be assessed with the region specific BMI≥ 28, instead of the 
universal BMI≥ 30 (54, 55). The universal obesity determining level (BMI≥30) used by 
the WHO to calculate the obesity prevalence may not be able to determine the actual 
prevalence of obesity in that area.   
In the modern diet, a majority of cereals are refined by the removal of germ, and bran, 
so that the remaining endosperm is mostly carbohydrate (56). Refined endosperm may 
be metabolized to satisfy human daily energy requirement earlier than the other two 
macro-nutrients which are fat and protein (46, 57-59). Globally, wheat, rice and maize 
supply around 93% of total daily energy from cereals and 50% of all food calories (59, 
60). A number of other studies also show that mixed cereals availability is not associated 
with obesity prevalence. In our study, obesity prevalence has been positively associated 
with wheat availability, but inversely with both rice and maize availability. These positive 
and negative associations may have been neutralized which may make mixed cereals 
appear as the healthy food types for body weight control.    
In terms of the association between obesity prevalence and rice availability only, our 
ecological study findings differ from the results of epidemiological studies in Japanese 
young women (61), in American Hispanic elders (62) and in Korean adult women (63). 
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There is a similarity among the three studies that the cohorts were on diet patterns which 
not only mainly consisted of rice, but also contained significant amount of soy products, 
such as miso soup, tofu or bean etc. Soy products contain anti-nutrients which may alter 
human metabolism and may contribute to obesity (7). Interestingly, a cohort of Brazilian 
adults in Sichieri’s studies mainly relied on rice and beans being protected against 
obesity (64). The underlying reason may be that the diet pattern for that particular cohort 
was that of low fat and low energy, or that too much rice and high fibre from rice and 
beans overcompensated the soy’s effect on causing obesity.      
There are a few limitations in this study. Firstly, lack of separate data of whole wheat and 
refined wheat availability. Secondly, although we attempted to remove confounding 
effects of variables such as GDP, caloric, fat availability etc. by means of partial 
correlation analysis, some confounding factors may still influence correlation we found. 
Some residual curvilinearity may remain even though a relationship between all studied 
variables appeared to be linear as indicated by similarity of values of Pearson and 
spearman nonparametric correlation coefficients. Secondly, there may be some 
variables not included in our analysis that influence found correlation. For instance, fruits 
availability correlated, however, poorly with prevalence of overweight in a similar 
ecological study (6). Other possible variables to be considered would be vegetables 
especially starch-rich varieties. Thirdly, we could only use an international food database 
that tracks the general market availability of different food types, not the actual human 
consumption. There are no direct measures of actual human consumption that can 
account for food wastage and provide precise measures of food consumption 
internationally. As Siervo et al. analysed (34), food disappearance data may not reflect 
precisely food available to household individual for consumption. Disappearance data 
may overestimate consumption by some ¼ of total amount. Finally, the data analysed 
are calculated per capita in each country, so we can only demonstrate a relationship 
between food group availability and obesity at a country level. Within a country, 
relationships between characteristics of individuals and their diets maybe different due 
to specific circumstances.    Cohort studies exploring cohort the association between 
different cereal species consumption and obesity prevalence would be useful.  
Conclusions  
Associations between obesity prevalence and wheat availability at country and regional 
levels suggest that wheat consumption may contribute to obesity. In ecological study, it 
may not be possible to reach reliable conclusions and therefore, there is a need to 
explore the association we found by specific studies of the type that can be more 
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Contexture Statement       
A large number of studies concluded that less childbearing may be a major risk of 
gynaecological cancers. A limited number of studies associated the number of children 
born into a family (family size) with the risk of non- gynaecological cancers of other family 
members. Studies also revealed that greater family size may create more positive 
psychological well-being for family members, which may offer the protection against 
cancer development.  
Ecological study has the advantages that more objective variables, which can even be 
backdated for predicting prolonged disease presentation, can be included for analysis. 
With these advantages, we collected the country specific incidence rates of all cancers 
and individual site cancers and analysed their relationships with family size (indexed by 
total fertility rate (TFR)). We found that TFR inversely correlated to the incidence rates 
of all cancers of both sexes, male and female and most of the individual site cancers. 
This may suggest that greater total fertility rate may protect all the family members from 






Abstract   
Background: Greater family size measured with total fertility rate (TFR) and with 
household size, may offer more life satisfaction to the family members. Positive 
psychological well-being has been postulated to decrease cancer initiation risk. This 
ecological study aims to examine the worldwide correlation between family size, used as 
the measure of positive psychological well-being, and total cancer incidence rates.    
Methods: Country specific estimates obtained from United Nations agencies on total 
cancer incidence rates (total, female and male rates in age range 0-49 years and all ages 
respectively), all ages site cancer incidence (bladder, breast, cervix uteri, colorectum, 
corpus uteri, lung, ovary and stomach), TFR, household size, life expectancy, 
urbanization, per capita GDP PPP and self-calculated Biological State Index (Ibs) were 
matched for data analysis. Pearson’s, non-parametric Spearman’s, partial correlations, 
independent T-test and multivariate regressions were conducted in SPSS.  
Results: Worldwide, TFR and household size were significantly and negatively correlated 
to all the cancer incidence variables. These correlations remained significant in partial 
correlation analysis when GDP, life expectancy, Ibs and urbanization were controlled for. 
TFR correlated to male cancer incidence rate (all ages) significantly stronger than it did 
to female cancer incidence rate (all ages) in both Pearson’s and partial correlations. 
Multivariate stepwise regression analysis indicated that TFR and household size were 
consistently significant predictors of all cancer incidence variables.    
Conclusions: Countries with greater family size have lower cancer risk in both females, 
especially males. It may be worthwhile to include more family life satisfaction as part of 
strategic plan of cancer prevention. 
Trial registration: Not applicable  
Keywords: Total fertility rate, Household size, Psychological well-being, Family life, Cancer 
initiation   
 
Introduction 
Total fertility rate (TFR) representing the total number of births during a lifetime of a 
female [1, 2] has been used to measure childbearing and family size [3-5] in a number 
of studies. The prevalent conclusions were that more childbearing (greater TFR) may 
protect against female breast cancer [6], corpus uteri cancer [7] and ovarian cancer [8] 
due to less oestrogen production or less menstrual cycles [9] and more oxytocin 
secretion [10, 11], but may contribute to cervix uteri cancer because of more exposure 
to infection risk [12].  
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The number of children born into a family does not only influence the mother’s 
physiological health of her reproductive system, but also has effects on health, including 
cancer development, and on her other systems and on all the other family members. For 
instance, greater family size has been postulated to protect family members from 
developing colorectal cancer [5], melanoma of skin [5], bladder cancer [5], breast cancer 
[5] and stomach cancer (in males only) [13]. Relationships between greater family size 
/household size and lung cancer [5, 14] and stomach cancer (females) [13] were 
explored, but without much success of seeing a clear trend. Aldrich et al. [14] reported 
that household size was in significant association with a risk of developing lung cancer 
in African Americans, but not in Latinos.  
These controversial and circumstantial correlations between reproductive behaviour and 
a comprehensive health effect on all family members directed our attention to seeking 
alternative explanation of the relationship between TFR and risk factors for cancer. 
Psychological factors have been suggested to be linked with cancer initiation, but the 
mechanism has been intriguing professionals and laypeople for decades [15, 16]. 
Although studies on the possible effects of positive and negative psychological factors 
arising from life events on cancer incidence and prognosis are numerous, the literature 
remains contradictory as to methods and impacts [14, 17-19]. Extensive studies have 
suggested that adverse life events and the associated psychological stress may 
predispose to cancers in various body sites [20-24]. Everson et al. [25] reported that 
more stress may increase the cancer risk. This might be because people tend to recall 
adverse life events, but easily forget those positive ones, which constantly happen in the 
daily life. Cancer patients may more easily recall those negative life events which have 
been considered as cancer risks [26-30]. Only a limited number of studies have 
addressed the relationship between life satisfaction and cancer risk [14, 31], but the 
conclusions were controversial.  
Research conducted into health effects of positive psychological well-being has 
concluded that family life satisfaction may stimulate oxytocin production in the human 
body [32-38], which may have the inhibitory effect on specific cancers [10, 11, 39, 40]. 
For example, positive psychological wellbeing has been postulated to protect against 
cancer risk in Israeli women [31], reduce the number of American cancer patients from 
going into metastasis [41] and help cancer patients with cancer’s detection, treatment, 
and survival [41]. Large families have greater life satisfaction in both Western and 
Eastern populations [42, 43]. Nan et al. [43] have also concluded that the bigger family 
size is, the higher Subjective Happiness Scale (SHS) result is in the family, regardless 
of cultural backgrounds.  
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Therefore, in this study, we assessed, from a global perspective, whether greater family 
size, measured with TFR [3] and household size may lower cancer risk using empirical, 
macro-level data obtained from international organizations.  
Materials and Methods  
Data Sources  
The population specific data were collected for this ecological study.   
1. The GLOBOCAN 2012 estimates of incidence rates (age standardised, world) of all 
cancers excluding non-melanoma skin cancer (C00-97, but C44) in total, and separately 
for males and females of all ages [44] were used. Crude estimates of incidence rates of 
all cancers excluding non-melanoma skin cancer (C00-97, but C44) in total, and for 
males and females in age group 0-49 years were also obtained.  
The incidence rates of the individual site-specific cancers (bladder, breast, cervix uteri, 
colorectum, corpus uteri, lung, melanoma and ovary) were extracted as the dependent 
variables for data analysis in this study. The results from this study were aligned with the 
findings of previous studies of the relationships between family/household size and each 
of these site-specific cancers namely lung cancer [14], bladder cancer, melanoma and 
colon cancer [5].  
GLOBOCAN is a project conducted by the International Agency for Research on Cancer 
(IARC) of the World Health Organization. This project provides contemporary population 
level estimates by cancer site and sex using the best available data in each population 
and uses nine comprehensive methods of estimation [45].   
2. The United Nations Statistics Division estimates of the life expectancy [46], the total 
population in households and the number of households [47].   
Life expectancy is the average number of years a person of a given age, residing in a 
given country is expected to live. We extracted the life expectancy at age of 60 years old 
(e60, 2005-2010) from abridged life tables (1950-2100) [46] published online. Ageing has 
been a significant risk predictor of cancer. In this study, life expectancy (e60) was 
considered as the indicator of ageing.  
As instructed by the United Nations Statistics Division, we created a new variable, 
household size, through dividing the total population in households [47] by the number 
of households [47] in each country.   
3. The World Bank published data [1] on Gross Domestic Product (GDP), total fertility 
rate (TFR) and urbanization.  
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GDP was expressed in per capita purchasing power parity (PPP in current international 
$) in 2010. The World Bank also clusters countries into 4 classifications in terms of their 
GDP per capita (High Income, Upper Middle Income, Low Middle Income and Low 
Income). In this study, we grouped countries with High Income and Upper Middle Income 
as developed countries, and countries with Low Middle Income and Low Income as 
developing countries.     
Urbanization was expressed with the percentage of total population living in urban areas 
in 2010.   
Total Fertility Rate (TFR) represents total births per woman during her lifetime. It 
indicates the number of children that would be born to a woman if she were to live to the 
end of her childbearing years and bear children in accordance with age-specific fertility 
rates of the specified year.  
Total births per woman have been used to indicate the family size in studies at an 
individual level [3, 4]. Therefore, we used TFR as the measure of family size in this study, 
and terms “TFR” and “family size” were interchangeably used thereafter. Household size 
is used as the proxy of family size in this study that has been calculated from data 
independent from those used for TFR.   
4. Biological State Index (Ibs) was self-calculated [48, 49] with the fertility data of each 
country published by United Nations in 2008 [50] and the mortality data of life tables 
(2009) published by World Health Organization (WHO) in 2012 [51]. 
Ibs was included as one of the confounding factors that indicates the level of adaptation 
of a population [52]. The Ibs values range between 0 and 1.0. A greater Ibs value of a 
population means less opportunity for natural selection, and vice versa. The simplest 
interpretation of Ibs is that it indicates a probability with which an average person born 
into a population is able to pass her/his genes to the next generation.  Recent studies 
have postulated that Ibs may indicate the magnitude of deleterious gene/mutation 
accumulation in a population due to relaxed natural selection [52-55]. The greater Ibs 
value means that a population has accumulated more deleterious gene/mutations of 
cancer [53], obesity [54] and type 1 diabetes [55], and vice versa [52-55]. Inclusion of Ibs 
as a confounder may remove the influence of cancer gene/mutation accumulation on the 
correlation between family size and cancer incidence.  
Data Selection  
We used country specific cancer incidence rates, TFR, GDP, urbanization, household 
size and life expectancies for all countries where the most updated and recent data were 
available (N=178). In order to capture as many countries as we could for this study, we 
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aligned country specific TFR with all cancer incidence rates, and then we matched other 
country-specific variables with the TFR.     
Each country was treated as an individual subject in the analysis. Numbers of countries 
included in analyses of relationships with other variables may differ somewhat because 
all information was not uniformly available for all countries. The list of countries included 
in this study can be found in Supplementary File 1, Table S1.  
We singled out the population segment aged 0-49 years because females enter 
menopause at around 50 years of age and since then they produce less and less female 
hormones. Numerous studies have associated female oestrogen level with cancer risk 
[9, 10].       
All the aforementioned data were freely available from the websites of the UN agencies. 
No ethical approval or written informed consent for participation was required.  
Data analysis 
Scatter plots were produced in Excel (Microsoft® 2016) to explore and visualize the 
correlations between family size and cancer incidence in total population, males and 
females respectively. Scatter plots allowed us to assess data quality and distributions of 
variables. In the supplemental material, family size was replaced with household size for 
performing the scatter plots (Supplemental File 2, Figure S1).   
Prior to correlation/regression analyses all data were log-transformed (ln) in order to 
reduce non-homoscedascity of their distributions and possible curvilinearity of 
regressions. To assess the relationships between each cancer incidence rate and family 
size, the analysis proceeded in four steps. 
1. Pearson’s and nonparametric correlations (Spearman’s rho) were used to evaluate 
the strength and direction of the associations between family size and all other variables, 
including independent variables and confounders. 
2. Partial correlation of Pearson’s moment-product approach was used to assess the 
relationship between each cancer incidence rate and family size respectively while we 
controlled for GDP PPP [44, 45], urbanization [56, 57], Ibs and life expectancy [58] which 
have been commonly considered as the contributing factors of cancer.  
Fisher’s r-to-z transformation was performed to test significance of differences between 
correlation coefficients.  
3. Standard multiple linear regression (stepwise) was performed to identify the most 
significant predictor(s) of cancer risk. The dependent variables included cancer 
incidence rate by sex (total, male and female, age group 0-49 and all ages respectively). 
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The independent variables/predictors entered into analyses were family size, 
urbanization, GDP, Ibs and life expectancy (not for cancer variables for 0-49 years).   
4. The independent samples t-test was performed to compare the means of each cancer 
variable in high and low fertility countries divided at the cut point of TFR=2.36. We used 
2.36 as the cut point because it is the world average TFR published by the United Nations 
for the period of 2010-2015 [59].  
Socioeconomic level plays a critical role in family happiness. In parallel to the analyses 
of the relationship between family size and cancer variables worldwide, the relationships 
between family size and each cancer variable in developed and developing country 
groupings were also examined respectively. Descriptive statistics including standard 
deviations of all variables were calculated for analysing and comparing the covariance 
(relationship between family size and cancer incidence) in all countries (n=178), in 
developed world (n=98) and in developing world (n=80).     
Subsequently, family size was substituted with household size for reanalysing the 
associations and regressions. The results were reported in Supplementary Files 3 (Table 
S2) and 4 (Tables S3). There was no stratification of country grouping in the 
supplemental analyses due to limited sample size of countries for which household size 
was available (n=58).  
Pearson’s, non-parametric Spearman’s rho correlations, partial correlation, stepwise 
multiple linear regression, independent samples t-test analyses and descriptive statistics 
were calculated using SPSS v. 22 (SPSS Inc., Chicago Il USA). To increase 
homoscedasticity of data distributions, log-transformed variables were used for 
correlation analyses. The significance was reported when P-value was <0.05, but the 
significance levels of p < 0.01 and p<0.001 were also indicated in the tables. Regression 
analysis criteria were set at probability of F to enter ≤ 0.05 and probability of F to remove 
≥ 0.10. The raw data were used for scatter plots.       
Results  
Figure 1 shows a negative and strong correlation of family size to cancer incidence rates 
in total population and in males and females separately (all ages). The non-linear 
relationships between family size and group cancer incidence variables identified in the 
scatterplots show the strong correlation between family size and cancer incidence rate 
(R2=0.4901, 0.5637 and 0.3755). Household size as the proxy of family size has shown 
the similar correlation to all cancers incidence rates (total, female and male) 
(Supplementary File 2: Figure 1).  
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Figure 1: The relationship between family size and all cancers incidence rates (total, male and 
female, all ages) 
 
The subsequent analyses of log-transformed data proved these relationships. Globally 
(n=178), Spearman’s rank correlation showed that family size was in significant negative 
correlation to all cancers incidence rates (both sexes) in all ages (r = -0.716, p < 0.001) 
and in age group 0-49 years (r = -0.752, p < 0.001), separately in females of all ages (r = -
0.640, p < 0.001) and age group 0-49 years (r = -0.762, p < 0.001) and in males of all 
ages (r =- 0.761, p < 0.001) and age group 0-49 years (r = -0.765, p < 0.001)(Table 1). 
Pearson’s r showed quite similar relationship trends between family size and the cancer 
variables (Table 1).  
When family size was replaced with household size for supplemental data analysis, 
household size also showed significant, negative and strong correlation to each cancer 
variable (both sexes, female and male in age groups, 0-49 and all ages respectively) 
(Supplementary File 3: Table S1).  
In developed countries grouping (n=98), Spearman’s rank correlation showed that family 
size was in significant negative correlation to all cancers incidence rates (both sexes) in 
all ages (r = -0.540, p < 0.001) and age group 0-49 years (r = -0.705, p < 0.001), 
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separately in females of all ages (r = -0.477, p < 0.001) and age group 0-49 years (r = -
0.581, p < 0.001) (Table 1) and in males of all ages (r =- 0.582, p < 0.001) and age group 
0-49 years (r = -0.705, p < 0.001). Pearson’s r showed quite similar relationship trends 
between family size and the cancer variables (Table 1). 
In developing countries grouping (n=80), Spearman’s rank correlation showed that family 
size was in significant negative correlation to all cancers incidence rates in all ages (r = -
0.334, p < 0.001) and age group 0-49 years (r = -0.498, p < 0.001), separately in females 
of age group 0-49 years (r = -0.482, p < 0.001) but not at all ages (r = -0.140) and in males 
of all ages (r =- 0.457, p < 0.001) and age group 0-49 years (r = -0.449, p < 0.001) (Table 
1). Pearson’s r showed quite similar relationship trends between family size and the 
cancer variables, except for all cancers incidence rate in females at all ages (r=-0.200, 
r<0.05) (Table 1). 
When, in the partial correlation analyses, we controlled for the major confounders (GDP, 
urbanization, life expectancy (not for cancer variable in age group 0-49 years) and Ibs): 
1) globally (n=178), family size remained in the significant correlation to all cancer 
incidence rates (both sexes) in all ages (r = -0.362, p < 0.001) and the age group 0-49 
years (r = -0.534, p < 0.001), in females of all ages (r = -0.230p < 0.001) and age group 
0-49 years (r = -0.492, p < 0.001) and in males of all ages (r = -0.449, p < 0.001) and age 
group 0-49 years (r = -0.542, p < 0.001) (Table 1). Family size correlated stronger with 
male cancers incidence than with female cancers in all ages group (n=178). This 
difference was shown to be statistically significant by Fisher’s r-to-z transformation in 
both Pearson’s (z= 2.43, p=0.015) and partial (z= 2.22, p=0.026) correlations. 2) In 
developed world (n=98), family size also remained in the significant correlation to all 
cancers incidence rates (both sexes) in all ages (r = -0.625, p < 0.001) and the age group 
0-49 years (r = -0.658, p < 0.001), in males of all ages (r = -0.470, p < 0.001) and age 
group 0-49 years (r = -0.581, p < 0.001) and in females of all ages (r = -0.362, p < 0.001) 
and the age group 0-49 years (r = -0.534, p < 0.001) (Table 1). 3) In developing world 
(n=80), family size remained in the significant correlation to all cancer incidence rates 
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(both sexes) in the age group 0-49 years (r = -0.430, p < 0.001) but not at all ages group, 
in females of age group 0-49 years (r = -0.384, p < 0.001) but not at all ages and in males 
of all ages (r = -0.303, p < 0.05) and the age group 0-49 years (r = -0.430, p < 0.001) 
(Table 1).  
Table 1 also shows that, globally (n=178) and in developed world (n=98), each of the 
incidence rates (all ages) of individual site cancers in bladder, breast, colorectum, corpus 
uteri, lung, skin (melanoma), ovary and stomach was in significant, negative and strong 
correlation to family size in both Pearson’s and partial correlation analyses (Table 1). 
Globally (n=178), cervix uteri cancer correlated with family size significantly and 
positively in both Pearson’s r and non-parametric correlation, but the correlation was 
neither strong nor significant in partial correlation (Table 1). In developed world (n=80), 
cervix uteri cancer did not show correlation (partial) or very weak correlation (Pearson’s 
r) with family size (Table 1) although it statistically significantly correlated with family size 
(r=0.223, p<0.05). In developing world (n=80), only correlations between family size and 
lung cancer and cervix uteri cancer were consistent with those revealed globally and in 
developed world (Table 1).         
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at 60 years GDP PPP Urbanization 
Pearson’s & nonparametric correlations           
Total Fertility Rate 1 0.491*** -0.746*** -0.717*** -0.745*** -0.695*** -0.747*** -0.607*** -0.704*** -0.764*** -0.574*** 
Household size 0.437*** 1 -0.668*** -0.646*** -0.634*** -0.654*** -0.615*** -0.641*** -0.477*** -0.427*** -0.381** 
Cancer incidence,0-49 years, Total -0.775*** -0.742*** 1 0.955*** 0.978*** 0.928*** 0.905*** 0.900*** 0.629*** 0.586*** 0.397*** 
Cancer incidence,0-49 years, Male -0.759*** -0.698*** 0.952*** 1 0.878*** 0.891*** 0.896*** 0.827*** 0.584*** 0.547*** 0.354*** 
Cancer incidence,0-49 years, Female -0.758*** -0.731*** 0.981*** 0.885*** 1 0.909*** 0.870*** 0.908*** 0.641*** 0.619*** 0.425*** 
Cancer incidence, All ages, Total -0.713*** -0.741*** 0.931*** 0.896*** 0.911*** 1 0.980*** 0.968*** 0.657*** 0.605*** 0.433*** 
Cancer incidence, All ages, Male -0.758*** -0.691*** 0.908*** 0.903*** 0.870*** 0.978*** 1 0.902*** 0.658*** 0.625*** 0.436*** 
Cancer incidence, All ages, Female -0.635*** -0.739*** 0.903*** 0.832*** 0.909*** 0.967*** 0.902*** 1 0.618*** 0.575*** 0.419*** 
Life expectancy at 60 years old -0.690*** -0.522*** 0.626*** 0.579*** 0.640*** 0.653*** 0.660*** 0.611*** 1 0.720*** 0.585*** 
GDPPPP -0.729*** -0.595*** 0.608*** 0.571*** 0.629*** 0.614*** 0.635*** 0.591*** 0.731*** 1 0.730*** 
Urbanization -0.559*** -0.283* 0.456*** 0.398*** 0.484*** 0.487*** 0.479*** 0.481*** 0.662*** 0.793*** 1 
Partial correlations, keeping DGP, urbanisation and life expectancy constant 
Total Fertility Rate 1 0.214 -0.511*** -0.500*** -0.473*** -0.367*** -0.466*** -0.222** - - - 
Household size  1 -0.526*** -0.514*** -0.459*** -0.509*** -0.448*** -0.491*** - - - 
Cancer incidence,0-49, Total   1 0.927*** 0.961*** 0.871*** 0.827*** 0.827*** - - - 
Cancer incidence,0-49, Male    1 0.795*** 0.818*** 0.827*** 0.715*** - - - 
Cancer incidence,0-49, Female     1 0.831*** 0.753*** 0.839*** - - - 
Cancer incidence, All ages, Total      1 0.962*** 0.946*** - - - 
Cancer incidence, All ages, Male       1 0.825*** - - - 
Cancer incidence, All ages, Female        1 - - - 
Pearson’s, nonparametric and partial correlation reported. *** p<0.001, ** p<0.01, * p<0.05;  n range: 52 or 58 for the correlation of household size to other variables, n range: 
163 or 176 for the correlation of TFR (total fertility rate) to other variables.   
All variables were log-transformed. In partial correlation analysis, life expectancy (e60), GDP and Urbanization were controlled for.  
Data sources and variable meanings:   
The data from the International Agency for Research on Cancer: cancer incidence rate (per 100,000 in 2012) by sex (total, male and female, age group (0-49 and all ages)  
the World Bank data: Total Fertility Rate (the mean number of children born to a woman between 2009-2011), GD PPPP (per capita purchasing power parity in current 
international $ in 2010) and Urbanization (the percentage of total population living urban areas in 2010)  




The correlations, especially the partial correlations between family size and cancer 
variables in all countries (n=178) and developed world (n=98) were stronger and more 
significant than those in developing world. Variances of cancer incidence variables in 
developing world (n=80) were smaller than their counterparts in the developed world and 
all countries grouping (Supplementary File 5).  
Table 2 shows that, globally (n=178), the mean incidence rate of each cancer variable in 
country group (n=95) with TFR ≥ 2.36 was significantly (p<0.001) lower than that of 
country group (n=83) with TFR < 2.36 except cervix uteri cancer. This trend remained in 
the developed country grouping (n=98) except cervix uteri and stomach cancers, and in 






In the standard multiple linear (stepwise) regression analyses, family size was the 
significant predictor of the total, male and female cancer incidence rates (with exception 
of all female cancers at all ages) in samples of all ages and in age group 0-49 years 
respectively when family size, GDP, life expectancy (not for age group 0-49 years) and 
Ibs were entered as the independent variables/predictors (Table 3). Although family size 
is a significant predictor of the variable of all cancers in females at all ages, the value of 
its beta coefficient was smaller than for the variable of all cancers in males at all ages. 
This finding was consistent with those reported in Table 1 that family size was in 
significantly stronger negative association with all cancers in males at all ages than it 
was with all cancers in females at all ages in both Pearson’s (z= 2.43, p=0.015) and 
partial (z= 2.22, p=0.026) correlation analyses. This means that greater family size may 




Comparing with those correlations in all countries and in developed world, correlations 
between family size and cancer variables became weak and/or insignificant in the developing 
country grouping when standard deviation of cancer variable became low (Supplementary File 
4: Table S2).  
As the proxy of family size, household size was identified as the significant predictor of the 
total, male and female cancer incidence rates in samples of all ages and in age group 0-49 
years respectively when household size, GDP, urbanisation, life expectancy (not for age group 
0-49 years) and Ibs were entered as the independent variables/predictors in the standard 
multiple linear (stepwise) regression analysis (Supplementary File 5: Table S3).  
Discussion   
Cancer risk has been associated with multiple aetiologies, which may act through various 
mechanisms. Our results showed that: 1) Worldwide, smaller family size may be an 
independent determinant of increased cancer risk. 2) increased family size may show more 
protecting effects on cancer risk in males than females.   
It is necessary to note the limitations of our work before analysing the public health implications 
of this study:  
First, we must highlight the ecological fallacy (intrinsic limitation) arising from the ecological 
study approach which was adopted in this study. The data included in this study were 
calculated for country/populations as a whole. Thus, values for risk-modifying factors do not 
always hold true for individuals to predict their cancer risk. However, we would like to note that 
it is nearly impossible to test the relationships at the individual family level due to rare 
occurrence rate of cancers, and even rarer in some individual site-specific cancers, such as 
ovarian cancer. 
Second, it is true that family size and family attitudes are influenced by many cultural, religious, 
economic, and social factors that vary substantially across different countries. However, there 
are no measures of such differeneces that can be used as confounders in our data analysis. 
Third, data compiled and/or collected by the major international agencies (WHO, IARC, the 
United Nations and the World Bank) might be crude and may contain some random errors 
arising from methods of reporting incidence of specific diseases, reliability of diagnoses and 
possible administrative errors. 
Finally, the observational data were used in our work, which makes the results subject to 
inherent bias, i.e. “correlation between two variables does not imply causality”.  
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Despite these limitations, findings from different data analyses in this study consistently show 
that country with greater TFR (family size) has lower cancer incidence rate regardless of age 
range and sex. This relationship trend has been observed in the correlations between family 
size and not only the individual site cancers, but also all cancers (in males, females and both 
sexes). The broad correlations between family size and cancers expressed in different 
individual sites, sexes and groups, may not be simply explained by the female hormonal 
fluctuation due to pregnancy and breastfeeding.  
The relationship between psychological well-being and diseases (body and mind) has been 
an old issue. In the past, research into well-being has mainly focused on negative attitudes 
and affects. The majority of the studies documented that negative life events (death, divorce, 
injury, car crash etc.,), stressful life style, depression and/or anxiety, may lead to developing 
cancers [31, 60]. However, there is a documented bias in the data collected from the individual 
based surveys. In general, cancer patients tend to report negative events in excess compared 
to other people with average or positive attitudes [27, 29, 30]. This has been reported or 
reflected in a number of studies [26-29] regarding the relationship between cancer risk and 
adverse life events. According to the ancient Chinese medicine textbook, which was compiled 
2,200 years ago, it has been believed that people have five internal organs of five gases (five 
emotions), i.e. happiness, anger, sadness, worry and fear. Among these five gases, only 
happiness makes the gas smooth [61], which keeps people healthy.  
Family has long been cited as a health promoting factor [62, 63], and family size has been 
associated with life satisfaction [42, 43, 64]. From the perspective of evolution, humans have 
adapted early to cooperative breeding [65, 66], and then evolved alloparental care [67], and 
biological foundations of such human love may be heritable generation by generation [68]. 
Our study has revealed that greater family size, and possibly its associated positive 
psychological well-being, may play a protective role against cancer initiation. The mechanisms 
may include following aspects: 
1. Physiological and pathological functions of oxytocin in human health 
Positive psychological well-being may make the functions of neuroendocrine and immune 
systems more efficient, which may reduce the risk of developing cancer [60, 69-71].  
Oxytocin is a peptide hormone and neuropeptide. Its production is associated with good 
feelings and emotions [72]. Males and females can produce and release similar quantities of 
oxytocin [73] within the hypothalamo-pituitary magnocellular systems. Researches constantly 
revealed that family related activities are the major promotors of oxytocin production. A stream 
of studies in the last decade reported that oxytocin release is not only associated with giving 
birth [74] and lactation [75], but also with daily interactions between family members, such as 
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spouses [32-34], mother and children [35], and father and children [36]. Oxytocin may be able 
to keep family happy and stable as it makes females and males stay monogamous [37, 38] 
and as it may bring positive psychological well-being to the family members. A self-reinforcing 
cycle is formed between family members interactions and oxytocin production.  
Concurrently with the research into oxytocin production, physiological and pathological 
functions of oxytocin in humans have been the foci of numerous studies. Oxytocin has been 
postulated to have a role in inhibiting proliferation of human cancer cells, which may offer 
protective role in preventing cancer initiation [40]. The inhibitory role of oxytocin has been 
tested in individual site specific cancers, such as human breast cancer [40, 76] and ovarian 
cancer (animal model) [11]. A recent study reported that oxytocin, selectively activated by 
peptidylglycine α -amidating monooxygenase (PAM), may play a role in preventing and 
controlling a small cell lung cancer [77].  
Bai et al. [26] reported that women with overall life satisfaction had less chance developing 
breast cancer. This may partly be true because life satisfaction may promote women to 
produce more oxytocin to prevent breast cancer cell initiation and proliferation. Another 
mechanism may be that greater TFR may make women produce less oestrogen and less 
menstrual cycles [9].  
2. Less cancer genes/mutations accumulated in population with greater TFR/family size  
Natural selection acts on each population [52, 78]. The total opportunity for natural selection 
in each population has been previously measured with the Biological State Index (Ibs) [48, 49, 
52-55, 79]. An Ibs value of one indicates total adaptation of the population to their environment. 
An Ibs value of zero signifies a total lack of adaptation (inability to overcome natural selection 
pressures that are present), and an impossibility to give life to the next generation [48, 49, 52-
55, 79].  
Our study indicated that Biological State Index (Ibs) was in negative, strong and significant 
correlation to TFR/family size globally, in developed world and developing country groups 
respectively (Table 1). This means that population with greater TFR/family size is subject to 
more effective natural selection. As the consequence of less fitness, mortality rate due to 
various diseases, such as cancers, may increase [48, 49, 52-55, 78, 79]. Thus, cancer 
genes/mutations would be more often eliminated from a population with greater TFR/family 
size. Moreover, greater total fertility rates indicate less birth control therefore allowing more 
biological variation in fertility [80]. A portion of this variation, however small, provides 




3. Family support and healthy lifestyle   
Family members from the greater family size may interact with each other more often to create 
life satisfaction [42, 43]. Meanwhile, one family member can remind and/or recommend other 
members to have necessary medical examination and have a healthy lifestyle [41].  
Bai et al. [26] reported that people with positive psychological well-being may practice healthy 
lifestyle, have the knowledge of cancer risks and benefits of regular physical examination. It 
was reported that such positive psychological well-being may decrease the risk in the 
development of breast cancer [26, 31, 81].  
In this study, we have also observed in Fisher’s analysis that family size was in significantly 
stronger correlation with all cancers incidence in males (all ages) than it was with all cancers 
incidence in females (all ages). This finding is supported by the studies which found that males 
psychologically benefited more from having an extended kinship network than females [41, 
62, 63]. However, this finding is inconsistent with Feller’s finding that reduced life satisfaction 
was more related to the development of cancer in women than in men [82]. The reason for 
this inconsistency might be that Feller’s data collection was based on the individual survey, 
which could be easily biased [30].    
Family size has been implicated in the aetiologies of several individual site cancers, in 
previous studies based on the data collected at the individual level. Our findings were in 
agreement with the conclusions from the previous studies that greater family size was 
negatively correlated to the risks of developing bladder cancer [5], breast cancer [5, 6], 
colorectum cancer [5] and melanoma of skin. Although correlation does not necessarily imply 
causality, it may be suggested that increased family size may protect against the incidence of 
corpus uteri cancer and ovary cancer, but increase the risk of developing cervical cancer. 
These findings were in agreement with the prevailing dogma about the relationship between 
parity and gynecologic cancers, that is that more childbearing (greater TFR) may protect 
against corpus uteri cancer [7] and ovary cancer [8] due to less oestrogen production (less 
menstrual cycles) [9] but may contribute to cervix uteri cancer because of more exposure to 
infection risk [12]. However, our results were not supported by the findings from the study 
conducted by Hemminki et al. [5] that there were no reportable significant correlations between 
family size and risks of cervix uteri cancer, corpus uteri cancer and ovarian cancer. A number 
of studies have reported that ageing is one of the major contributors of corpus uteri cancer [83] 
and ovary cancer [41]. that findings of Hemminki et al. [5] were not compatible with our findings 
may be because only young females (aged mostly 5-43 years, up to 55 years) were included 
in their studies.  
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Poor hygiene level related infection with human papillomavirus is associated with cervical 
cancer initiation [84]. In the developed world, like Sweden, high level of hygiene or sanitation 
is accessible to almost all the residents. This reduces risk for females to have human 
papilloma virus infection, which may decrease the cervical cancer risk. This may be the 
explanation why Hemminki et al. [5] did not find the correlation between family size and 
cervical cancer incidence.  
Blaser et al. [13] have reported that greater family size increased the risk of developing 
stomach cancer only for male family members, but not for all family members or female family 
members [13]. Aldrich et al. [14] reported that greater household size correlated with higher 
risk of lung cancer only in African Americans, but not in Latinos. However, sex specific or 
ancestry specific site cancer incidence was not included in our study. Thus, we may not be 
able to align our findings with the conclusions drawn by Blaser et al. [13] or Aldrich et al. [14].  
The correlations, especially the partial correlations between family size and cancer variables 
in developing world were not as strong or significant as those identified in all countries (n=178) 
and developed world (n=98). This may be due to small variances (low standard deviations) of 
cancer incidence variables, which may reduce the covariance (correlation between family size 
and cancer variable), compared to those in the developed world and all countries grouping.  
We must note an important strength of our study. Cancer risk studies based on surveys of 
individual persons have demonstrated a bias that is, in general, cancer patients tend to 
exaggerate negative life events in comparison to people with average or positive attitudes [30]. 
The methods employed in this study may have excluded this major bias because: 1) we used 
the objective measurement (TFR), instead of individual subjective psychological feeling 
assuming that TFR may be the family happiness index; 2) ecological study at population/group 
level, rather than individual based research method was adopted in this study. Ecological 
studies are based on aggregated quantitative data, not on the interviews with individual 
patients, so they are often used to determine the presence of effect of cancer risk-modifying 
factors in advance of, or impossible to identify in other epidemiological or laboratory 
approaches. Therefore, ecological study may be a better method to conduct the study of 
cancer incidence and its potential predictors, as cancer is one of the relatively rare diseases.  
Conclusions  
In this study of the relationship between the family size and cancer incidence in 178 countries, 
we have identified that countries with greater family size have lower cancer incidence rates in 
males and females. This indicates that in terms of cancer prevention it may be worthwhile to 
consider whether both females, and especially males may benefit from greater family size. 
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Having more family life satisfaction may be included as a part of strategic plan of cancer 
prevention. 
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Egypt 2.882 152 147.8 158.4 42.865 50.584 35.363 13.1 49.5 2.3 5.6 3.8 7.2 0.2 6.4 2.5 10405.85 43.019    17 0.970774956 Lower middle income
El Salvador 2.263 153.4 167.2 136.6 47.819 66.709 27.604 1.5 23.7 24.8 8.5 16.3 5.9 0.2 4 16.4 7090.6338 64.286    22 0.969379018 Lower middle income
Equatorial Guinea 5.138 86.4 98.5 76.1 38.608 50.651 26.997 2.6 25.2 25.1 4.3 5.4 3.9 0.2 4 2.3 33765.48 39.223    15 0.766811221 Upper middle income
Eritrea 4.969 101.7 118.6 82.8 30.871 41.143 20.623 2.2 35.9 17.4 6 2.2 2.5 0.5 7.6 2.4 1061.3342 20.572    15 0.914840478 Low income
Estonia 1.677 8.42041474 242.8 202.7 321.9 72.368 93.414 51.564 7 51.6 19.9 27.2 14.6 24.4 7.4 11.8 13.8 21085.2 68.094    20 0.98914898 High income
Ethiopia 4.905 4.88315386 108 140.9 73.2 38.247 52.386 24.145 2.5 41.8 26.4 7.3 2 3.2 0.1 8.6 3 1059.4511 17.319    17 0.815116195 Low income
Fiji 2.671 139.1 189.3 91.3 70.771 112.069 31.759 3.1 65 37.8 7 11.3 6 0.8 14.9 2.4 6954.0226 51.828    17 0.967330789 Upper middle income
Finland 1.853 2.01672397 256.8 234.2 290.1 75.169 95.695 55.500 8.3 89.4 4.3 23.5 13.9 20.1 12.6 8.4 5.2 38300.788 83.558    23 0.990882332 High income
French Polynesia 2.111 255 227.3 287.4 69.026 104.407 35.419 6 92.2 8.2 13.3 15.2 37.1 5.9 9 7.4 56.479    19 High income
FYR Macedonia 1.452 239.3 220.8 265.5 79.421 97.722 62.162 11.5 76.2 12.4 24.3 29 40.8 4.8 11.3 16.5 11366.125 56.992    19 0.986258559 Upper middle income
Gabon 4.213 90.2 101.5 79.9 31.457 41.726 21.346 3.8 16.1 19.9 5.2 7.5 6.2 1.2 4.8 2.4 16387.647 85.697    18 0.889527438 Upper middle income
Georgia 1.817 3.51647578 181 163.7 207.8 72.862 95.825 49.485 4.1 44 14.2 8.5 14.2 15.9 1.7 3.7 9.6 5818.2471 52.869    19 0.962737814 Lower middle income
Germany 1.370 2.22772901 283.8 252.5 323.7 106.685 128.829 85.307 13.4 91.6 8.2 30.9 11.9 27.5 11.4 7.4 7.8 39557.603 74.291    23 0.992090967 High income
Ghana 4.052 3.45922966 91.7 104.8 79.2 27.423 37.305 17.966 2.1 25.6 35.4 4.1 3 2.4 0.8 4.1 2.9 3002.9708 50.713    15 0.884556472 Lower middle income





Guam 2.473 3.68355304 167.7 143 198 48.963 61.739 36.826 2.9 49.4 9 20.5 12.2 34.7 2.9 2.8 1.6 94.099    21 High income
Guatemala 3.975 130.4 142.7 116.4 32.471 42.725 21.818 0.6 11.9 22.3 4.3 17.4 6.5 1.1 2.3 23.7 6710.795 49.323    21 0.938546115 Lower middle income
Guinea 5.174 90 94 88.9 15.556 22.503 8.842 0.9 14.5 38.4 1.8 2.6 1.4 1.3 3 3.2 1161.4787 34.856    15 0.79172525 Low income
Guinea-Bissau 5.116 83.1 96 70 22.395 30.461 14.295 2.2 26 29.8 3.5 2.4 1.6 0.6 3.8 3.3 1340.2172 45.221    15 0.733617368 Low income
Guyana 2.679 165.9 193.5 144.4 46.466 72.969 20.851 0.5 50.4 46.9 9.3 22.6 4.1 0 7.9 3.9 5430.0032 28.239    16 0.949433557 Upper middle income
Haiti 3.351 106.9 111.5 102.9 29.720 42.055 17.373 1.2 22 24.9 6.8 3.2 7.1 0.1 3 7.7 1487.0111 52.016    17 0.870884327 Low income
Honduras 3.156 131.2 146.7 116 36.924 51.660 22.305 1 19.9 29.4 6.9 14.8 6.4 0.7 2.5 17 4183.7238 51.696    21 0.954928722 Lower middle income
Hungary 1.277 2.73506387 285.4 236.5 356.1 100.964 106.925 95.192 14.1 54.5 18 42.3 7.5 51.6 7.1 10.6 9.5 21480.001 68.859    19 0.989011398 High income
Iceland 2.150 284.3 274.2 299.5 71.976 102.447 42.739 11.5 96.3 7.9 28.4 11.8 29.8 12.1 6 5 38663.421 93.624    24 0.994339886 High income
India 2.565 4.40924943 94 97.4 92.4 30.835 41.162 21.307 1.6 25.8 22 6.1 2.3 6.9 0.2 4.9 6.1 4544.2929 30.93    17 0.898263498 Lower middle income
Indonesia 2.432 133.5 134.4 136.2 44.899 58.558 31.407 3.2 40.3 17.3 12.8 5.6 16.3 0.5 8.4 2.8 7864.4155 49.924    17 0.945065241 Lower middle income
Iran  Islamic Repub                                                         1.903 3.46087562 127.7 120.1 134.7 39.578 47.429 31.956 8.3 28.1 2.8 11.1 2.5 7.7 0.8 4.8 15.2 15387.319 70.626    19 0.963201795 Upper middle income
Iraq 4.211 135.3 131.7 144.6 30.885 38.674 23.392 11.4 42.6 2.8 7.1 1.4 14 0.3 4.3 5.3 12080.445 69.034    17 0.935835896 Upper middle income
Ireland 2.047 2.4675299 307.9 278.9 343.3 85.865 111.643 60.941 8.9 92.3 13.6 34.9 11.1 31.3 13.7 11.2 6.5 42904.849 61.84    23 0.98988536 High income
Israel 2.990 3.38411446 283.2 258.7 318 66.907 84.028 50.199 12.6 80.5 4.6 35.9 15.4 21.2 11.4 7.3 7.1 28588.83 91.824    24 0.991156199 High income
Italy 1.450 2.61320392 278.6 255.2 312.9 111.089 141.483 82.253 11.8 91.3 6.7 33.9 14 24.5 11.4 10.2 8.2 34719.963 68.327    24 0.992006133 High income
Jamaica 2.334 198.5 179.2 222 52.991 73.362 32.341 3.3 55.8 26.3 14.4 12 18.2 0.9 6 9.1 8201.1989 53.743    21 0.956146048 Upper middle income
Japan 1.383 4.82303535 217.1 185.7 260.4 68.254 97.217 40.359 5.6 51.5 10.9 32.2 10.6 24.6 0.6 8.4 29.9 33916.472 90.522    26 0.993244417 High income
Jordan 3.457 155.4 157.8 153.3 38.825 49.437 28.846 7.1 61 2.4 25.6 5.2 15.7 0.5 5.4 5.9 11028.5 82.473    19 0.961171052 Lower middle income
Kazakhstan 2.580 236.5 216.7 282.2 75.212 99.458 51.066 6.7 63 29.4 22.8 12.9 27.9 3 9.7 21.6 19204.759 53.732    16 0.954558068 Upper middle income
Kenya 4.615 181.8 196.6 167.2 41.046 48.641 33.546 1.7 38.3 40.1 8.6 6.6 2.6 1.2 6.4 9.5 2451.7771 23.571    17 0.871652279 Lower middle income
Korea  Democratic                                                     2.002 181.2 170.8 204.2 64.089 75.337 53.232 4.6 36.8 12.4 21.8 5 44.2 0.2 6.8 14.3 60.21    16 0.952413886 Low income
Korea  Republic of                                                              1.206 3.31220901 307.8 293.6 340 154.930 220.523 93.005 5.2 52.1 9.5 45 5.8 28.7 0.9 6.8 41.8 30422.952 81.936    23 0.988347461 High income
Kuwait 2.669 102.1 123.3 89.8 23.350 32.780 16.836 5.5 46.7 4 12.8 7.5 8 0 4.7 2.6 76319.392 98.263    17 0.980383745 High income
Kyrgyzstan                                                                      3.020 137.6 129.4 151.6 39.059 52.804 25.401 2.8 27.3 23.7 8.2 8.4 15.6 1.1 6.3 21.4 2733.7542 35.303    17 0.951036801 Lower middle income
Lao PDR 3.286 141.8 122.4 165.5 34.924 39.893 30.027 2.1 19 12.5 8.8 3.4 13.2 0.5 5.2 2.3 3821.876 33.123    17 0.903514396 Lower middle income
Latvia 1.383 2.98778811 246.8 206.5 325 77.276 95.052 59.678 9.2 52.1 17.3 23.7 16.7 27.8 5.6 14.2 14.3 17592.15 67.692    19 0.985139438 High income
Lebanon 1.517 197.4 192.8 203.9 65.304 83.585 46.772 16.6 78.7 4.6 16.1 7.7 19.8 1.1 7.5 5.5 15934.14 87.183    22 0.979697241 Upper middle income
Lesotho 3.208 4.4430915 103 96.7 114 36.142 40.299 32.088 1.2 9 38.4 2 2.5 2.8 0.5 1.7 1.1 2183.4685 24.753    15 0.78463986 Lower middle income
Liberia 5.025 89.2 97 82.9 19.909 27.414 12.612 1.1 24.1 30.1 3.2 3.2 1.5 1 3.4 3.7 674.6061 47.801    15 0.818162224 Low income
Libya 2.525 124.1 113.1 135.9 33.461 44.257 22.566 8.6 24.1 9.7 14.5 3.8 15.6 0.4 5 3.6 29649.271 77.642    19 0.966322628 Upper middle income
Lithuania 1.517 2.7312225 251.9 224 311.8 85.800 115.614 56.225 8.7 48.7 26.1 23.4 17.7 26.2 5.2 12.2 13.8 19843.44 66.757    19 0.987817471 High income
Luxembourg 1.580 2.55256541 280.3 259.6 309.1 88.710 112.102 66.106 8.7 89.1 4.9 31.5 24.2 28.4 11.4 7.3 7.6 84210.015 88.547    23 0.992357704 High income
Madagascar 4.655 137.5 134.3 142.4 37.494 47.056 27.942 3.2 26.6 44.6 8 2.9 7.2 1.3 2.2 4.7 1362.3112 31.929    17 0.911507927 Low income
Malawi 5.634 156 186.4 123.5 61.693 75.804 47.896 7 16.8 75.9 3.4 2.2 0.9 1.5 2.5 2.7 722.38784 15.54    17 0.777079695 Low income
Malaysia 2.004 143.6 143.4 144.9 45.486 57.071 34.291 3.7 38.7 15.6 18.3 5.3 17.9 0.5 7.8 7.8 19985.916 70.912    19 0.984797747 Upper middle income
Maldives 2.338 88.9 84.8 91.6 19.789 28.138 11.484 2 31.6 11 5.8 3.1 7.7 0 7.1 3.7 10465.204 39.984    20 0.979947754 Upper middle income
Mali 6.840 111.4 135.6 83.8 32.862 44.087 21.896 6.7 29.8 44.2 6 3.5 2.7 0.9 5.2 9.2 1630.0012 35.996    15 0.774009131 Low income
Malta 1.410 2.71689491 242.9 228.9 267.7 73.077 95.833 51.343 15.8 85.9 3.8 31.9 15.3 20.4 6.2 11.8 8 26671.467 94.665    22 0.990072799 High income
Mauritania 4.836 85.7 97.7 74.4 25.517 34.527 16.767 2.2 25.8 29.4 3.6 2.7 1.4 0.8 3.9 3.5 2619.8656 56.682    16 0.828872462 Lower middle income
Mauritius 1.570 180.2 193.9 171.1 63.403 82.849 44.164 4.3 64.2 15 18.6 11.5 9.9 0.3 8.3 8 14917.42 40.579    19 0.977322443 Upper middle income
Mexico 2.281 3.4076092 131.5 139.9 123.9 48.260 63.430 32.948 2.9 35.4 23.3 7.8 4.9 7.5 1.8 5.6 6.9 14726.446 77.825    22 0.976184901 Upper middle income
Micronesia                                                                      3.461 171.4 146.3 202.1 46.506 59.655 33.631 2.9 48.8 8.7 20.4 12.3 34.8 3.1 3.1 1.7 3269.6711 22.298    17 Lower middle income
Mongolia 2.431 200.9 171.9 237.7 40.423 41.639 39.209 1.1 9.4 24.3 6 1.9 15.6 0.1 3.7 32.5 6344.5119 67.567    16 0.964403327 Lower middle income
Montenegro 1.698 238.3 219.7 262.7 112.392 131.442 93.668 10.1 59.7 20.2 28.2 15.3 39.6 4.7 12 9.5 13325.031 63.096    19 0.987371013 Upper middle income
Morocco 2.581 117.8 114.4 122.7 40.690 54.102 26.776 5.8 40.8 14.3 8.5 3 13.6 0.4 4.7 4 6334.9581 57.684    18 0.954920903 Lower middle income
Mozambique 5.408 136.8 153 118.3 55.340 68.501 41.798 1.5 14.5 65 1.2 1.9 2.8 1.3 0.9 0.9 913.89597 30.955    16 0.752170541 Low income
Myanmar 2.003 140.5 134.6 149.4 48.005 58.192 37.732 2.1 22.1 20.6 8.7 2.4 20.2 0.3 5.5 11.2 31.405    16 0.901564516 Lower middle income
Namibia 3.230 82.7 81.5 86.3 25.466 31.340 19.704 2.1 24.4 14.7 4.8 2.6 3.3 2.1 2.8 1.6 8267.3391 41.616    17 0.881203108 Upper middle income
Nepal 2.623 85.2 85.6 85.6 24.848 31.708 18.047 2 13.7 19 3.2 0.9 12.3 0.2 5.8 5.3 1958.6623 16.822    17 0.931676131 Low income
New Caledonia 2.173 297.9 269.3 330.7 78.178 112.809 43.885 4.5 87.6 15.3 24.1 22.1 40.1 7.2 7.6 7.8 67.273 19.700 High income
New Zealand 2.110 2.48849734 295 274.3 320.1 90.008 115.955 63.939 2.9 85 5.3 37.3 13.9 25.9 35.8 8 5.2 30336.916 86.165    24 0.987538394 High income
Nicaragua 2.630 114.4 123.1 106.1 33.898 47.608 20.087 0.9 23.9 36.2 7.9 2.8 7 0.5 2.1 11.1 3962.7333 57.255    21 0.964828261 Lower middle income
Niger 7.583 63.4 71 56.7 20.738 26.540 14.966 1.9 23.8 8.6 4.8 3.1 0.2 0.6 7.3 1.9 824.20535 17.559    15 0.796596007 Low income
Nigeria 6.020 100.1 121.7 79 29.975 42.991 17.465 1 50.4 29 4.2 3.4 1.1 0.5 3.1 2 5010.3365 43.48    13 0.782234559 Lower middle income
Norway 1.937 2.3047853 318.3 277.1 368.7 88.025 105.949 70.980 13.5 73.1 9.8 38.9 16.9 30 18.8 9.5 4.6 57739.041 79.102    23 0.991312752 High income
Oman 2.898 82.1 92.4 78.6 22.046 27.644 18.078 4.8 26 5.3 7.4 3.8 5.1 0.4 3.3 5.3 48497.048 75.161    20 0.991312752 High income
Pakistan 3.429 111.8 127.7 96 40.326 51.609 29.394 3.4 50.3 7.9 4 3.6 5.8 0.2 5.6 3 4134.2353 36.598    17 0.876554278 Lower middle income
Panama 2.549 148.4 148.8 150.1 47.011 66.396 28.207 2.3 43 18.7 12.5 7.7 9 1.4 6.4 10.6 14619.586 65.115    23 0.967054161 Upper middle income
Papua New Guinea 3.954 165.2 179.8 156.7 48.203 71.502 26.241 1.5 33.7 34.5 8.1 9.3 8 4.2 7 6.9 2071.4873 13.019    15 0.892398564 Lower middle income
Paraguay 2.970 147.5 153 143.2 43.623 64.310 23.402 2.2 43.8 34.2 12.1 5.8 14 1.5 5.1 6.3 6865.8846 58.487    21 0.966617037 Upper middle income
Peru 2.512 4.17362513 154.5 169.8 140.9 46.689 65.242 28.564 3.1 28 32.7 11.1 3.7 10.1 1.6 4.9 15.8 9714.6375 76.915    21 0.967407676 Upper middle income
Philippines 3.154 5.13756125 140 143.4 139.9 42.919 58.209 28.070 1.5 47 16 13.1 5.6 19.3 0.4 5.9 3.8 5500.2372 45.255    17 0.952944127 Lower middle income
 
236 
Poland 1.360 3.24831429 229.6 205.6 269.2 62.543 74.630 50.808 11 51.9 12.2 27 16.9 38 4.1 13.6 8.4 20683.139 60.892    20 0.988809463 High income
Portugal 1.360 2.89386299 246.2 198.1 306.3 101.877 110.554 93.380 12 67.6 9 31.7 12.6 20.2 6.7 6.2 13.1 26927.431 60.567    22 0.990743134 High income
Puerto Rico 1.657 3.01953105 211.1 193.5 237.2 72.707 98.906 46.307 5.5 57.5 11.4 24.6 16 9.2 2.1 4.6 4.1 33759.999 93.825    23 High income
Qatar 2.091 9.18350419 108.8 134.5 104 28.719 50.248 21.838 5.3 46.1 5.1 12.6 5.7 10.7 0.5 4.6 5.8 126613.79 98.655    21 0.985182321 High income
Republic of Moldov 1.476 194.1 170.2 230 64.194 76.157 52.032 6.3 38.7 19.6 28.3 12.8 23.5 2.3 7.5 11.5 3831.8627 44.886    16 0.979509629 Lower middle income
Romania 1.523 3.02381665 224.2 190.6 271 82.738 95.967 69.951 9.7 50 28.6 26.4 8.5 32.6 3.5 10.3 10.4 16252.231 53.829    19 0.98265702 Upper middle income
Russian Federation 1.563 2.75399249 204.3 187.1 245.8 69.573 90.248 48.848 5.7 45.6 15.3 24.5 16.1 24 4.1 11.3 16 20541.334 73.687    17 0.976110152 Upper middle income
Rwanda 4.841 2.97399284 135.8 142.3 130.2 32.732 41.506 23.737 3.5 15.9 41.8 5.1 5.3 1.2 2.4 4.2 8.2 1236.476 23.952    17 0.839898749 Low income
Samoa 4.335 92.7 96.1 92.5 29.915 45.359 15.824 1.3 23.2 17.1 6.5 7.4 4.7 0.9 3.9 9.7 5307.7036 20.078    18 0.964750824 Upper middle income
Saudi Arabia 2.830 91.1 102.8 85.9 28.025 38.452 19.434 3.6 29.5 2.7 11.6 5.8 5.1 0.3 3.4 3.1 45247.385 82.084    18 0.965797508 High income
Senegal 5.049 101.2 115 85.5 25.216 35.331 15.068 3.9 22.4 41.4 3.9 3 2.1 1.1 4.2 6.2 2137.5803 42.23    16 0.870409233 Low income
Serbia 1.413 269.7 247.6 299.2 99.341 118.559 80.972 10.6 69 23.8 32.6 17.9 45.6 7.1 12.8 8.6 11805.284 55.208    18 0.988676774 Upper middle income
Sierra Leone 4.945 92.3 97.7 83.8 21.286 29.100 13.165 1 24.3 30.2 3.4 3.2 1.5 0.9 3.3 3.8 1319.2568 38.241    12 0.727886294 Low income
Singapore 1.190 3.57709406 206.4 198.7 218.8 74.461 102.602 47.684 4.3 65.7 8.1 33.7 13.9 24.9 0.5 9.9 8.2 70364.208 100    24 0.993723047 High income
Slovakia                                                                        1.440 3.1886377 276.9 238 338.2 83.123 93.386 73.235 10.1 57.5 16.1 42.7 19 28.3 9.9 11.6 9.6 24434.94 54.685    19 0.98890098 High income
Slovenia 1.553 2.9476531 296.3 251.5 358.2 105.499 125.201 86.730 10.7 66.5 10.5 37 15 33.9 16.2 10.4 10.4 27566.802 50.04    22 0.98958832 High income
Solomon Islands 4.235 116.3 145.2 89.3 44.369 66.601 23.875 1.5 47.6 28.5 6.9 10.2 7.6 0.6 10.1 2 1750.3006 20.048    17 0.946529387 Lower middle income
Somalia 6.868 139.1 165.2 111.9 36.113 48.428 23.736 2.1 40.6 33.4 8 4.3 2.9 0.7 7.5 6.3 37.259    16 0.726995383 Low income
South African Repu                                                           2.468 187.1 168.9 224.3 51.815 68.617 35.533 4.4 41.5 31.7 11.9 6.9 18.5 4.5 5.5 5.1 11415.27 62.218    15 0.81134756 Upper middle income
South Sudan 5.194 132.7 143 123.1 35.665 43.847 27.578 1.9 31.8 30.4 6.6 3.8 2.3 1.2 6.4 5 3760.456 17.855    16 Low income
Spain 1.363 2.87917702 249 198.2 312.8 88.128 109.409 67.965 13.9 67.3 7.8 33.1 11.6 30.3 6.9 7.7 7.8 32354.127 78.442    24 0.991649103 High income
Sri Lanka 2.342 94.8 102.7 86.9 32.586 41.798 23.410 1.8 30.9 13.1 3.7 1.5 6.2 0.1 5.8 5.8 7418.9043 18.321    19 0.968771239 Lower middle income
Sudan 4.638 91.1 91 92 24.468 29.736 19.286 2.3 27.8 7.9 4.6 2.4 2 0.7 6.4 1.8 3259.4073 33.08    17 0.820980152 Lower middle income
Suriname 2.346 159.6 162.7 163.8 53.954 77.399 31.369 3.1 41.4 38 16.7 4 12.8 0.5 8.6 5 14034.923 66.344    18 0.956288068 Upper middle income
Swaziland 3.558 4.79959 115.3 111.9 122.1 39.740 47.239 32.238 1.9 10.5 53.1 2.3 5.3 3 0.6 2.5 2.1 6379.9884 21.492    16 0.80146329 Lower middle income
Sweden 1.940 270 248.7 296.8 79.343 105.049 54.799 10.3 80.4 7.4 29.2 13.5 19.1 18 7.5 3.7 41731.84 85.056    24 0.992422252 High income
Switzerland 1.513 2.39680956 287 245.9 337.9 96.142 117.225 75.586 12.2 83.1 3.6 29.4 12.6 27.3 20.3 7.9 4.2 51327.255 73.663    25 0.992895335 High income
Syrian Arab Republ 3.080 145.9 145.2 148.3 37.806 48.734 27.229 9.6 52.5 2.6 16.2 3.3 15.1 0.4 4.8 5.6 55.677    20 0.975967947 Lower middle income
Tajikistan 3.777 119.1 112.3 128.7 35.870 41.201 30.451 3 20.4 9.9 5.5 12.2 7.7 1 2 21.7 2067.6194 26.516    18 0.937648873 Lower middle income
Tanzania 5.426 123.7 132.7 115.8 33.776 39.486 28.148 3.2 19.4 54 4.8 1.5 0.7 1.6 2 3.1 1513.96 28.114    17 0.829695397 Low income
Thailand 1.443 137.5 128.8 149.6 57.275 70.517 44.083 2.7 29.3 17.8 12.4 3.9 20.9 0.4 5.9 3.1 12562.433 44.08    21 0.970930809 Upper middle income
The Gambia 5.794 68.2 69.6 67.3 15.846 14.789 16.936 0.8 9.8 26.1 1.3 1.1 2.4 0.9 1.2 1.7 1633.3732 56.297    15 0.848684102 Low income
The Netherlands 1.780 304.8 289.6 327.8 103.206 136.038 71.460 8.2 99 6.8 40.2 12.4 37.2 19.4 6.8 5.6 44747.976 87.061    23 0.991178479 High income
Timor-Leste 5.600 5.50669848 165.4 149.6 183.9 27.088 32.684 21.764 3.5 32.6 13.3 13.4 9.3 31 1.7 5.1 2.3 1741.1962 29.507    16 0.924547722 Lower middle income
Togo 4.791 91.1 104.8 77.2 28.816 38.094 19.476 1.8 27.2 21.5 3.8 4.1 1.4 1 5 5.8 1220.822 37.533    14 0.853879923 Low income
Trinidad and Tobag 1.801 210.9 180.3 273.5 60.151 82.396 37.776 3.3 56.9 24.5 23.5 14.6 12.2 1.3 10.6 4.4 28728.157 9.092    18 0.956069163 High income
Tunisia 2.110 110.6 95.7 127 37.733 46.114 29.442 8.3 31.8 4.8 10.9 3.3 16 0.5 4.2 4.2 10198.464 65.934    19 0.972061666 Lower middle income
Turkey 2.101 205.1 161.6 257.8 65.428 75.226 55.813 15.2 39.1 4.3 16.6 10.1 34.7 2.1 6.3 14.2 16195.185 70.715    20 0.974579606 Upper middle income
Turkmenistan 2.413 144 132.8 159.4 52.557 59.904 45.214 3.5 26.8 13.1 9 6.1 12.7 1.2 2.6 18.2 9828.8076 48.402    17 0.936137764 Upper middle income
Uganda 6.154 169.7 167.4 175.7 40.141 44.766 35.572 0.9 27.5 44.4 7.1 4 2.7 1.8 6.9 5.1 1267.8395 14.492    17 0.817073102 Low income
Ukraine 1.455 192.9 174.7 231.9 76.978 98.174 55.728 6 41.3 16.6 23.4 16.6 22.2 4 10.7 14.3 7697.9839 68.686    17 0.977451168 Lower middle income
United Arab Emirat 1.871 92.5 127.1 83.8 19.951 38.228 11.605 4.3 39.2 9.5 8.5 6 9.4 0.2 6.4 4.8 55764.873 84.055    19 0.986916907 High income
United Kingdom 1.907 272.9 267.3 284 85.956 113.088 59.511 5.8 95 7.1 30.2 13.9 30 14.6 11.7 4.7 35924.014 81.302    23 0.989882467 High income
United States of Am                                                         1.943 318 297.4 347 101.350 126.577 77.022 11.6 92.9 6.6 25 19.5 38.4 14.3 8 3.9 48377.394 80.772    23 0.985353656 High income
Uruguay 2.080 251 220.9 297.5 72.147 91.718 52.822 8.5 69.8 18.9 29.5 9.5 27.4 4.1 8.4 10 16160.788 94.414    21 0.979863168 High income
Uzbekistan 2.390 99.7 103.5 96.9 37.112 47.766 26.596 2.3 27.1 13.5 5.3 5.8 8 0.8 2.1 12.5 4100.5201 36.191    18 0.9542107 Lower middle income
Vanuatu 3.501 107.8 117 98.2 39.690 53.397 26.525 1.4 31.8 19.2 6.5 10.2 9.6 1.1 4.2 3.3 2888.8251 24.589    17 0.962863745 Lower middle income
Venezuela 2.472 150 155 146.9 51.465 72.566 30.855 3.7 41.2 32.8 10.7 5.4 16 1.1 5.1 9.6 16202.142 88.769    21 0.973793981 Upper middle income
Vietnam 1.819 140.4 114.2 172.9 62.740 60.579 64.867 1.1 23 10.6 10.1 5.4 25.2 0.2 2.6 16.3 4395.5501 30.392    22 0.965838559 Lower middle income
Yemen, Rep. 4.501 80.4 80.7 81.2 24.521 28.304 20.838 1.8 27.4 3.1 4.5 0.1 3.8 0.3 3.8 4 4442.5431 31.732    16 0.902273096 Lower middle income
Zambia 5.812 136.2 157.8 115.1 41.861 51.846 32.093 2.8 22.4 58 4.8 3.3 1.8 0.9 4 4.4 3381.0597 38.725    16 0.761352332 Lower middle income
Zimbabwe 3.719 190.3 209.1 167 44.841 48.064 41.644 2.9 28.5 56.4 8.8 9.1 4.9 1.6 6.6 8 1454.2285 33.196    18 0.8087404 Low income
* Age-standardised rates per 100,000. This rate is same for all the other cancer rates.
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Supplementary File 2:  
Figure S1. The relationship between household size and all cancers incidence rates (total, male 






Supplementary File 5:  




N Minimum Maximum Mean Std. Skewness Std. N Minimum Maximum Mean Std. Skewness Std. N Minimum Maximum Mean Std. Skewness Std. Data 
Statistic Statistic Statistic Statistic Deviation Statistic Error Statistic Statistic Statistic Statist c Deviation Statistic Error Statistic Statistic Statistic Statistic Deviation Statistic Error Source
Total Fertility Rate (Mean 2009-2011) 178 1.19 7.58 2.97 1.52 0.97 0.18 98 1.19 5.14 2.05 0.70 1.83 0.24 80 1.45 7.58 4.09 1.49 0.12 0.27 The World Bank 
Household Size 58 2.02 9.18 3.58 1.35 2.25 0.31 46 2.02 9.18 3.37 1.38 2.94 0.35 12 2.97 5.94 4.35 0.97 -0.01 0.64 The United Nations
All cancers excl. non-melanoma skin cancer 
(C00-97, but C44) - all ages: total
178 63.40 338.10 168.84 70.47 0.61 0.18 98 82.10 338.10 206.35 69.52 -0.06 0.24 80 63.40 257.00 122.89 36.14 1.00 0.27 The IARC of WHO 
All cancers excl. non-melanoma skin cancer 
(C00-97, but C44)- all ages: female 
178 69.60 328.80 163.57 57.93 0.63 0.18 98 81.50 328.80 192.96 57.70 0.08 0.24 80 69.60 226.40 127.57 32.36 0.64 0.27 The IARC of WHO 
All cancers excl. non-melanoma skin cancer 
(C00-97, but C44) - all ages: male
178 56.70 373.90 180.03 90.31 0.57 0.18 98 76.10 373.90 228.88 87.79 -0.15 0.24 80 56.70 305.60 120.20 47.18 1.40 0.27 The IARC of WHO 
All cancers excl. non-melanoma skin cancer 
(C00-97, but C44) – 0-49: totalǂ
178 15.56 154.93 53.15 25.95 0.84 0.18 98 19.79 154.93 66.69 25.86 0.32 0.24 80 15.56 84.66 36.56 13.49 1.30 0.27 The IARC of WHO 
All cancers excl. non-melanoma skin cancer 
(C00-97, but C44) – 0-49: femaleǂ
178 14.79 220.52 68.42 32.97 0.95 0.18 98 27.64 220.52 86.24 32.26 0.58 0.24 80 14.79 107.69 46.58 16.78 1.29 0.27 The IARC of WHO 
All cancers excl. non-melanoma skin cancer 
(C00-97, but C44) – 0-49: maleǂ
178 8.84 95.19 38.43 20.47 0.91 0.18 98 11.48 95.19 48.04 21.23 0.39 0.24 80 8.84 64.87 26.65 11.43 1.32 0.27 The IARC of WHO 
Bladder (C67), all ages 178 0.50 17.50 5.13 4.09 1.01 0.18 98 0.50 17.50 7.06 4.18 0.47 0.24 80 0.50 13.10 2.77 2.41 2.47 0.27 The IARC of WHO 
Breast(C50), all ages 178 4.60 111.90 44.67 23.71 0.79 0.18 98 16.10 111.90 57.37 23.21 0.34 0.24 80 4.60 74.10 29.11 12.39 0.85 0.27 The IARC of WHO 
Cervix uteri (C53), all ages 178 2.30 75.90 20.01 13.94 1.19 0.18 98 2.70 46.90 14.76 9.69 0.98 0.24 80 2.30 75.90 26.44 15.61 0.84 0.27 The IARC of WHO 
Colorectum (C18-21), all ages 178 1.20 45.00 15.11 11.41 0.81 0.18 98 3.50 45.00 21.56 10.97 0.21 0.24 80 1.20 28.30 7.22 5.42 2.15 0.27 The IARC of WHO 
Corpus uteri (C54), all ages 178 0.00 34.10 8.37 6.20 1.09 0.18 98 1.40 34.10 11.06 6.04 0.83 0.24 80 0.00 26.70 5.09 4.64 2.24 0.27 The IARC of WHO 
Lung (C33-34), all ages 178 0.20 51.60 15.41 12.43 0.65 0.18 98 3.30 51.60 21.52 11.47 0.20 0.24 80 0.20 44.20 7.93 9.03 1.96 0.27 The IARC of WHO 
Melanoma of skin (C43), all ages 178 0.00 35.80 3.40 5.57 3.14 0.18 98 0.00 35.80 5.38 6.87 2.21 0.24 80 0.00 4.20 0.98 0.81 1.81 0.27 The IARC of WHO 
Ovary (C56), all ages 178 0.80 14.90 6.25 2.96 0.61 0.18 98 1.60 14.90 7.53 2.98 0.30 0.24 80 0.80 10.70 4.69 2.05 0.55 0.27 The IARC of WHO 
Stomach (C16), all ages 178 0.90 41.80 7.83 6.17 2.08 0.18 98 0.90 41.80 8.79 6.18 2.34 0.24 80 0.90 32.50 6.67 5.98 1.96 0.27 The IARC of WHO 
GDP PPP 2010 178 12.35 25.51 18.90 2.87 0.23 0.18 98 15.21 25.51 20.53 2.41 -0.17 0.24 80 12.35 23.43 16.90 2.01 0.90 0.27 The World Bank 
Urbanization 2010 170 671.01 126613.79 16232.57 18632.70 2.32 0.19 94 5307.70 126613.79 26553.24 19622.99 2.13 0.25 76 671.01 11028.50 3467.53 2492.11 1.11 0.28 The World Bank 
Life Expectancy (e60, 2005-2010) 178 9.09 100.00 55.88 23.28 -0.06 0.18 98 9.09 100.00 69.69 18.39 -0.71 0.24 80 10.64 82.47 38.95 16.51 0.46 0.27 The United Nations
Biological State Index (Ibs) 172 0.63 0.99 0.92 0.08 -1.32 0.19 94 0.77 0.99 0.97 0.03 -3.79 0.25 78 0.63 0.98 0.87 0.09 -0.46 0.27 Self calculated 
Valid N (listwise) 56 44 12
Developed Countries Developing CountriesAll countries
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3rd response to reviewers’ comments 
 
BCAN-D-16-02324R2 
Greater family size is associated with less cancer risk: an ecological analysis of 178 




1.Please include e-mail addresses for all authors on the title page. 
Authors:  Now all the authors’ email addresses are included in the title page.  
 
2. Please remove the point-by-point response to the reviewers from the additional files. 
Authors: Will not upload the response as the additional file this time.   
 
BMC Cancer operates a policy of open peer review, which means that you will be able 
to see the names of the reviewers who provided the reports via the online peer review 
system. We encourage you to also view the reports there, via the action links on the left-
hand side of the page, to see the names of the reviewers. 
Authors: Thanks for your reminding.   
 
Reviewer reports: 
Hauke Thomsen (Reviewer 1): Dear Ladies and Gentlemen, although the comments of 
my last review have been considered in the latest revision of the manuscript, I still a few 
comments that need to be taken care of: 
1. in the third section of the discussion you state: "Our findings were supported by the 
hypotheses that ..." This is the complete wrong way: Hypotheses should be supported 
by findings ! 
Authors: Now this sentence has been revised as  
Our findings were in agreement with the conclusions from previous studies that greater 




2. in the next paragraph you state that your study revealed that family size protects 
against corpus uteri cancer. However, in the beginning of the discussion you state: 
"correlation between two variables does not imply causality." Therefore, I would like to 
ask you to change the statements such as "family size protects ..." or "family size 
increase risk ...." in the third section of the discussion to something like "family size is 
negatively/positively correlated with cancer risk. One might speculate about the reason 
for this correlation, but there is clearly no evidence for any protection. By the way: in one 
of our recent studies (Thomsen et al., European Journal of Human Genetics, Sept. 2014) 
we have included the number of children as a covariate in our estimation of heritability 
for Hodgkin lymphoma, because it had a significant effect. 
Authors: Thanks. The original descriptions have been amended and the suggestion has 
been included.     
 
3. The point raised in #2 should also be changed in the conclusion. This holds especially 
for the last sentence. Considering your statement: what is your recommendation to 
reduce cancer risk? For males: just having more children? I am not sure whether this 
should be a "strategic plan". 
Authors: The conclusion has been revised. The two points concerning the reviewer have 
been incorporated in the updated conclusion.  
In this study of the relationship between the family size and cancer incidence in 178 
countries, we have identified that countries with greater family size have lower cancer 
incidence rates in males and females. This indicates that it may be worthwhile to consider 
in terms of cancer prevention whether both females, and especially males, may benefit 
from greater family size. Having more family life satisfaction may be included as a part 
of strategic plan of cancer prevention. 
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Contextual Statement 
Breast cancer has been associated with decreasing birth rate, urbanization, overweight, 
ageing and GDP. However, these studies did not identify which risk factor is significant 
contributor to breast cancer. Additionally, it is confusing that WHO and its cancer 
research agent constantly stated that breast cancer incidence is greater in the developed 
world.  
This study examined and identified that low birth rate is the significant determinant of 
breast cancer. We also found that decreasing birth rate, instead of GDP, may determine 







Purpose: Urbanization, obesity and ageing and their associated with lifestyle changes 
(Westernized diet patterns, pollution, physical inactivity) have been proposed as the 
major contributing factors for the global rise in breast cancer (BCa) and have been the 
variables used to predict the future breast cancer rate. At the same time, socio-economic 
level, instead of birth rate, has been proposed for explanation of dramatic regional 
variations of breast cancer incidence. We sought to determine which factor plays the 
determining role in predicting worldwide breast cancer incidence rates and regional 
variations.     
Methods: Bivariate correlation was conducted to examine the relationships between 
country-specific estimates of birth rate, BCa incidence, urbanization, overweight, ageing 
and GDP. Partial correlation was performed to identify the correlation between BCa 
incidence with each independent variable while we controlled the other four variables. 
Multiple linear regression was used to identify the most significant predictors of BCa 
incidence. Post hoc Scheff and independent T-Test analysis were performed to compare 
mean differences in BCa incidence rates and residuals of BCa standardised on birth rate 
in the WHO regions, and UN developed and developing regions respectively.   
Results: Worldwide, BCa incidence rate tends to increase while birth rate decreases 
and urbanization, overweight, ageing and GDP increase. However, birth rate was the 
only variable that had a significant correlation with BCa incidence when controlled for the 
other four variables. Birth rate was the only significant predictor of BCa incidence in 
regression analysis. Multiple mean differences of BCa incidence between regions were 
significant, but all disappeared when the contributing effect of birth rate on BCa incidence 
rate was removed.  
Conclusions: Birth rate plays a determining role in worldwide BCa incidence rate and 
regional variations. Current BCa projection methods may estimate future rates of BCa 
poorly if they fail to incorporate the impact of birth rate.  
Keywords: Regional variations, Hormones, Breast cancer, Birth rate, Mean difference 
comparison   
Introduction 
The global incidence rate of female breast cancer (BCa) has been on the rise since the 
1970s even in the countries in Asia and Africa that had previously reported low rates. 
BCa is the most common invasive cancer in women, accounting for over 25% of all 
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cancer cases [1] and affecting about one in eight women during their lives. The WHO 
has concluded that life expectancy, urbanization and western lifestyles [2] are the major 
risk factors for BCa. 
BCa is a disease with genetic background, but genetics may only explain 5–10% of all 
cases [3]. Most BCa cases occur due to the mutations caused by the interaction between 
an environmental factor and a genetically susceptible host [3].  
Ageing, which may influence carcinogenesis, has been regarded as a prime contributing 
factor to BCa [4]. Tobacco smoking has been long postulated as one of the 
environmental factors to cause BCa [5]. For instance, the risk of BCa may be increased 
from 35% to 50% in female smokers. Anti-smoking campaigns have reduced the rate of 
smoking in women in the developed world [6], but the BCa incidence rate remains much 
greater [7] than in the developing world, and the incidence rate in the developed world 
continues to rise [8].  
Several other alternative hypotheses about the relationships between BCa and 
contributing environmental factors have been explored in the past decades. Decreasing 
physical activity has been associated with the increase of BCa risk, although the 
mechanism of effect of exercise is not fully established. Supplemental to this conclusion, 
the Lancet Physical Activity Series Working Group [9] reported that BCa risk may be 
reduced when females become physically active [9]. High-fat [10] and/or high-alcohol 
[11] diet patterns have been related to BCa risk.        
The incidence of BCa varies greatly around the world. The WHO has associated regional 
variations with country groups due to their different socio-economic levels [12]. Genetic 
differences between ethnic groups have also been implicated in the genesis of regional 
variations. Perhaps relaxed natural selection is involved through the accumulation of 
BCa genes or mutations due to modern medicine advancement, which allows early onset 
BCa patient to survive, but makes BCa genes inheritable to their next generation [13].   
Female reproductive behaviour was initially postulated to be associated with BCa risk 
since it was greater among nulliparous Catholic nuns 300 years ago [14]. Specifically, 
the postulation that female childbearing reduces BCa risk was advanced in the 1920s 
and confirmed in 1970’s [15]. The underlying mechanism for this relationship is that 
pregnancy breaks menstrual cycles, which reduces breast exposure to estrogen. Studies 
have identified that estrogen may cause DNA damage and thus initiation of BCa [16]. 
Recent studies have shown that estrogen receptor (ER) positive BCa may make up 
approximately 70% of all BCa [17] and that child-bearing may decrease the risk of 
developing BCa by up to 50% [18].   
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The incidence of BCa varies greatly around the world. Genetic differences between 
ethnic groups have been implicated in the genesis of regional variations. Perhaps 
relaxed natural selection is involved through the accumulation of BCa genes or mutations 
due to modern medicine advancement, which allows early onset BCa patient to survive, 
but makes BCa genes inheritable to their next generation [13, 19].   
Professionals and laypeople are still intrigued with the mechanisms about how physical 
activities, diet patterns, genetic background and reproduction behaviour contribute to 
BCa from the perspective of physiology. However, a number of publications have 
reported that females with higher socioeconomic levels may be subject to higher risk of 
BCa [20, 21]. Furthermore, as the directing and coordinating authority for health within 
the United Nations system, the WHO and its cancer research agent, the International 
Agency for Research on Cancer (IARC) also support the theory that female’s 
socioeconomic level is associated with BCa risk [12, 22]. Therefore, females in the 
developed world and those at high socioeconomic levels in developing countries may 
have wondered what is wrong to be at higher socioeconomic level?  
The present study starts with measures of proximal causes of BCa, analysing how BCa 
incidence rate relates to birth rate, socio-economic factors, urbanization, overweight and 
ageing. It then assesses which underlying factors, from socio-economic factors, 
urbanization, overweight to ageing to birth rate, account for significant proximal risks and 
overall BCa incidence. Finally, it shows that birth rate plays the determining role in 
contributing to regional variations of BCa incidence rate.  
Materials and Methods  
Data Sources  
The country specific variables were collected for this ecological study.   
The GLOBOCAN 2012 estimates of incidence rate of female BCa (C50) [7]  
BCa incidence rate indicates the number per 100,000 females who were diagnosed with 
BCa in 2012. The rate was age-standardized using the World standard population to 
increase the comparability.  
GLOBOCAN is a project conducted by the International Agency for Research on Cancer 
(IARC) of the WHO. This project provides contemporary population level estimates by 
cancer site and sex using the best available data in each population and nine 
comprehensive methods of estimation [23].   
The World Bank published data on birth rate, GDP and urbanization   
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Birth rate indicates the number of live births per 1,000 population occurring at midyear 
during the year 1992.   
Socio-economic levels measure with GDP have been related to BCa incidence rate [7]. 
GDP is used as the index of socio-economic level and it is expressed in per capita 
purchasing power parity (PPP in current international $) in 2010.  
Urbanization is expressed with the percentage of total population living in urban areas in 
2010. Urbanization, representing a major demographic shift, entails lifestyle changes, 
including diet with more energy dense components, such as high fat and high alcohol in 
daily diet, and less physical exercise [24]. Therefore, urbanization has been postulated 
as a major BCa predictor [24].   
The United Nations Statistics Division estimates of the life expectancy    
Life expectancy, indexed as ageing in this study, has been considered as an attributable 
factor to BCa [25]. Women age 50+ enter menopause, which is leads to fall in estrogen 
levels.  Therefore, life expectancy (e50, 2005-2010) was extracted from abridged life 
tables (1950-2100) published online by the United Nations.     
The WHO Global Health Observatory (GHO) has published data on the estimated 
prevalence rate of women who are overweight. The overweight prevalence is expressed 
as the percentage of the population (2010) aged 18+ with a BMI ≥ 25 kg/m2. Being 
overweight also has been postulated as a risk factor of BCa.  
Data Selection  
We used country specific BCa incidence rate, birth rate, GDP (index of socio-economic 
level), urbanisation, overweight prevalence (Western lifestyle) and life expectancy 
(ageing) for all countries where data were available. We matched BCa incidence rates 
and birth rate by country and we obtained a set of data consisting of 179 countries.  
Each country was treated as an individual in the analysis. the numbers of countries 
included in the analysis of relationships with other variables may have differed somewhat 
because all information was not uniformly available for all countries.    
Data analysis 
Various statistical analysis methods were applied in this study to explore the correlation 
between birth rate and BCa incidence rate.   
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Data robustness and variable distributions check  
Scatter plots were used to explore and visualize the correlations between birth rate and 
BCa incidence rate. The strength and form of the relationship between BCa and birth 
rate were analysed using actual values of the two variables. For other analyses, variable 
values were logarithmically transformed to bring their distributions closer to normality.  
To examine the correlation between birth rate and BCa incidence, the underlying 
contributing factors of BCa risk and the determining role of birth rate in regional variation, 
the analysis proceeded in four steps:  
Pearson’s r and nonparametric correlations were used to evaluate the strength and 
direction of the correlation between all the variables.  
The independent relationships between BCa and each of the five independent variables 
are explored with partial correlation of Pearson’s moment-product approach while we 
controlled for the other four variables. This allows the identification of the strongest 
correlation and its independency.  
Standard multiple linear regression (enter) was performed to describe the relationships 
between the outcome variable and the explanatory variables. In order to highlight that 
birth rate is the major population-level contributor to BCa incidence, standard multiple 
linear regression (enter) was also conducted to calculate the correlation between BCa 
incidence and the risk factors when birth rate is included and excluded respectively.    
The equation of the best fitting trendline (polynomial) displayed in the scatter plots 
analysis of relationship between birth rate and BCa incidence was used to calculate and 
remove the contributing effect of birth rate on BCa incidence rate, which allowed the 
creation of a new dependent variable, “Residual of BCa standardised on birth rate”. 
Means of the BCa incidence rate and the “Residuals of BCa standardised on birth rate” 
of all the countries were calculated for mean difference comparison. Countries were 
categorized as per the UN common practice of defining more developed and developing 
countries and WHO regions for investigating the regional variations based on mean 
difference.  
Independent Samples T-test was conducted to compare the means of the two BCa 
incidence variables of the pairs of UN country groupings. Post hoc Scheffe (Oneway 
ANOVA) testing was performed to compare difference of multiple means between six 
WHO regions.  
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Scatter plots and calculation of means were performed in Excel® (Microsoft 2016). 
Pearson and partial correlations, multiple linear regression analysis, Independent 
Samples T-test and Post hoc Scheffe for mean comparison were conducted using SPSS 
v. 22 (SPSS Inc., Chicago Il USA). The original data was used for scatter plots and mean 
calculation of BCa incidence rate and “Residual of BCa standardised on birth rate”. To 
increase homoscedasticity of data distributions log transformed variables were used for 
correlation analyses. The significance was kept at the 0.05 level, but 0.01 and 0.001 
levels are also reported. Standard multiple linear regression analysis criteria were set at 
probability of F to enter ≤ 0.05 and probability of F to remove ≥ 0.10.  
Results  
Figure 1 shows that the relationship between the birth rate and BCa incidence rate is 
polynomial with a strong negative correlation (R2=0.5024).  
Figure 1. The relationship between birth rate and breast cancer incidence rate 
 
The non-linear relationship between birth rate and BCa incidence variables identified in 
the scatterplots shows the strong correlation between birth rate and BCa incidence. This 
relationship was confirmed by the subsequent analyses of log-transformed data and in 
nonparametric analysis.  
Worldwide, birth rate was significantly correlated to BCa incidence (r=-0.680 and rho= -
0.723, p<0.001 respectively in Pearson and non-parametric analyses) (Table 1).  
Table 1 showed that not only birth rate, but also GDP, urbanization, overweight 
prevalence and ageing correlate significantly to BCa incidence rates in both Pearson and 
non-parametric analyses.  
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There was a strong and highly significant correlation between GDP and birth rate (r=-
0.760 and rho= -0.797, p<0.001 respectively in Pearson and non-parametric analysis).  
Table 1:  Pearson r (above the diagonal) and nonparametric (below the diagonal) correlation 
between all variables 
 
The relationship between dependent variable (BCa) and each independent variable 
(birth rate, GDP, urbanization, overweight and ageing) was examined by controlling for 
the other four variables in a partial correlation analysis. Birth rate was the only the 
independent variable to have a strong and significant correlation (r= -0.330, p< 0.001) 
with BCa independent of the other four variables (Table 2). None of the other four 
variables (GDP, urbanization, overweight and ageing) showed a correlation with BCa 
incidence independent of the other four variables despite the fact that each of them (GDP, 
urbanization, overweight and ageing) had a strong significant correlation to BCa 
incidence in Pearson r and non-parametric correlation analysis. This suggests that birth 
rate is the independent determinant of the secondary association between BCa 
incidence and environmental factors.    
 Birth rate  
Breast 
Cancer  GDP  Urbanization  Overweight  Ageing  
Birth rate  1 -0.680*** -0.760*** -0.557*** -0.397*** -0.753*** 
Breast Cancer  -0.723*** 1 0.639*** 0.474*** 0.394*** 0.611*** 
GDP  -0.797*** 0.694*** 1 0.702*** 0.581*** 0.766*** 
Urbanization  -0.619*** 0.551*** -0.764*** 1 0.482*** 0.618*** 
Overweight   -0.401*** 0.385*** 0.519*** 0.475*** 1 0.414*** 
Ageing  -0.784*** 0.649*** 0.775*** 0.676*** -0.392*** 1 
The table describes the bivariate correlation between all the variables. *** p<0.001; Country number: 171-
179.   
Breast cancer incidence rate is from the International Agency for Research on Cancer. Birth rate, GDP 
and urbanization are from the World Bank. Ageing expressed as life expectancy (e50) is from the United 
Nations. Overweight prevalence is the World Health Organization.  
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Table 2 Comparison of partial correlation coefficients between breast cancer incidence and each variable when the other four variables are kept constant 
  
Variables 
Birth rate  GDP  Urbanization  Overweight  Ageing 
r p df  r p df  r p df  r p df  r p df 
Birth rate -0.330 <0.001 162  - - -  - - -  - - -  - - - 
GDP  - - -  0.129 0.099 162  - - -  - - -  - - - 
Urbanization  - - -  - - -  0.001 0.994 162  - - -  - - - 
Overweight - - -  - - -  - - -  0.077 0.327 162  - - - 
Ageing  - - -  - - -  - - -  - - -  0.103 0.187 162 
The table describes the partial correlation between breast cancer incidence between each variable while the other four variables are controlled for. - Controlled variable  
Breast cancer incidence rate is from the International Agency for Research on Cancer. Birth rate, GDP and urbanization are from the World Bank. Ageing expressed as life 




Standard multiple linear regression (enter) analysis was applied to further predict BCa 
incidence when birth rate, GDP, urbanization, overweight and ageing were used as the 
independent variables.  
When birth rate is excluded as one of the independent variables, GDP (β=0.401, p<0.001) 
and ageing (β=0.300, p<0.001) are the two significant predictors of BCa incidence. 
However, when birth rate was included as an independent variable, the correlations 
between BCa incidence and both GDP and ageing become very weak and no longer 
reach statistical significance (Table 3). This supports our previous suggestion that birth 
rate is the principal and independent determinant of BCa incidence in partial correlation 
analysis.  
Table 3 Independent predictors of breast cancer incidence rate based on multiple linear 
regression modelling   
Variable β Std. Error Sig.  β Std. Error Sig. 
Birth rate - 
- -  -0.460 0.106 <0.001 
GDP 0.401 0.050 <0.001 
 0.193 0.051 0.083 
Urbanization -0.015 0.093 0.856 
 -0.008 0.086 0.916 
Overweight 0.038 0.111 0.605 
 0.048 0.104 0.480 
Ageing 0.300 0.369 <0.001  0.102 0.380 0.285 
The table describes the multiple linear regression analysis results including and excluding birth rate as a predictor 
of breast cancer. df = 167; - excluded variable 
Breast cancer incidence rate is from the International Agency for Research on Cancer. Birth rate, GDP and 
urbanization are from the World Bank. Ageing expressed as life expectancy (e50) is from the United Nations. 




Table 4 shows that the mean BCa incidence rate was lowest in South-East Asia (26.31) 
and highest in Europe (63.60). The means of BCa in the other four regions are Africa 
(26.99), Eastern Mediterranean (40.77), Western Pacific (43.03) and Americas (46.98). 
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A post hoc Scheffe analysis conducted on the multiple mean comparisons revealed that 
there were a number of significant mean differences in BCa incidence rates between 
different WHO regions (Table 4). Mean of BCa incidence in Africa was significantly lower 
than that in Americas, Europe and Western Pacific. Mean of BCa incidence in the 
Americas was significantly lower than that in Europe and Western Pacific. Mean of BCa 
incidence in Eastern Mediterranean was significantly lower than that in Europe. The 
mean BCa incidence in South-Eastern Asia was significantly lower than that in Americas, 
Europe and Western Pacific. Whilst the mean BCa incidence in Western Pacific was 
significantly lower than that in Europe.  
A subsequent ANOVA with post hoc Scheffe procedure performed on the means of 
“Residual of BCa standardised on birth rate” in different WHO regions showed no 
significant differences among and between regions (Table 4). 
Interestingly, mean BCa incidence in the developed regions was significantly greater 
than that in the developing regions (mean difference=9.75, p<0.001). However, the 
difference between the means of the “Residual of BCa standardised on birth rate” in the 
developed region and developing region is weak and does not reach statistical 
significance (Table 4).  
The results from post hoc Scheffe tests conducted on mean comparison between the 
WHO regions suggest that regional variations of BCa incidence may only reach 
statistically significant levels if the contribution of their respective birth rates is included. 
In other words, except for birth rate, the contribution of the other BCa predicting factors 
to BCa incidence may not be sufficient for the difference in mean rates to reach 
significance. This result is supported by the findings identified in our previous partial 
correlation (Table 2) and multiple linear regression (Table 3) that birth rate is the critical 






Discussion   
The worldwide trend of increased BCa incidence may have multiple aetiologies, which 
may act through multiple mechanisms. Our ecological analysis suggests that birth rate 
may be a determining factor of BCa incidence at the population level. This study also 
reveals that the effect of birth rate on BCa incidence is independent of the effects of 
socio-economic factors, urbanization, overweight and ageing.  
The results of this study show that, a country with greater birth rate may have lower BCa 
incidence. This supports the observation from previous studies that higher parity is 
associated with a decreased risk of BCa based on observational approaches. This study 
used the ecological approach, which has an advantage over the observational studies in 
terms of obtaining more variables [26] for data analysis. For instance, we were able to 
use 5 variables, which allowed us to control for four variables, including the socio-
economic factor (GDP), which has been used by the WHO to interpret the regional 
variations of BCa incidence [23].  
The prevalent interpretation that greater birth rate protects against female BCa [26] is 
that the interruption in the normal menstrual cycle during pregnancy and subsequent 
breast feeding is associated with an interruption in the normal cyclical production of 
oestrogen [27], but an increase in oxytocin [28]. The public have been extensively 
educated for decades that oestrogen contributes to BCa as it fuels the growth of most 
breast cancer tumours [18].  
Oxytocin, produced during pregnancy, delivery and breastfeeding, may have a role in 
the control of mammary cell growth [29] and inhibiting proliferation of human BCa cells, 
which may offer BCa prevention and treatment [30]. These findings have driven a 
hypothesis that oxytocin may have therapeutic effects on cancer [28]. Similarly, Misra et 
al. (2012) reported that females with greater parity may reduce their long-term BCa risk 
because of multiple hormones released during pregnancy that generate genetic changes 
in the mammary glands which decrease BCa risk in mature breast cells [31]. 
The WHO and its agent the IARC have endorsed the paradigm that BCa incidence is 
lower in less-developed countries but greater in the more-developed countries and this 
has been widely cited in a large body of literature to describe regional variations of BCa 
incidence [1]. This may lead to the impression that that GDP is the main risk factor of 
BCa. However, this paradigm is not supported by the results of the three statistical 
analyses in this study. Firstly, birth rate, other than GDP, is the only predicting factor 
which is correlated to BCa incidence independent of all the other four confounders in 
partial correlation analysis. Secondly, in this study, once the effects of birth rate are 
considered in multiple linear correlation analysis, the correlation between BCa incidence 
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and GDP and other variables disappears. Finally, it is the contribution of birth rate instead 
of GDP that accounts for the statistically significant regional variations.  
In this study, birth rate was the principal determining predictor of BCa incidence and it 
may explain the correlation between GDP and BCa incidence. GDP shows a significant 
and strong correlation to birth rate in both Pearson r and non-parametric correlation 
analysis. This relationship is consistent with the theory of the demographic transition 
which proposed that a country or region may transition from high birth to lower birth rate 
when it is transforming to an industrialized economic system [32].  
There are several caveats, including the one conceptualized as the ecological fallacy 
[33], to this study.  
Firstly, each country is considered as a subject in this study. The country-specific data 
included in this study were aggregated, different from data collected from individual 
patients. Therefore, values for risk-modifying factors may not hold true for individuals to 
develop BCa.  
Secondly, data aggregated and/or collected by the UN and its agencies (WHO, IARC 
and the World Bank) may include some random errors arising from methods of reporting 
incidence of BCa, reliability of diagnoses and possible administrative errors. For instance, 
data quality of the BCa incidence depends upon the quality and on the amount of the 
information available for each country. In general, data from developing countries are 
less complete than those from developed countries.   
Finally, there are around 20 sub-types of BCa, such as ductal carcinomas and lobular 
carcinomas. This study only focuses on the hormone receptor-positive BCa. Recently, 
scientists at Boston University found that high parity was associated with an increased 
estrogen and progesterone receptor negative (ER-/PR-) BCa [34]. This suggests that 
high parity has dual effect on BCa, which our data analysis may not be able to explain.    
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Contexture Statement  
Ovarian cancer (OC56) has multiple aetiologies which may act through different risk 
factors, such as ageing, GDP, obesity, low parity, reduced natural selection and 
urbanization.  
This study compared the contributing effects of ageing, GDP, obesity, low parity, reduced 
natural selection and urbanization on OC56, and we identified that low birth rate may be 
a significant determinant of OC56.  
More oestrogen production due to less childbearing has been linked to high risk of OC56. 
This may be a suggestion to health research authority for prioritizing the studies on how 
to reduce ovulation rates for those females who do not want to have children or do not 






Abstract   
Background: Ageing, GDP, obesity, fertility, reduced natural selection (measured by Ibs) 
and urbanization have been postulated as the risk factors of ovarian cancer (OC56). We 
sought to identify which factor plays the most significant role in predicting OC56 
incidence rate worldwide.   
Methods: Bivariate correlation was performed to assess the correlations between 
country-specific estimates of ageing (measured by life expectancy), GDP PPP, obesity 
prevalence, fertility (indexed by birth rate), Ibs and urbanization. Partial correlation was 
used to compare variables and identify that fertility was the only variable strongly 
correlated to OC56 independent of the other five variables. Fisher A-to-Z was used to 
compare the correlation coefficients. Multiple linear regression (Enter and Stepwise) was 
conducted to identify significant determinants of OC56 incidence. Post hoc Bonferroni 
analysis was performed to compare mean differences between the means of OC56 
incidence rate and residuals of OC56 standardised on fertility and GDP respectively 
between the six WHO regions.  
Results: Bivariate analyses revealed that OC56 was significantly and strongly correlated 
to ageing, GDP, obesity, fertility, Ibs and urbanization. However, partial correlation 
analysis only identified that fertility and ageing were the two variables that had significant 
and strong correlation to OC56 incidence when the other five variables are kept 
statistically constant, but Fisher A-to-z revealed that fertility correlated to OC56 
significantly stronger than ageing. Both Enter and Stepwise regression analyses 
indicated that fertility was the only significant variable predicting OC56 risk. Post hoc 
Bonferroni analysis showed that, between the six WHO regions, multiple mean 
differences of OC56 incidence were significant, but all disappeared when the contributing 
effect of fertility on OC56 incidence rate was removed.  
Conclusions: Low fertility may be the significant determinant of OC56 incidence 
increase worldwide. The health research authorities need to prioritize the studies into 
reducing the number of ovulation cycles for protecting those females who choose to be 
nulliparous or not to have more children from developing OC56.  
Keywords: Ovarian cancer, Fertility, Oxytocin, Significant predictor, Psychological well-
being 
Introduction 
Ovarian Cancer (OC56) [1] has been a leading cause of cancer incidence and mortality 
globally. It ranks among the top ten diagnosed cancers and top five deadliest cancers in 
most countries [2, 3]. In 2015, OC56 was present in 1.2 million women and resulted in 
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161,100 deaths worldwide [4]. In the 21st century, a woman’s overall lifetime risk of 
developing OC is around 1.6% [5,2, 6], and her chance of dying of the disease is 1 in 
100 [2, 6]. 
Although OC56 has been known to scientists for over 150 years [7], the etiology of this 
lethal disease is not well understood. Traditionally, the majority of researches into OC56 
has focused directly on the carcinogenic factors, such as talc, pesticides, red meat and 
alcohol in diet, smoking, and herbicides. However, to date, none of these factors has 
been consistently considered as the real risk factor of OC56 [8] due to circumstantial 
study designs and controversial conclusions.    
In the past decades, alternative hypotheses have also been explored. Various studies 
postulated that, overall, obese women (those with a body mass index of at least 30) may 
have a higher risk of developing OC56 because their rising levels of estrogen circulation 
[9-11]. Increased age has been considered as a risk factor for OC56 because more 
mutations in cells can accumulate and eventually cause OC56 [9]. Urbanization may 
have improved public hygiene, sanitation and access to health care for females [12], but 
it has been associated with public health issues, including OC56 [13] due to the changes 
in occupational, dietary and exercise patterns in females [12]. Dietary factors, such as 
alcohol consumption [6] and low level of Vitamin D [14], and lifestyles, such as physical 
activities [6] and smoking [15] are also associated with OC56, but so far the available 
results are not conclusive [6].     
Recently, the researchers from the University of Adelaide have conducted a number of 
studies of the role of the relaxed natural selection (measured by Biological State Index, 
Ibs) in accumulating the deleterious genes/mutations of non-communicable diseases, 
including cancers [16], Type 1 diabetes [17] and obesity [18]. Conclusions from these 
studies indicate that reduced natural selection may be an important contributor of 
increasing OC56 incidence globally [16].  
An in-depth internet and literature search was conducted for associations between 
fertility and female behaviours. It has turned out that the OC56 risk increases in women 
who have ovulated more over their lifetime due to infertility and less fertility as they may 
produce more oestrogen which increases the OC56 risk [6, 19-21], but less oxytocin, 
which has been associated with less OC56 risk [22, 23]. Therefore, studies have shown 
that fertility may outscore the importance of other reproduction related factors [24-26].  
To the best of our knowledge, despite that fertility is a well-established risk factor of OC56, 
no research has compared the contributing effects of fertility on CO56 with other OC56 
risk factors, such as ageing, Ibs (index of magnitude of OC56 gene accumulation in 
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human population), obesity and socioeconomic factors (GDP and urbanization) 
respectively.  
Globally, OC56 incidence presents significant variations in different geographic regions 
[2, 3, 27-29]. This phenomenon has also been observed in different populations [6, 13] 
within the same countries [30, 31]. A number of publications suggest that the disparity 
between regions and populations has been associated with socioeconomic level. Some 
of these studies were published in the reputable journals by the International Agency for 
Research on Cancer (IARC), the specialized cancer agency of World Health 
Organization (WHO). Therefore, the empirical findings in those publications may have 
easily intrigued the professionals and laypeople. Females in the developed 
regions/nations may wonder why their wealth makes them exposed to high risk of 
developing OC56? 
In this study, we drew on the empirical and macro-level data to test the hypotheses that 
fertility (measured by birth rate) is the significant determinant of OC56, and that it is 
fertility, instead of GDP, that is most important factor in shaping the regional variation of 
OC56 incidence rate. 
Materials and Methods  
The country specific data published by the agencies of the United Nations were collected 
for this study.   
1. The GLOBOCAN 2012 estimates of incidence rate of female OC56 [28]  
GLOBOCAN provides contemporary population level estimates by cancer site and sex 
[2].  This project is conducted by the WHO cancer research agency, the International 
Agency for Research on Cancer (IARC). 
OC56 incidence rate is expressed as the number per 100,000 females who were 
diagnosed with OC56 in 2012. The age-standardized OC56 incidence rate was selected 
in the interest of the data comparability between countries.  
2. The World Bank published data [32] on birth rate, per capita GDP PPP and 
urbanization  
Crude birth rate indicates the number of live births occurring during the year, per 1,000 
population estimated at midyear. Crude birth rate (CBR) was used to index the fertility in 
this study, and it is backdated 20 years (1992) to reflect long exposure with delayed 
presentation of OC56.   
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Socio-economic level has been associated with OC56 risk [33] [2, 28, 34]. We chose per 
capita GDP purchasing power fertility (GDP PPP in 2012 international $) because it takes 
into account the relative cost of local goods, services and inflation rates of the country.  
Urbanization has been postulated as a major OC56 predictor [35, 36] because it 
represents the major demographic shift entailing lifestyle changes [12, 37, 38]. 
Urbanization is expressed with the country-specific percentage of total population living 
in urban areas in 2012.  
3. The United Nations Statistics Division estimates of the life expectancy [39]   
The country-specific life expectancy, which indexes the ageing, has been well 
established as the attributable factor to OC56 [40] [41]. Therefore, we selected life 
expectancy (e65, 2005-2010) [39] to index the ageing process at population level.  
4. The magnitude of OC56 gene accumulation in a population indexed with the Biological 
State Index (Ibs)  
Country specific Ibs was downloaded from the previous publication [18]. It has been 
postulated that reduced natural selection (measured by Ibs) may have accumulated the 
deleterious genes of non-communicable diseases such as cancers [16], Type 1 diabetes 
[17] and obesity [18] at population level.  
5. The WHO Global Health Observatory (GHO) data on obesity prevalence  
Obese females may pose more risk to OC56 than those who are not obese [42]. The 
country-specific percentage of the females aged 18+ with a BMI ≥ 30 kg/m2 in 2010 was 
extracted from the GHO data repository [43].  
Data Selection  
We collected country specific OC56 incidence rates, ageing, fertility, GDP, Ibs, obesity 
and urbanization for all countries where data were available. We extracted OC56 
incidence rates for 182 countries and then the other variables were matched individually 
with OC56.  
Each country is treated as an individual study subject in the data analysis. Not all the 
countries (subjects) have all the information for all the variables. The numbers of 
countries(subjects) included for analysing the correlations to other variables may differ 
as such.    
The relevant United Nations agencies offer free online access to data required for the 
analyses in this study. There are no individual patients involved in the study. Therefore, 
there is no need to obtain the ethical approval or consent during our entire study process.  
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Data multicollinearity check 
In order to avoid the inter-correlation between predictor variables, the multicollinearity 
statistics were calculated to test the correlations among the variables. Each variable was 
alternated as the dependent variable, and all the others were considered as the predictor 
variables in our analysis with the regression model. It turned out that collinearities 
between variables are insignificant since the tolerance of less than 0.20 and a VIF of 
more than 5 indicates a multicollinearity problem [44]. Details see the Additional File, AF 
1 Collinearity among the variables. 
Data analysis 
To assess the population level determinants of OC56, the analysis proceeded in five 
steps. 
1. Scatter plots were produced with the original data in Microsoft Excel® to explore and visualize 
the strength, shape and direction of correlations of OC56 to fertility and GDP respectively. 
2. Bivariate (Pearson’s r and nonparametric) correlations were performed to evaluate the 
direction and strength of the correlations between all the variables of all the subjects.  
3. Partial correlation of Pearson’s moment-product approach was performed to identify 
the strongest correlation and its independency. We alternated each of the six variables 
(ageing, fertility, GDP, Ibs, obesity and urbanization) as the independent predictor when 
all the five variables were included as the potential confounding factors.  
Fisher’s r-to-z transformation was conducted to assess the significance level of 
difference between correlation coefficients.  
4. Standard multiple linear regression (Enter) was performed to describe the correlations 
between the dependent variable (fertility) and the predicting variables. In order to explore 
if low fertility can partially explain why ageing, GDP, Ibs, obesity and urbanization are 
correlated with OC56, the enter multiple linear regression was performed to calculate the 
correlations between OC56 incidence and the risk factors when fertility was incorporated 
and excluded as a predicting variable respectively.  
Subsequently, standard multiple linear regression (Stepwise) was performed to select 
the predicting variable(s) which have the greatest influence on OC56 when fertility was 
incorporated and excluded as a predicting variable respectively.     
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5. The equations of the best fitting trendlines displayed in the scatter plots analysis of 
relationships between OC56 incidence and fertility (y = 0.006x2 - 0.504x + 14.816, R² = 
0.485) and GDP PPP (y = 0.7167x + 0.2225, R² = 0.2571) were used to calculate and 
remove the contributing effects of fertility and GDP PPP on OC56 incidence rate 
respectively. This allowed us to create of two new dependent variables, “Residual of 
OC56 standardised on fertility” and “Residual of OC56 standardised on GDP PPP”.  
Means of the OC56 incidence rate, the “Residuals of OC56 standardised on fertility” and 
“Residual of OC56 standardised on GDP PPP” of all the countries were calculated for 
mean difference comparison. 
Analysis of variance (ANOVA) was conducted to detect the significant differences among 
the means of OC56 incidence rate, “Residual of OC56 standardised on fertility” and 
“Residual of OC56 standardised on GDP PPP” between the six WHO regions [45]. 
Further post-hoc (Bonferroni) tests were performed to identify the source of the 
significant difference and to compare the magnitude of the difference.  
Bivariate correlations, multiple linear regression analysis (Enter and Stepwise) and 
ANOVA post hoc (Bonferroni) for mean calculation and comparison were conducted with 
SPSS v. 24. The raw data were used for mean calculation of OC56 incidence rate and 
“Residual of OC56 standardised on fertility” and “Residual of OC56 standardised on GDP 
PPP”. The variables were log transformed to increase homoscedasticity for the 
correlation analyses. The significance was kept at the 0.05 level, but 0.01 and 0.001 
levels were also reported. Standard multiple linear regression analysis criteria were set 
at probability of F to enter ≤ 0.05 and probability of F to remove ≥ 0.10.  
Results  
The relationship identified in the scatterplots between fertility and OC56 was noted to be 







Figure 1. The relationship between parity and ovarian cancer incidence rate 
 
 
                                               Parity indexed by birth rate (per 1,000) 
 
The strong relationship between fertility and OC56 identified in the scatterplots was 
confirmed by the subsequent Pearson r nonparametric analyses based on the log-
transformed data.  
Globally, fertility was significantly, but inversely correlated to OC56 incidence (r=-0.632 
and rho= -0.655, p<0.001 respectively in Pearson and non-parametric analyses) (Table 
1).  
It is also revealed that ageing, GDP, Ibs, obesity and urbanization were also in strong and 
significant correlations to OC56 incidence in both Pearson and non-parametric analyses 





Table 1: Pearson r (above the diagonal) and nonparametric (below the diagonal) correlation 
between all variables 
 
The relationship between OC56 and each independent variable (ageing, fertility, GDP, 
Ibs, obesity and urbanization) was tested by keeping the other five variables statistically 
constant in partial correlation analysis. Fertility was the only predictor showing a 
significant correlation (r= -0.448, p< 0.001) with OC56 independent of the other five 
variables (Table 2). Ageing showed significant, but weak correlation to OC56 (r= -0.178, 
p<0.05). The Fisher r-to-z transformation revealed that fertility correlated to OC56 
significantly stronger than ageing (z=2.68, p<0.01). GDP, Ibs, obesity and urbanization 
showed the strong and significant correlation to OC56 in the bivariate correlation 
analyses respectively. However, none of them presented a strong or significant 
correlation with OC56 independent of the other five predictors. This indicates that fertility 
is the only strong and significant predictor of OC56 independent of the secondary 
association between OC56 incidence and Ibs (magnitude of OC56 accumulation) and 
environmental factors (ageing, fertility, GDP, obesity and urbanization).    
 OC56 Ageing  
Birth 
rate GDP Ibs Obesity Urbanization 
OC56 1 0.394
*** -0.632*** 0.507*** 0.455*** 0.189* 0.280*** 
Ageing 0.428




-0.769*** 1 -0.772*** -0.712*** -0.338*** -0.557*** 
GDP PPP 0.531
*** 0.759*** -0.813*** 1 0.742** 0.485*** 0.713*** 
Ibs  0.602
*** 0.849*** -0.883*** 0.858*** 1 0.457*** 0.551*** 
Obesity 0.169
* 0.350*** -0.377*** 0.453*** 0.409*** 1 0.484*** 
Urbanization 0.345
*** 0.657*** -0.628*** 0.781*** 0.711*** 0.506*** 1 
The table describes the bivariate correlation between all the variables. *** p<0.001; Country number: 
167-182.   
Ovary cancer (OC56) incidence rate is from the International Agency for Research on Cancer. Birth rate 
indexing parity, GDP PPP and urbanization are from the World Bank. Ageing expressed as life 
expectancy (e65) is from the United Nations. Obesity prevalence is the World Health Organization.  
Biological State Index (Ibs) is downloaded from previous publication which were calculated with the data 
of the world fertility and life tables.      
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Table 2 Comparison of partial correlation coefficients between ovary cancer incidence and each variable when the other five variables are controlled for   
  
Variables 
Fertility  Ageing  GDP  Ibs   Obesity   Urbanization 
r P df  R p df  r p df  r p df  r p df  r p df 
Fertility -0.448 <0.001 160  - - -  - - -  - - -  - - -  - - - 
Ageing - - -  -0.178 0.02
3 
160  - - -  - - -  - - -  - - - 
GDP  - - -  - - -  0.14
8 
0.060 160  - - -  - - -  - - - 
Ibs - - -  - - -  - - -  0.079 0.315 160  - - -  - - - 
Obesity - - -  - - -  - - -  - - -  -0.048 0.544 160  - - - 
Urbanizatio
n 
- - -  - - -  - - -  - - -  - - -  -0.131 0.09
5 
160 
The table describes the partial correlation between Ovary cancer (OC56) incidence between each variable while the other four variables are controlled for. - Controlled variable  
Ovary cancer (OC56) incidence rate is from the International Agency for Research on Cancer. Fertility indexed by birth rate, GDP PPP and urbanization are from the World Bank. Ageing 
expressed as life expectancy (e65) is from the United Nations. Obesity prevalence is the World Health Organization.  





Standard multiple linear regression (enter) analysis was applied to further predict OC61 
incidence when ageing, parity, GDP, obesity and urbanization were included as the 
independent predicting variables.  
When fertility was excluded as one of the independent variables, GDP PPP (β=0.471, 
p<0.001) and Ibs (β=0.250, p<0.05) were the two significant variables of OC61 incidence. 
However, when fertility was included as an independent predictor, only the correlation 
between fertility and OC61 incidence was strong and significant. None of the other five 
predictors showed strong and significant correlation to OC56 (Table 3). Similarly, in a 
stepwise linear regression model, when fertility was not included as one of the 
independent predictors, GDP and Ibs were selected as the most influential variables on 
OC56. However, when fertility was included together with the other five independent 
variables, only fertility was selected as the most influential predictor of OC56 with the R2 
increase from 0.278 to 0.434. This suggested that GDP and Ibs did not appear to account 
for the major part of the impact of OC56 incidence. This finding supports our previous 
suggestion that fertility is the significant predictor of OC56 incidence in partial correlation 
analysis.  
Table 3 Independent predictors of ovarian cancer incidence rate based on multiple linear 
regression modelling   
Variable  β Std. Error Sig.  β Std. Error Sig. 
Fertility - - -  -0.694 0.111 <0.001 
Ageing -0.037 0.341 0.752  -0.207 0.309 0.052 
GDP 0.471 0.055 <0.001 
 0.163 0.052 0.174 
Ibs 0.250 0.658 0.032 
 0.100 0.589 0.342 
Overweight -0.056 0.069 0.496 
 -0.020 0.060 0.778 
Urbanization  -0.122 0.105 0.211 
 -0.125 0.092 0.146 
The table describes the multiple linear regression analysis (Enter) results including and excluding birth rate as a 
predictor of breast cancer. df = 164; - excluded variable  
Ovary cancer (OC56) incidence rate is from the International Agency for Research on Cancer. Fertility indexed by 
birth rate, GDP PPP and urbanization are from the World Bank. Ageing expressed as life expectancy (e65) is from 
the United Nations. Obesity prevalence is the World Health Organization.  
Biological State Index (Ibs) is downloaded from previous publication which were calculated with the data of the world 




Table 4 showed that the mean OC56 incidence rate was lowest in Africa (4.19) and 
highest in Europe (8.70). The means of OC56 in the other four regions are Americas 
(5.89), Eastern Mediterranean (5.19), South East Asia (5.90) and Western Pacific (6.63). 
A post hoc Bonferroni analysis conducted on the multiple mean comparisons revealed 
that there were a number of significant mean differences in OC56 incidence rates 
between different WHO regions (Table 4). Mean of OC56 incidence in Europe was 
significantly greater than in Africa, Americas, East Mediterranean, South East Asia and 
West Pacific. Mean of OC56 in Americas was significantly greater than in Africa. The 
regions with greater means of fertility had lower means of OC56 incidence rates (r=0.985, 
p<0.001, n=6).    
A subsequent ANOVA with post hoc Bonferroni procedure performed on the means of 
“Residual of OC56 standardised on fertility” in different WHO regions showed there was 
no significant difference among and between regions (Table 4). Whilst the same 
procedure was performed on the means of “Residual of OC56 standardised on GDP 
PPP”, the developed region, Europe still had the significantly higher “Residual of OC56 
standardised on GDP PPP” than Africa, Americas and East Mediterranean (Table 4). 
The results from the post hoc Bonferroni tests conducted on mean comparisons between 
the WHO regions suggested that regional variations of OC56 incidence may only reach 
statistically significant levels if the contributing effect of their respective fertility was 
included. In other words, except for fertility, the total contribution of the other OC56 risk 
factors to OC56 incidence may not be sufficient for the difference in mean rates to reach 
significance level. This result was supported by the findings identified in our previous 
partial correlation (Table 2) and multiple linear regression (Table 3) that fertility is the 
critical risk factor of OC56.     
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Table 4 Comparison of mean difference of fertility, Residuals of OC56 standardised on fertility and GDP PPP respectively between WHO regions  
OC56 incidence rate  Residual of OC56 standardised on fertility  Residual of OC56 standardised on GDP 
I 
n 



















 AM -1.70*  AF  
n=45  
Mean= -0.29 




 EM -0.99  EM -0.29  EM 1.03 
 EU -4.50***  EU -0.30  EU -2.15*** 
 SEA -1.71  SEA -0.67  SEA -1.02 













 EM 0.70  EM -0.13  EM 1.06 
 EU -2.81***  EU -0.15  EU -2.12** 
 SEA -0.01  SEA -0.52  SEA -0.99 













 AM -0.70  AM 0.13  AM -1.06 
 EU -3.51***  EU -0.01  EU -3.18*** 
 SEA -0.71  SEA -0.38  SEA -2.05 






 AF 4.50***  EU 
n=49  
Mean=0.14 




 AM 2.81***  AM 0.15  AM 2.12** 
 EM 3.51***  EM 0.01  EM 3.18*** 
 SEA 2.80*  SEA -0.37  SEA 1.13 




 AF 1.71  SEA  
n=11 
Mean= 0.38 




 AM 0.01  AM 0.52  AM 0.99 
 EM 0.71  EM 0.38  EM 2.05 
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OC56 incidence rate  Residual of OC56 standardised on fertility  Residual of OC56 standardised on GDP 
I 
n 
















  EU -2.80*  EU 0.37  EU -1.13 
 WP -0.73  WP -0.13  WP 0.04 
WP 
n= 22  
Mean=6.63 
 AF 2.44**  WP 
n=21  
Mean=-0.01 
AF 0.81  WP 
n= 19  
Mean=0.83 
AF 0.98 
 AM 0.74  AM 0.65  AM 0.95 
 EM 1.45  EM 0.52  EM 2.01 
 EU -2.06*  EU 0.50  EU -1.17 
 SEA 0.73  SEA 0.13  SEA -0.04 
The mean difference comparison results conducted with One-way ANOVA Post hoc Bonferroni are reported.  * p<0.05, ** p<0.01, *** p<0.001 
Ovary cancer (OC56) incidence rate is from the International Agency for Research on Cancer. Fertility indexed by birth rate, GDP PPP and 
urbanization are from the World Bank. Ageing expressed as life expectancy (e65) is from the United Nations. Obesity prevalence is the World 
Health Organization.  




Discussion   
The present ecological study suggests that:  
1. Low fertility, not only ageing, GDP, Ibs, obesity and urbanization, may be a significant 
determinant of OC56 incidence.  
2. The low fertility has a statistically significant effect on OC56 that is independent of the 
effect of ageing, GDP, Ibs, obesity and urbanization. 
3. Once the effects of low fertility are taken into account, the correlations between OC56 
and ageing, GDP, Ibs, obesity and urbanization statistically disappear, indicating that low 
fertility may be an explanation for why ageing, GDP, Ibs, obesity and urbanization have 
been correlated with OC56. 
4. Statistically, outscoring ageing, GDP, Ibs, obesity and urbanization, low fertility may be 
a significant risk factor of OC56.  
The relationship between female reproductive behaviour and gynecological cancers has 
been under research for over 300 years [25, 47]. In general, extensive studies of the 
strong protective effect on OC56 in Asian, African, American and European populations 
have concluded that nulliparous women may have a 30%-60% higher risk than parous 
women [48] [49] . Studies also reported that each additional full-term pregnancy lowers 
OC56 risk by approximately 15% [49] [50].   
Full-term pregnancy and the subsequent lactation cause anovulation and suppresses 
secretion of pituitary gonadotropins, which may make women produce less oestrogen or 
less menstrual cycles [51]. This formed the three prevailing hypotheses to explain the 
relationship between fertility and OC56 risk: 1) The incessant-ovulation hypothesis 
postulates that pregnancies reduce the number of times a woman ovulates in her life and 
thus the chance for mutation to occur during the repair of ruptured epithelial tissue is 
reduced [52] [53] [54]. 2) The inflammation hypothesis implicates that epithelial cells may 
be exposed to less chronic inflammation and mutation due to less ovulations [55]. 3) The 
pituitary/gonadotropin hypothesis considers pregnancy may prevent gonadotropins from 
being overstimulated, which may reduce the proliferation of malignant transformation in 
the inclusion cysts and clefts invaginated and formed in the ovarian epithelium [56].  
A self-reinforcing cycle may be formed between more and positive family member 
interactions and oxytocin production, which may protect female from OC56 initiation. 
Greater fertility not only provides the direct physiological protective effects from 
developing OC56, but also offers the heathy benefit to females as it protects females 
through reacting to positive psychological well-being. Oxytocin is a peptide hormone and 
neuropeptide. Its production is associated with good feelings and emotions [57]. Recent 
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studies have reported that oxytocin not only helps with birth, bonding with the baby, 
and milk production, but also inhibits the progression of human ovarian carcinoma cells 
[23, 24] and shows the therapeutic effects on other cancers [23]. Researches constantly 
reported that family related activities are the major promotors of oxytocin production. 
Bigger family size due to greater fertility may offer more positive psychological feeling 
through more daily interactions between family members [58, 59], such as spouses [60-
62], mother and children [63], and father and children [64]. Positive psychological feeling 
from greater family size may also be able to bond couples to keep monogamous [65, 66].  
Studies also reported that positive psychological well-being may make the functions of 
neuroendocrine and immune systems more efficient, which may also reduce the risk of 
developing OC56 [67-70].  
Family member from bigger family may be reminded and/or recommended more by other 
members to have necessary medical examination and have a healthy lifestyle [71]. A 
number of studies have shown that greater family size may decrease breast cancer cells, 
from initiating and proliferating [72-74].  
Our finding showed that fertility was negatively correlated to OC56 incidence significantly 
stronger than other factors (ageing, GDP, Ibs, obesity and urbanization). This may be 
because fertility affects OC56 risk from both physiological and psychological 
perspectives, but ageing, GDP, Ibs, obesity and urbanization may not be able to offer that 
much protection.    
The strength of this study is that it suggests that fertility is a significant determinant of 
OC56 risk, despite that we used a new approach to test the fertility has the protective 
role in female OC56 initiation at population level. This finding is in agreement with three 
studies conducted by Hankinson et al. [27], Vachon et al [26] and Cramer et al [48] 
respectively which concluded that, outscoring other risk factors, fertility is a significant 
predictor of OC56.   
Our study indicates that when the contributing effect of the fertility is not incorporated as 
the risk factor of OC56, the difference of regional variations of OC56 between the six 
WHO regions does not reach significant level. This supports our hypothesis that low 
fertility is a significant risk factor of OC56, but it does not support the WHO and IARC’s 
statement that OC56 incidence rate is associated with regions with different 
socioeconomic level [2, 29] [7]. Although GDP and fertility, the significant risk predictor 
of OC56, are highly correlated, it is still debated whether industrialization and higher 
incomes lead to lower fertility, or whether lower fertility leads to industrialization and 
higher incomes [77] [78] [79]. Interestingly, studies have shown that fertility increases 
when the socioeconomic development is beyond some level [77].  
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This study has several limitations: 1) Each country was considered as a whole subject 
for the ecological study. The country-specific data included in this study may be different 
from the data collected from individual participants. Therefore, the correlations identified 
from the data analysis may not hold true for all the individuals to have the risk in OC56 
development. 2) There may be some random errors when the United Nations and its 
agencies collected and aggregated data at country level. Data from developed countries 
may be more complete than those from developing countries. 4) There are different 
categories of OC56, but we could not differentiate them for the correlation analysis due 
to the unavailability of such data. 
Conclusion 
Low fertility may be a significant and strong determinant of OC56 risk independent of 
ageing, GDP, Ibs, obesity and urbanization. The effects of low fertility on predicting OC56 
are outscoring ageing, GDP, Ibs, obesity and urbanization. Our finding may be helpful for 
governments, policy-makers, funders and researchers to track and investigate the 
priorities of OC56 research when they allocate the funds and resources to meet the 
research priorities.  For example, while ageing, and socioeconomic factors (urbanization 
and GDP) and its associated factors (obesity and Ibs), and stable fertility (birth rate) 
worldwide cannot be modified, can the health authorities prioritize the research to reduce 
the number of ovulation cycles of females [27, 75,76]? Considering the main contributing 
effects of fertility on ovarian cancer have not been fully investigated, currently, can the 
studies of gynaecological cancers prioritize the improvement and diversification of those 
ovulation-inhibiting contraceptive approaches for females who choose to be nulliparous 
or not to have more children?      
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